[{"created_at":"2017-05-31T12:43:45.000Z","id":"869897183784468480","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/YYhbRNEg4a","expanded_url":"http://bit.ly/2smcvst","display_url":"bit.ly/2smcvst"},{"start":139,"end":162,"url":"https://t.co/pxP4XEVJJm","expanded_url":"https://twitter.com/EGGVPEurope/status/869897183784468480/photo/1","display_url":"pic.twitter.com/pxP4XEVJJm"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":28,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":107,"end":114,"tag":"brexit"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_869896868855255040"]},"source":"Twitter Web Client","text":"@EMA_News and @EU_Commission publish first set of guidance to help pharmaceutical companies to prepare for #brexit https://t.co/YYhbRNEg4a https://t.co/pxP4XEVJJm","conversation_id":"869897183784468480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"810844336376123392","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-31T05:11:37.000Z","id":"869783402236477440","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/UklbtFNk3m","expanded_url":"http://www.aifa.gov.it/content/ema-consultazione-pubblica-sul-progetto-di-linee-guida-la-notifica-delle-violazioni-gravi-de#.WS5QS3fmhuA.twitter","display_url":"aifa.gov.it/content/ema-co…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":115,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News progetto per la notifica delle violazioni gravi delle norme sulla sperimentazione clinica @Aifa_ufficiale https://t.co/UklbtFNk3m","conversation_id":"869783402236477440","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"450621858","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-30T12:45:29.000Z","id":"869535233980477440","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/pCqUOUIsQR","expanded_url":"http://www.healthparadigmchange.it","display_url":"healthparadigmchange.it"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Medical Science and Health Paradigm Change \nhttps://t.co/pCqUOUIsQR  \nAn historical Conference","conversation_id":"869535233980477440","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"50355768","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-30T06:48:38.000Z","id":"869445429699674112","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/9ckvEESEBF","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/05/news_detail_002743.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":110,"end":133,"url":"https://t.co/nzeh6aycfN","expanded_url":"https://twitter.com/Jordi_Falco/status/869445429699674112/photo/1","display_url":"pic.twitter.com/nzeh6aycfN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_869445381863743489"]},"source":"Twitter Web Client","text":"@EMA_News Progress on science, medicines and health. EMA 2016 annual report published https://t.co/9ckvEESEBF https://t.co/nzeh6aycfN","conversation_id":"869445429699674112","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-29T07:58:36.000Z","id":"869100648746414080","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/coFNgEXk86","expanded_url":"https://www.linkedin.com/pulse/us-eu-legislators-open-door-silico-trial-european-welcomes-marchal?trk=v-feed","display_url":"linkedin.com/pulse/us-eu-le…"},{"start":139,"end":162,"url":"https://t.co/dbTNVZWPzl","expanded_url":"https://twitter.com/novadiscovery/status/869100648746414080/photo/1","display_url":"pic.twitter.com/dbTNVZWPzl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":113,"username":"AvicennaAlly","id":"707843478307397633"}],"hashtags":[{"start":51,"end":60,"tag":"insilico"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_869100398367440896"]},"source":"Twitter Web Client","text":"@EMA_News Regulation Vote result – major gains for #insilico. \nThe European Parliament Welcomes the @AvicennaAlly  https://t.co/coFNgEXk86 https://t.co/dbTNVZWPzl","conversation_id":"869100648746414080","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"194113151","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-25T12:25:44.000Z","id":"867718325341696000","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/mUtZ0rzsIZ","expanded_url":"https://www.wsj.com/articles/doctor-who-battled-against-hysterectomy-procedure-dies-1495676064","display_url":"wsj.com/articles/docto…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":[{"start":53,"end":64,"probability":0.5604,"type":"Person","normalized_text":"Morcellators"},{"start":108,"end":115,"probability":0.4716,"type":"Person","normalized_text":"Amy Reed"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @EU_Commission J&amp;J did worldwide recall of Morcellators but told HPRA Irish ones r safe?R.i.P. Dr Amy Reed\nhttps://t.co/mUtZ0rzsIZ","conversation_id":"867718325341696000","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3401365311","in_reply_to_user_id":"116716199","geo":{"place_id":"7dde0febc9ef245b"},"referenced_tweets":{}},{"created_at":"2017-05-25T08:13:00.000Z","id":"867654721057820676","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News How are you doing? You've known about a increased suicide risk in adults on SSRIs for years but remained silent. First class.","conversation_id":"867654223378382848","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"867654223378382848"}]},{"created_at":"2017-05-24T15:31:42.000Z","id":"867402735087480832","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/UnDszdQ2gD","expanded_url":"http://bit.ly/2qOIW4S","display_url":"bit.ly/2qOIW4S"},{"start":162,"end":185,"url":"https://t.co/dLXfQYa11j","expanded_url":"https://twitter.com/sanoysalvoblog/status/867402735087480832/photo/1","display_url":"pic.twitter.com/dLXfQYa11j"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":79,"end":92,"tag":"antibióticos"}],"annotations":[{"start":129,"end":134,"probability":0.8917,"type":"Place","normalized_text":"España"}],"cashtags":{}},"attachments":{"media_keys":["3_867402249223405573"]},"source":"Twitter Web Client","text":"@EMA_News @EU_Health Informe sobre importancia de recoger datos del consumo de #antibióticos en animales https://t.co/UnDszdQ2gD España, de países UE con más uso https://t.co/dLXfQYa11j","conversation_id":"867400500748189696","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"216527950","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"867400500748189696"}]},{"created_at":"2017-05-23T15:01:30.000Z","id":"867032746077679616","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/djQCNArI6G","expanded_url":"http://ow.ly/I26a30bRLFv","display_url":"ow.ly/I26a30bRLFv"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News released its 2016 Annual Report. Read more. https://t.co/djQCNArI6G","conversation_id":"867032746077679616","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-22T00:22:16.000Z","id":"866449096026017792","entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/qw6ViO0EXY","expanded_url":"http://bit.ly/2r0pu6f","display_url":"bit.ly/2r0pu6f"},{"start":111,"end":134,"url":"https://t.co/mu5t5WAVjz","expanded_url":"http://bit.ly/2qMgP4C","display_url":"bit.ly/2qMgP4C"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":51,"tag":"vaccines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Please be critical of IT law on #vaccines vs. human rights https://t.co/qw6ViO0EXY the best approach https://t.co/mu5t5WAVjz","conversation_id":"866449096026017792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"375370966","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-19T12:30:40.000Z","id":"865545238747545601","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":88,"end":97,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":57,"end":63,"tag":"brand"}],"annotations":[{"start":25,"end":31,"probability":0.9904,"type":"Place","normalized_text":"Germany"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News The company is Germany's CO.DON but is there a #brand name change? Spherox in @EMA_News release but Chondrosphere/Condrosphere before.","conversation_id":"865533262952677378","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"552617924","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"865533262952677378"}]},{"created_at":"2017-05-19T09:00:18.000Z","id":"865492299639173121","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/Kit5UP0ZF5","expanded_url":"http://ow.ly/1LJ630bRkFG","display_url":"ow.ly/1LJ630bRkFG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":92,"end":104,"username":"adnk_salute","id":"393908405"}],"hashtags":[{"start":60,"end":67,"tag":"Milano"},{"start":107,"end":111,"tag":"ECM"},{"start":112,"end":116,"tag":"FAD"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News la squadra italiana punta su qualità della vita a #Milano https://t.co/Kit5UP0ZF5 @adnk_salute | #ECM #FAD","conversation_id":"865492299639173121","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"545016297","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-19T08:46:40.000Z","id":"865488867477995522","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/xlFGZjP3yd","expanded_url":"http://haiweb.org/wp-content/uploads/2016/04/Consultation-Response-on-PRIME-Scheme.pdf","display_url":"haiweb.org/wp-content/upl…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":66,"end":79,"username":"HAImedicines","id":"429122255"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News 'accelerated market approvals' -what cost for patients? @HAImedicines @CochraneNordic response https://t.co/xlFGZjP3yd","conversation_id":"865488867477995522","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2834844207","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-19T08:32:53.000Z","id":"865485398780157952","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/vgvbz42WXA","expanded_url":"http://bit.ly/2qYVcku","display_url":"bit.ly/2qYVcku"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":49,"tag":"PRIME"},{"start":94,"end":103,"tag":"oncology"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News out of 96 requests processed for #PRIME eligibility 20 have been granted, mainly in #oncology&amp; haematology https://t.co/vgvbz42WXA","conversation_id":"865485398780157952","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1408190809","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-17T18:30:44.000Z","id":"864911074658844672","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/NUHtreLo4H","expanded_url":"http://ow.ly/FHQe30bCesE","display_url":"ow.ly/FHQe30bCesE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":72,"end":85,"probability":0.4616,"type":"Organization","normalized_text":"European Union"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News plans to clarify its role regarding drugs manufactured in the European Union solely for the export market. https://t.co/NUHtreLo4H","conversation_id":"864911074658844672","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-16T15:28:44.000Z","id":"864502886960648192","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/3xQIX2RWH7","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Annual_report/2017/05/WC500227334.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":131,"end":154,"url":"https://t.co/QdHtVdkPAb","expanded_url":"https://twitter.com/ESCMID/status/864502886960648192/photo/1","display_url":"pic.twitter.com/QdHtVdkPAb"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":73,"tag":"antimicrobial"},{"start":88,"end":96,"tag":"vaccine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_864502593325641728"]},"source":"Twitter Web Client","text":"@EMA_News 2016 annual report focuses on product approvals, #antimicrobial surveillance, #vaccine hesitancy https://t.co/3xQIX2RWH7 https://t.co/QdHtVdkPAb","conversation_id":"864502886960648192","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"107346436","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-15T14:11:16.000Z","id":"864121003391299584","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News When are you publishing this month CHMP agenda? You seem to be a bit slow on that front. Should be uploaded by now!!","conversation_id":"864121003391299584","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3436006492","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-12T14:00:20.000Z","id":"863031088599400448","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/IHLLSXnlaq","expanded_url":"http://ow.ly/iRwr30bFrFq","display_url":"ow.ly/iRwr30bFrFq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":33,"end":41,"tag":"Patient"},{"start":73,"end":78,"tag":"CHMP"},{"start":112,"end":129,"tag":"PatientsIncluded"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News to continue to involve #Patient in benefit/risk discussions at #CHMP meetings https://t.co/IHLLSXnlaq #PatientsIncluded","conversation_id":"863031088599400448","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-12T11:51:45.000Z","id":"862998730949177345","entities":{"urls":[{"start":44,"end":67,"url":"https://t.co/9FqSIMm4hu","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Annual_report/2017/05/WC500227334.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":68,"end":91,"url":"https://t.co/gwGzkJ2fPh","expanded_url":"https://twitter.com/luipavia/status/862998730949177345/photo/1","display_url":"pic.twitter.com/gwGzkJ2fPh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_862998571628580864"]},"source":"Twitter Web Client","text":"@EMA_News 2016 annual report available here:https://t.co/9FqSIMm4hu https://t.co/gwGzkJ2fPh","conversation_id":"862998730949177345","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"775596124623278080","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-12T07:59:21.000Z","id":"862940245553270788","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":124,"end":137,"username":"VikasReports","id":"29193745"}],"hashtags":{},"annotations":[{"start":121,"end":122,"probability":0.7067,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News says mkting authorization holders be estd in EU; Must perform activities lik pharmacovigilance, manf,import in EU @VikasReports","conversation_id":"862940245553270788","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"18473269","in_reply_to_user_id":"116716199","geo":{"place_id":"7929cea6bd5b32bd"},"referenced_tweets":{}},{"created_at":"2017-05-11T21:25:35.000Z","id":"862780751523328000","entities":{"urls":[{"start":128,"end":151,"url":"https://t.co/L2zM0jNRA6","expanded_url":"https://twitter.com/Technrespsante/status/862780751523328000/photo/1","display_url":"pic.twitter.com/L2zM0jNRA6"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_862780746204839937"]},"source":"Twitter for Android","text":"@EMA_News @DroitSante Responsabilités individuelles vs sociétale: quelles incidences de la médecine des 4P sur nos concitoyens? https://t.co/L2zM0jNRA6","conversation_id":"861607847481790466","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"862391770302361603","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"861607847481790466"}]},{"created_at":"2017-05-11T15:00:43.000Z","id":"862683896714076162","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/7DxMBqHW83","expanded_url":"http://ow.ly/FRcU30bCZpn","display_url":"ow.ly/FRcU30bCZpn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":91,"end":106,"username":"AboutPharmaHPS","id":"861552570"}],"hashtags":[{"start":47,"end":55,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News: nel 2016 ok a 81 prodotti di cui 27 #farmaci innovativi https://t.co/7DxMBqHW83 @AboutPharmaHPS","conversation_id":"862683896714076162","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"545016297","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-11T12:58:00.000Z","id":"862653014145769472","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/ZhQGbOjVRX","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000345.jsp&","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":90,"tag":"nanomedicine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News When will be released the next update of the \"Reflection papers on #nanomedicine \" ? https://t.co/ZhQGbOjVRX","conversation_id":"862653014145769472","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2340417870","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-11T11:24:51.000Z","id":"862629572952641536","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/iGoHZkBMpM","expanded_url":"http://www.agi.it/regioni/lombardia/2017/05/05/news/_ema_maroni_sopralluogo_a_milano_il_17_e_il_18_maggio-1743329/","display_url":"agi.it/regioni/lombar…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":83,"end":97,"username":"clusteralisei","id":"3017358193"}],"hashtags":[{"start":68,"end":75,"tag":"health"},{"start":76,"end":82,"tag":"italy"}],"annotations":[{"start":47,"end":51,"probability":0.9703,"type":"Place","normalized_text":"Milan"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News reported to have an on-site visit in Milan next 17/18 May #health #italy @clusteralisei https://t.co/iGoHZkBMpM","conversation_id":"862629572952641536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"775596124623278080","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-10T17:05:01.000Z","id":"862352791590899713","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/ZzxamelgP3","expanded_url":"http://bit.ly/2px7ewd","display_url":"bit.ly/2px7ewd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":70,"end":82,"tag":"biosimilars"},{"start":100,"end":112,"tag":"biosimfacts"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News rpt says providers need \"access to reliable information\" on #biosimilars--find it at AMCP #biosimfacts https://t.co/ZzxamelgP3","conversation_id":"862352791590899713","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"717067144064868352","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-10T16:50:40.000Z","id":"862349177912799233","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/0QIyukjBlh","expanded_url":"http://bit.ly/2px7ewd","display_url":"bit.ly/2px7ewd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":17,"end":29,"tag":"biosimilars"}],"annotations":[{"start":79,"end":80,"probability":0.8606,"type":"Place","normalized_text":"US"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News issues #biosimilars SAFETY rpt--11 yrs, 28 approvals, 0 concerns. In US, AMCP BBCIC's monitoring 4 safety https://t.co/0QIyukjBlh","conversation_id":"862349177912799233","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"56764823","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-10T12:53:00.000Z","id":"862289369134247936","entities":{"urls":[{"start":161,"end":184,"url":"https://t.co/4wuJ506KFP","expanded_url":"https://twitter.com/KNReddy_Namo/status/862289369134247936/photo/1","display_url":"pic.twitter.com/4wuJ506KFP"},{"start":161,"end":184,"url":"https://t.co/4wuJ506KFP","expanded_url":"https://twitter.com/KNReddy_Namo/status/862289369134247936/photo/1","display_url":"pic.twitter.com/4wuJ506KFP"},{"start":161,"end":184,"url":"https://t.co/4wuJ506KFP","expanded_url":"https://twitter.com/KNReddy_Namo/status/862289369134247936/photo/1","display_url":"pic.twitter.com/4wuJ506KFP"},{"start":161,"end":184,"url":"https://t.co/4wuJ506KFP","expanded_url":"https://twitter.com/KNReddy_Namo/status/862289369134247936/photo/1","display_url":"pic.twitter.com/4wuJ506KFP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":15,"username":"ansm","id":"2443530930"},{"start":46,"end":53,"username":"CimGOI","id":"2534310320"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_862289220995567616","3_862289261793595392","3_862289306232213504","3_862289343888719872"]},"source":"Twitter for Android","text":"@EMA_News @ansm Well you are doing great, but @CimGOI &amp; EU compromised on my public info on GVK Bio data fraud. Due to your scam my family is on roads.Reply https://t.co/4wuJ506KFP","conversation_id":"862235526811746305","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"839985545287720965","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"862235526811746305"}]},{"created_at":"2017-05-10T11:12:12.000Z","id":"862263999471247360","entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/mMAcSn98bf","expanded_url":"https://twitter.com/gusbaratta/status/862236847593967617","display_url":"twitter.com/gusbaratta/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":27,"username":"biocat","id":"48553192"}],"hashtags":{},"annotations":[{"start":10,"end":18,"probability":0.3211,"type":"Organization","normalized_text":"Barcelona"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web App","text":"@EMA_News Barcelona @biocat bid: growing pack of competitors https://t.co/mMAcSn98bf","conversation_id":"862263999471247360","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3520541957","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"862236847593967617"}]},{"created_at":"2017-05-10T09:30:09.000Z","id":"862238320151187456","entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/DzcZvyUsLL","expanded_url":"http://ow.ly/xcCt30bAFY3","display_url":"ow.ly/xcCt30bAFY3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":94,"end":109,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":48,"end":60,"tag":"biosimilari"},{"start":85,"end":93,"tag":"farmaci"},{"start":112,"end":116,"tag":"ECM"},{"start":117,"end":121,"tag":"FAD"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News e Commissione UE pubblicano guida sui #biosimilari https://t.co/DzcZvyUsLL #farmaci @Aifa_ufficiale | #ECM #FAD","conversation_id":"862238320151187456","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"545016297","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-10T07:48:11.000Z","id":"862212657646116865","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/uciwadUrQx","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/05/news_detail_002742.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":115,"end":138,"url":"https://t.co/LG7Cm9Vjnv","expanded_url":"https://twitter.com/EMA_News/status/861607847481790466","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Report on Pilot to involve patients in benefit/risk\ndiscussions at CHMP meetings https://t.co/uciwadUrQx https://t.co/LG7Cm9Vjnv","conversation_id":"862212657646116865","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1095479161","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"861607847481790466"}]},{"created_at":"2017-05-09T21:05:30.000Z","id":"862050920024199169","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/7f2rfzG5MH","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/05/news_detail_002739.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":141,"end":164,"url":"https://t.co/TfkXylwog0","expanded_url":"https://twitter.com/MorseConsult/status/862050920024199169/photo/1","display_url":"pic.twitter.com/TfkXylwog0"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":94,"end":105,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_862050587151671296"]},"source":"Twitter Web Client","text":"@EMA_News &amp; @EU_Commission published an information guide for healthcare professionals on #biosimilar medicines. https://t.co/7f2rfzG5MH https://t.co/TfkXylwog0","conversation_id":"862050920024199169","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"822092741937086464","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-09T15:01:38.000Z","id":"861959353284390912","entities":{"urls":[{"start":64,"end":87,"url":"https://t.co/FxdTsxtQky","expanded_url":"http://ow.ly/vLWR30btoP0","display_url":"ow.ly/vLWR30btoP0"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News revises guidance on clinical data publication policy. https://t.co/FxdTsxtQky","conversation_id":"861959353284390912","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-09T13:31:26.000Z","id":"861936651316211713","entities":{"urls":[{"start":26,"end":49,"url":"https://t.co/EUvQg7yuL0","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/05/news_detail_002739.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":85,"end":108,"url":"https://t.co/Bsr3o9xaEx","expanded_url":"http://www.ideas-itn.eu/projects/optimal-designs-and-analysis-methods-for-the-development-of-biosimilars/","display_url":"ideas-itn.eu/projects/optim…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":109,"end":115,"tag":"H2020"},{"start":117,"end":134,"tag":"ResearchImpactEU"}],"annotations":[{"start":70,"end":76,"probability":0.4557,"type":"Person","normalized_text":"Johanna"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News on Biosimiliars https://t.co/EUvQg7yuL0\nrelating to our ESR Johanna's work https://t.co/Bsr3o9xaEx\n#H2020 \n#ResearchImpactEU","conversation_id":"861936651316211713","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2967509883","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-08T11:52:54.000Z","id":"861549465685172224","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/kKQA0FJuml","expanded_url":"http://ow.ly/VIer30bwCK7","display_url":"ow.ly/VIer30bwCK7"},{"start":122,"end":145,"url":"https://t.co/O2aqK7YEvl","expanded_url":"https://twitter.com/EAHPtweet/status/861549465685172224/photo/1","display_url":"pic.twitter.com/O2aqK7YEvl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":69,"end":83,"tag":"EUBiosimilars"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_861549396974030848"]},"source":"Twitter Web Client","text":"@EMA_News &amp; @EU_Commission have launched an information guide on #EUBiosimilars READ IT HERE: https://t.co/kKQA0FJuml https://t.co/O2aqK7YEvl","conversation_id":"861549465685172224","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"203357203","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-08T07:28:34.000Z","id":"861482945537871873","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/2RSodt30eK","expanded_url":"http://bit.ly/2p3ZVAQ","display_url":"bit.ly/2p3ZVAQ"},{"start":143,"end":166,"url":"https://t.co/YLtI6R1MOI","expanded_url":"https://twitter.com/PGEU/status/861482945537871873/photo/1","display_url":"pic.twitter.com/YLtI6R1MOI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":61,"end":73,"tag":"biosimilars"},{"start":128,"end":142,"tag":"BiosimilarsEU"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_861482732064559106"]},"source":"Twitter Web Client","text":"@EMA_News &amp; @EU_Commission have published a new guide on #biosimilars for healthcare professionals: https://t.co/2RSodt30eK #BiosimilarsEU https://t.co/YLtI6R1MOI","conversation_id":"861482945537871873","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"459292439","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-08T07:19:25.000Z","id":"861480641589805056","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/aZNdpWJcaG","expanded_url":"https://www.diariofarma.com/2017/05/05/nueva-guia-la-ema-la-ce-despejar-dudas-los-biosmilares","display_url":"diariofarma.com/2017/05/05/nue…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":61,"end":74,"tag":"biosimilares"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @EU_Commission \"las diferencias entre biológicos y #biosimilares no son clínicamente significativa\" https://t.co/aZNdpWJcaG","conversation_id":"861480641589805056","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1003782248","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-07T20:00:50.000Z","id":"861309872129937410","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":107,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":67,"end":71,"tag":"ALS"},{"start":77,"end":87,"tag":"edaravone"},{"start":128,"end":139,"tag":"cannotwait"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News  Can you please tell me when you will make available new #ALS drug #edaravone approved by @US_FDA couple of days ago? #cannotwait","conversation_id":"861309872129937410","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":1},"author_id":"3345374145","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-06T18:34:36.000Z","id":"860925783547813889","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":16,"end":21,"probability":0.5701,"type":"Other","normalized_text":"Brexit"},{"start":33,"end":34,"probability":0.9634,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News After Brexit, will the UK still be involved with the EMA? If not, it is with regret that I and many other Rare Disease Charities lose you.","conversation_id":"860153870319857664","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2856768321","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"860153870319857664"}]},{"created_at":"2017-05-06T11:45:41.000Z","id":"860822876232011776","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/Gwyv2vtSyJ","expanded_url":"https://twitter.com/agenersurrell/status/860822876232011776/photo/1","display_url":"pic.twitter.com/Gwyv2vtSyJ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":89,"end":97,"username":"BCN4EMA","id":"857604076804206593"}],"hashtags":[{"start":74,"end":84,"tag":"Barcelona"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_860822862114025473"]},"source":"Twitter for Android","text":"@EMA_News European Medicines Agency\nThat's what you can do on saturday in #Barcelona ;-)\n@BCN4EMA https://t.co/Gwyv2vtSyJ","conversation_id":"860822876232011776","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":2,"like_count":7,"quote_count":0},"author_id":"1194745704","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-05T18:30:46.000Z","id":"860562431919239168","entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/8OB7klgYds","expanded_url":"http://ow.ly/TCGg30bgYSP","display_url":"ow.ly/TCGg30bgYSP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":46,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News released a report on the EMA/@US_FDA QbD pilot program. https://t.co/8OB7klgYds","conversation_id":"860562431919239168","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-05T13:51:59.000Z","id":"860492273146093569","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"esno_web","id":"1185837546"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News @esno_web advise nurses in specialist area's take notice of this Guideline.  Gives  most detailled insight of complexity and teaches trust.","conversation_id":"860462701390303232","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1185837546","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"860462701390303232"}]},{"created_at":"2017-05-05T12:35:54.000Z","id":"860473126471258112","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/2RSodt30eK","expanded_url":"http://bit.ly/2p3ZVAQ","display_url":"bit.ly/2p3ZVAQ"},{"start":134,"end":157,"url":"https://t.co/A5C94cVoYA","expanded_url":"https://twitter.com/PGEU/status/860473126471258112/photo/1","display_url":"pic.twitter.com/A5C94cVoYA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":28,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_860472551373504512"]},"source":"Twitter Web Client","text":"@EMA_News and @EU_Commission launch an information guide for healthcare professionals ‘Biosimilars in the EU’ https://t.co/2RSodt30eK https://t.co/A5C94cVoYA","conversation_id":"860473126471258112","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"459292439","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-05T10:18:12.000Z","id":"860438471097425921","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":18,"end":28,"username":"kardamyla","id":"59722141"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News Bonjour @kardamyla, je serais heureux de participer comme juriste. Pourriez-vous me guider pour déposer une candidature ?","conversation_id":"860153870319857664","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"105275296","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"860153870319857664"}]},{"created_at":"2017-05-05T07:18:33.000Z","id":"860393263005671424","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/5rPR0OQcC3","expanded_url":"http://bit.ly/2pMQF0X","display_url":"bit.ly/2pMQF0X"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":78,"end":85,"tag":"Brexit"},{"start":112,"end":125,"tag":"lifesciences"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News and heads of national competent authorities discuss consequences of #Brexit - https://t.co/5rPR0OQcC3 #lifesciences","conversation_id":"860393263005671424","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4873826249","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-01T16:38:48.000Z","id":"859084700396244994","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/2qd52d9GJL","expanded_url":"https://twitter.com/SMANewsToday/status/859014624875827200","display_url":"twitter.com/SMANewsToday/s…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":49,"tag":"treatsma"}],"annotations":[{"start":32,"end":37,"probability":0.9949,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News do we have similar in Europe? #treatsma today and for all https://t.co/2qd52d9GJL","conversation_id":"859084700396244994","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"821066624623054848","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"859014624875827200"}]},{"created_at":"2017-05-01T15:55:10.000Z","id":"859073722216579078","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/BT90RsGvCQ","expanded_url":"http://ow.ly/hj6N30bjInw","display_url":"ow.ly/hj6N30bjInw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":117,"end":124,"username":"QSanit","id":"321385733"}],"hashtags":[{"start":29,"end":33,"tag":"Sma"},{"start":48,"end":61,"tag":"MalattiaRara"},{"start":84,"end":92,"tag":"bambini"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News: un farmaco per la #Sma e uno per una #MalattiaRara neurodegenerativa dei #bambini https://t.co/BT90RsGvCQ @QSanit","conversation_id":"859073722216579078","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"545016297","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-05-01T13:10:10.000Z","id":"859032196069433345","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/Ul8zVkxnDS","expanded_url":"http://ow.ly/hj6N30bjInw","display_url":"ow.ly/hj6N30bjInw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":117,"end":124,"username":"QSanit","id":"321385733"}],"hashtags":[{"start":29,"end":33,"tag":"Sma"},{"start":48,"end":61,"tag":"MalattiaRara"},{"start":84,"end":92,"tag":"bambini"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News: un farmaco per la #Sma e uno per una #MalattiaRara neurodegenerativa dei #bambini https://t.co/Ul8zVkxnDS @QSanit","conversation_id":"859032196069433345","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"814441321813393408","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-29T12:11:16.000Z","id":"858292597504303104","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/KzIjuxyVQ0","expanded_url":"http://www.affaritaliani.it/affari-europei/ema-entro-giugno-la-nuova-sede-barcellona-prova-a-beffare-milano-475562.html","display_url":"affaritaliani.it/affari-europei…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":51,"tag":"Barcellona"},{"start":68,"end":75,"tag":"Milano"},{"start":100,"end":108,"tag":"Farmaci"},{"start":109,"end":126,"tag":"Farmacovigilanza"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News , entro giugno la nuova sede. #Barcellona prova a beffare #Milano\nhttps://t.co/KzIjuxyVQ0\n#Farmaci #Farmacovigilanza","conversation_id":"858292597504303104","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3986808075","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-28T09:09:43.000Z","id":"857884520493854721","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News I call on you. End animal testing and vivisection. \nDon't be a hypocrite.","conversation_id":"857883975142060032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"857883975142060032"}]},{"created_at":"2017-04-27T21:55:09.000Z","id":"857714763945525248","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/F59ObN3JNM","expanded_url":"http://www.in-pharmatechnologist.com/Regulatory-Safety/EMA-and-FDA-aligned-on-how-pharmas-should-include-QbD-in-applications?utm_source=AddThis_twitter&utm_medium=twitter&utm_campaign=SocialMedia#.WQJoOahi0A4.twitter","display_url":"in-pharmatechnologist.com/Regulatory-Saf…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":18,"username":"US_FDA","id":"208120290"},{"start":85,"end":101,"username":"GarethMacdonald","id":"18800238"},{"start":102,"end":117,"username":"InPharmaTechno","id":"106444052"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News, @US_FDA agree how drug firms should include Q8, Q9 &amp; Q10 QbD concepts @GarethMacdonald @InPharmaTechno - https://t.co/F59ObN3JNM","conversation_id":"857714763945525248","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"1263165697","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T15:08:46.000Z","id":"857612493933379584","entities":{"urls":[{"start":127,"end":150,"url":"https://t.co/ifbeWjFwbA","expanded_url":"https://twitter.com/lauren_becnel/status/857612493933379584/photo/1","display_url":"pic.twitter.com/ifbeWjFwbA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":126,"username":"CDISC","id":"36317302"}],"hashtags":{},"annotations":[{"start":10,"end":19,"probability":0.8869,"type":"Person","normalized_text":"Dr Eichler"}],"cashtags":{}},"attachments":{"media_keys":["3_857612471074422787"]},"source":"Twitter for iPhone","text":"@EMA_News Dr Eichler \"Data standardization will be more important than ever\" for or level data sharing &amp; reanalysis @CDISC https://t.co/ifbeWjFwbA","conversation_id":"857612493933379584","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"724923633118941185","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T15:01:53.000Z","id":"857610759496503297","entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/iTWchQuz9Z","expanded_url":"http://ow.ly/2rkJ30b3oOq","display_url":"ow.ly/2rkJ30b3oOq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News released a draft guideline on trial master files. Comment by Jul.11. https://t.co/iTWchQuz9Z","conversation_id":"857610759496503297","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T15:00:56.000Z","id":"857610520945360896","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/D3drr8s3UW","expanded_url":"http://ow.ly/85Xf30bdzyp","display_url":"ow.ly/85Xf30bdzyp"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":87,"end":93,"probability":0.3116,"type":"Place","normalized_text":"Kevzara"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News ha emitido una opinión favorable para la autorización de comercialización de Kevzara (sarilumab) https://t.co/D3drr8s3UW","conversation_id":"857610520945360896","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"821464826","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T14:55:27.000Z","id":"857609139652100096","entities":{"urls":[{"start":136,"end":159,"url":"https://t.co/tFSBeAfCEe","expanded_url":"https://twitter.com/lauren_becnel/status/857609139652100096/photo/1","display_url":"pic.twitter.com/tFSBeAfCEe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":129,"end":135,"username":"CDISC","id":"36317302"}],"hashtags":{},"annotations":[{"start":10,"end":19,"probability":0.8488,"type":"Person","normalized_text":"Dr Eichler"}],"cashtags":{}},"attachments":{"media_keys":["3_857609131901018112"]},"source":"Twitter for iPhone","text":"@EMA_News Dr Eichler: Need for comparative trials to give pts access to data on different txs to make informed choice w their dr @CDISC https://t.co/tFSBeAfCEe","conversation_id":"857609139652100096","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"724923633118941185","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T14:51:49.000Z","id":"857608224786264065","entities":{"urls":[{"start":138,"end":161,"url":"https://t.co/htVtks5CAC","expanded_url":"https://twitter.com/lauren_becnel/status/857608224786264065/photo/1","display_url":"pic.twitter.com/htVtks5CAC"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":16,"probability":0.9559,"type":"Person","normalized_text":"Dr Hans"},{"start":18,"end":30,"probability":0.7517,"type":"Person","normalized_text":"Georg Eichler"}],"cashtags":{}},"attachments":{"media_keys":["3_857608200350302210"]},"source":"Twitter for iPhone","text":"@EMA_News Dr Hans-Georg Eichler on the future of data standards w an example of questions on staton rx even with 136k randomized subjects https://t.co/htVtks5CAC","conversation_id":"857608224786264065","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"724923633118941185","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-27T06:56:02.000Z","id":"857488490489155588","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/c8ZW0dJYft","expanded_url":"http://www.telegraaf.nl/t/28062163","display_url":"telegraaf.nl/t/28062163"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":62,"username":"telegraaf","id":"2902821"},{"start":112,"end":122,"username":"telegraaf","id":"2902821"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News contract break value vastly overstated by @telegraaf, never heard of NPV? https://t.co/c8ZW0dJYft via @telegraaf","conversation_id":"857488490489155588","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19791474","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-26T20:03:37.000Z","id":"857324304215756800","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/AZk3hFaE07","expanded_url":"https://twitter.com/euobs/status/857133403824685056","display_url":"twitter.com/euobs/status/8…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":50,"tag":"Copenhagen"},{"start":51,"end":59,"tag":"EMA2CPH"},{"start":60,"end":66,"tag":"dkpol"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News you are welcome to Wonderful #Copenhagen #EMA2CPH #dkpol https://t.co/AZk3hFaE07","conversation_id":"857324304215756800","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"21391324","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"857133403824685056"}]},{"created_at":"2017-04-26T18:30:51.000Z","id":"857300962037420032","entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/lV2FjSYrHW","expanded_url":"http://ow.ly/b96730b3o6C","display_url":"ow.ly/b96730b3o6C"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News lists sponsor requirements for completing periodic safety reports. https://t.co/lV2FjSYrHW","conversation_id":"857300962037420032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-26T12:15:00.000Z","id":"857206375310667781","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"MHRAgovuk","id":"330993102"},{"start":21,"end":31,"username":"Emma4facs","id":"277466861"},{"start":32,"end":42,"username":"Emma4facs","id":"277466861"},{"start":43,"end":59,"username":"epilepsymidwife","id":"2804204820"}],"hashtags":[{"start":70,"end":87,"tag":"valproatetoolkit"},{"start":107,"end":123,"tag":"mandatoryaction"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News @MHRAgovuk @Emma4facs @Emma4facs @epilepsymidwife lets hope #valproatetoolkit assessment creates #mandatoryaction for prescribing","conversation_id":"857206375310667781","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":1,"quote_count":0},"author_id":"250163834","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-25T19:14:01.000Z","id":"856949434055262208","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/tNmtUm6Kmd","expanded_url":"https://slingshotinsights.com/catalysts/3566","display_url":"slingshotinsights.com/catalysts/3566"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":[{"start":31,"end":36,"tag":"QURE"}]},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News Designates UniQure's $QURE AMT-060 for PRIME Status in Hemophilia B https://t.co/tNmtUm6Kmd","conversation_id":"856949434055262208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4827482940","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-25T12:36:08.000Z","id":"856849306275508225","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/n0o5RSmpQe","expanded_url":"https://twitter.com/LeireSolis/status/856848351651930113","display_url":"twitter.com/LeireSolis/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":34,"username":"WorldPIWeek","id":"1068116664"}],"hashtags":[{"start":41,"end":58,"tag":"patientsinvolved"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News presence at @WorldPIWeek event #patientsinvolved https://t.co/n0o5RSmpQe","conversation_id":"856849306275508225","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1117085011","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"856848351651930113"}]},{"created_at":"2017-04-22T11:53:20.000Z","id":"855751371420815360","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/8br1TR4MK9","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002735.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":69,"tag":"Spinraza"},{"start":71,"end":82,"tag":"nusinersen"},{"start":107,"end":111,"tag":"SMA"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News recommends granting a marketing authorisation for #Spinraza (#nusinersen) to treat patients with #SMA https://t.co/8br1TR4MK9","conversation_id":"855751371420815360","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"55569332","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-21T19:49:48.000Z","id":"855508889185505282","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"Mimouna","id":"17482371"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News @Mimouna Ah, tu me l'apprends tiens. ^^","conversation_id":"855479014814777344","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"101232575","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"855479014814777344"}]},{"created_at":"2017-04-20T06:20:02.000Z","id":"854942718681853952","entities":{"urls":[{"start":140,"end":163,"url":"https://t.co/4QRGtmtac8","expanded_url":"https://twitter.com/montse_barcelo/status/854942718681853952/photo/1","display_url":"pic.twitter.com/4QRGtmtac8"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":88,"end":100,"username":"XavierLuria","id":"3125056167"},{"start":101,"end":117,"username":"BarcelonaGlobal","id":"419664131"},{"start":118,"end":128,"username":"biocat_en","id":"96532455"},{"start":129,"end":139,"username":"jordicami","id":"346156753"}],"hashtags":[{"start":10,"end":20,"tag":"Barcelona"},{"start":43,"end":47,"tag":"EMA"},{"start":69,"end":78,"tag":"research"},{"start":79,"end":87,"tag":"passion"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_854942697588748288"]},"source":"Twitter for iPhone","text":"@EMA_News #Barcelona could be 1 of 5 final #EMA venues. WE ARE ready #research #passion @XavierLuria @BarcelonaGlobal @biocat_en @jordicami https://t.co/4QRGtmtac8","conversation_id":"854942718681853952","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2854680832","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-19T20:06:22.000Z","id":"854788284878172160","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/024R2InfYk","expanded_url":"http://www.in-pharmatechnologist.com/Regulatory-Safety/EMA-sets-up-inbox-for-whistle-blowers-and-adopts-investigation-policy?utm_source=AddThis_twitter&utm_medium=twitter&utm_campaign=SocialMedia#.WPfC7NHMUEo.twitter","display_url":"in-pharmatechnologist.com/Regulatory-Saf…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":111,"end":126,"username":"InPharmaTechno","id":"106444052"}],"hashtags":[{"start":28,"end":35,"tag":"pharma"},{"start":36,"end":50,"tag":"whistleblower"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News sets up inbox for #pharma #whistleblower and adopts investigation policy https://t.co/024R2InfYk via @InPharmaTechno","conversation_id":"854788284878172160","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1263165697","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-19T12:59:50.000Z","id":"854680942912450560","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/XJM7U7nIi7","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002727.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News introduces new whistle blower policy. Important! https://t.co/XJM7U7nIi7","conversation_id":"854680942912450560","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"4652634088","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-18T08:15:21.000Z","id":"854246961658163200","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/n1wjuvI8m6","expanded_url":"http://bit.ly/2ojn8KX","display_url":"bit.ly/2ojn8KX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":67,"end":71,"tag":"ICH"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News has published the Guideline on the Implementation of the #ICH Q3D \"Guideline on Elemental Impurities\" - https://t.co/n1wjuvI8m6","conversation_id":"854246961658163200","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4873826249","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-16T13:07:59.000Z","id":"853595830380617728","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":17,"probability":0.9874,"type":"Place","normalized_text":"Bulgaria"},{"start":20,"end":26,"probability":0.9692,"type":"Place","normalized_text":"Romania"},{"start":32,"end":39,"probability":0.9924,"type":"Place","normalized_text":"Slovakia"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Bulgaria, Romania and Slovakia are the only countries without an agency. Are you moving to one of them?","conversation_id":"853595830380617728","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2875141417","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-11T16:30:22.000Z","id":"851834820699271168","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/tg0jqDPQXi","expanded_url":"http://ow.ly/3rd530aLxoL","display_url":"ow.ly/3rd530aLxoL"},{"start":142,"end":165,"url":"https://t.co/vLYCudAIeL","expanded_url":"https://twitter.com/EuropaBio/status/851834820699271168/photo/1","display_url":"pic.twitter.com/vLYCudAIeL"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":53,"tag":"EUAcademia"},{"start":124,"end":141,"tag":"StrongerTogether"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_851834818258116608"]},"source":"Hootsuite","text":"@EMA_News 2 collaborate more closely with #EUAcademia. Check their new action plan &amp; framework: https://t.co/tg0jqDPQXi #StrongerTogether https://t.co/vLYCudAIeL","conversation_id":"851834820699271168","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-11T03:44:56.000Z","id":"851642195572658176","entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/Nbd93LcIeb","expanded_url":"https://twitter.com/bowermannmd/status/851316754664091648","display_url":"twitter.com/bowermannmd/st…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News https://t.co/Nbd93LcIeb","conversation_id":"851642195572658176","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1545630956","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"851316754664091648"}]},{"created_at":"2017-04-10T07:38:04.000Z","id":"851338476658229248","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/e6P7KrWMIL","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2017/04/WC500225227.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 3-6 April 2017 available at: https://t.co/e6P7KrWMIL","conversation_id":"851338476658229248","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-07T08:42:12.000Z","id":"850267451019243520","entities":{"urls":[{"start":43,"end":66,"url":"https://t.co/kJZLVQYmaf","expanded_url":"https://www.surveymonkey.co.uk/r/COREUtilitySurvey","display_url":"surveymonkey.co.uk/r/COREUtilityS…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":33,"tag":"CORERef"}],"annotations":[{"start":111,"end":112,"probability":0.84,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News How do you use #CORERef. Survey:\nhttps://t.co/kJZLVQYmaf …. Results @EMWA_Official Conference, B'ham UK, 04May17. Pls share.","conversation_id":"850267451019243520","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"2407513628","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-06T06:45:32.000Z","id":"849875703394951168","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/ogT4ZqEsX2","expanded_url":"http://bit.ly/2p3VTDX","display_url":"bit.ly/2p3VTDX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News publishes framework and action plan for closer interaction with academia - https://t.co/ogT4ZqEsX2","conversation_id":"849875703394951168","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4873826249","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-04T16:00:30.000Z","id":"849290591175413760","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/k01D3qFWml","expanded_url":"http://ow.ly/fxbr30ayxoF","display_url":"ow.ly/fxbr30ayxoF"},{"start":137,"end":160,"url":"https://t.co/rZv2noyACr","expanded_url":"https://twitter.com/EuropaBio/status/849290591175413760/photo/1","display_url":"pic.twitter.com/rZv2noyACr"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":51,"tag":"OrphanDrugs"},{"start":72,"end":85,"tag":"NewSolutions"},{"start":102,"end":112,"tag":"Path2Cure"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_849290586070945793"]},"source":"Hootsuite","text":"@EMA_News recommends EU approval for 3 #OrphanDrugs. This means finding #NewSolutions 2 old problems! #Path2Cure https://t.co/k01D3qFWml https://t.co/rZv2noyACr","conversation_id":"849290591175413760","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-04T14:27:15.000Z","id":"849267123839021061","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News In which country though are you recruiting?","conversation_id":"849256094820126722","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"49917846","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"849256094820126722"}]},{"created_at":"2017-04-04T13:21:39.000Z","id":"849250613783343110","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/1mbxxPVkTT","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/03/news_detail_002722.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News  publishes framework and action plan for closer interaction with academia https://t.co/1mbxxPVkTT","conversation_id":"849250613783343110","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"55569332","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-04T11:14:34.000Z","id":"849218635105271809","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/Odud9H2lKt","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000325.jsp&mid=WC0b01ac058080c49f","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":110,"end":113,"tag":"EU"},{"start":114,"end":119,"tag":"Jobs"},{"start":120,"end":123,"tag":"uk"}],"annotations":[{"start":23,"end":49,"probability":0.4524,"type":"Organization","normalized_text":"Information Systems Manager"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News is hiring an Information Systems Manager and PMO lead. Apply by 04/05/17 at https://t.co/Odud9H2lKt #EU #Jobs #uk","conversation_id":"849218635105271809","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"17485749","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-03T16:58:41.000Z","id":"848942844215795712","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/ixVQB4SXdM","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/general/general_content_001818.jsp&mid=WC0b01ac0580b982b3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":33,"end":42,"tag":"academia"},{"start":54,"end":64,"tag":"framework"},{"start":68,"end":82,"tag":"collaboration"},{"start":87,"end":96,"tag":"webpages"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News supporting the work of #academia with a new #framework of #collaboration and #webpages https://t.co/ixVQB4SXdM","conversation_id":"848942844215795712","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-03T12:30:12.000Z","id":"848875278776639489","entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/4SxfDia6Yt","expanded_url":"https://goo.gl/qxyDO4","display_url":"goo.gl/qxyDO4"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News relaesed guideline on multiplicity issues in clinical trials(https://t.co/4SxfDia6Yt) for consultation. Comment until 30.03.2017.","conversation_id":"848875278776639489","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"770931273753882625","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-03T12:28:03.000Z","id":"848874738034368512","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/WnyrzxxyJD","expanded_url":"https://goo.gl/qbqaam","display_url":"goo.gl/qbqaam"},{"start":141,"end":164,"url":"https://t.co/EqJbDvhd0N","expanded_url":"https://twitter.com/inarond/status/848874738034368512/photo/1","display_url":"pic.twitter.com/EqJbDvhd0N"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":130,"end":140,"tag":"RPstatsQA"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_848874700499550209"]},"source":"Twitter Web Client","text":"@EMA_News released RP on statistical methodology for comparisons of quality attributes(https://t.co/WnyrzxxyJD) for consultation. #RPstatsQA https://t.co/EqJbDvhd0N","conversation_id":"848874738034368512","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"770931273753882625","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-03T11:45:17.000Z","id":"848863974280105985","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/XK2JqSJWpa","expanded_url":"http://ow.ly/iIMz30alioU","display_url":"ow.ly/iIMz30alioU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":110,"end":116,"username":"Merck","id":"35961145"}],"hashtags":[{"start":91,"end":99,"tag":"Hodgkin"},{"start":100,"end":109,"tag":"Lymphoma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News CHMP Recommends Approval of Mercks KEYTRUDA for Relapsed or Refractory Classical #Hodgkin #Lymphoma @Merck https://t.co/XK2JqSJWpa","conversation_id":"848863974280105985","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"154611507","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-04-03T11:40:15.000Z","id":"848862709580009474","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Most important: collaboration in order to end animal research &amp; testing. \nEnd to vivisection. Within 3 years.","conversation_id":"848860913453150208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"848860913453150208"}]},{"created_at":"2017-03-31T15:33:31.000Z","id":"847834250590269440","entities":{"urls":[{"start":37,"end":60,"url":"https://t.co/3O7BZ7ZQqg","expanded_url":"https://twitter.com/BFMTV/status/847109478264770560","display_url":"twitter.com/BFMTV/status/8…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":20,"end":22,"probability":0.447,"type":"Person","normalized_text":"EMA"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News what does EMA have to say? https://t.co/3O7BZ7ZQqg","conversation_id":"847834250590269440","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"416095845","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"847109478264770560"}]},{"created_at":"2017-03-30T11:54:04.000Z","id":"847416635111522304","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":15,"username":"ansm","id":"2443530930"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @ansm  😀","conversation_id":"845245461497888769","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1622837215","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"845245461497888769"}]},{"created_at":"2017-03-30T10:42:16.000Z","id":"847398565437620225","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":39,"end":90,"probability":0.1563,"type":"Product","normalized_text":"AcelRx Pharmaceuticals' sublingual Sufentanil tablet"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News begins evaluation of MAA for AcelRx Pharmaceuticals' sublingual Sufentanil tablet (ARX-04) for moderate to severe acute pain","conversation_id":"847398565437620225","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":6,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-30T09:24:53.000Z","id":"847379092248772608","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":59,"end":69,"username":"solnastad","id":"469354717"},{"start":73,"end":88,"username":"Stockholmsstad","id":"15862571"}],"hashtags":{},"annotations":[{"start":31,"end":36,"probability":0.9569,"type":"Place","normalized_text":"London"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News EU Medical agency of London now packing bags for @solnastad in @Stockholmsstad ?","conversation_id":"847379092248772608","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"104368455","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-29T19:47:57.000Z","id":"847173504919388162","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News How many of them are rare or neglected diseases?","conversation_id":"847131535878828032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"105275296","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"847131535878828032"}]},{"created_at":"2017-03-29T14:30:09.000Z","id":"847093526722756608","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/JlnzZm611P","expanded_url":"http://ow.ly/8GJJ30amTEx","display_url":"ow.ly/8GJJ30amTEx"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":42,"tag":"BigData"},{"start":53,"end":64,"tag":"Innovation"},{"start":117,"end":136,"tag":"MoreProgressToCome"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News set up new taskforce on #BigData 2 support #Innovation &amp; medicines development https://t.co/JlnzZm611P #MoreProgressToCome","conversation_id":"847093526722756608","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-28T18:03:19.000Z","id":"846784783048953856","entities":{"urls":[{"start":55,"end":78,"url":"https://t.co/HWNY8Xg0yO","expanded_url":"https://youtu.be/fGrMLpK6nMo","display_url":"youtu.be/fGrMLpK6nMo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":44,"tag":"primodos"},{"start":45,"end":54,"tag":"duogynon"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News Don't forget the victims #primodos #duogynon https://t.co/HWNY8Xg0yO","conversation_id":"846366659271147520","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":4,"quote_count":1},"author_id":"21743594","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"846366659271147520"}]},{"created_at":"2017-03-28T15:01:40.000Z","id":"846739070046883843","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/V36Ws7zDPR","expanded_url":"http://ow.ly/wtWi30aeEdG","display_url":"ow.ly/wtWi30aeEdG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News recently met with African regulators to discuss potential areas of collaboration. https://t.co/V36Ws7zDPR","conversation_id":"846739070046883843","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-27T13:15:07.000Z","id":"846349869040193536","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/pfV1E09pWS","expanded_url":"http://bit.ly/2nnbfEd","display_url":"bit.ly/2nnbfEd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":99,"end":103,"tag":"CRO"},{"start":128,"end":135,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News recommends the suspension of over 300 drugs due to unreliable studies of an Indian based #CRO https://t.co/pfV1E09pWS #pharma","conversation_id":"846349869040193536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"353634229","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-27T12:32:12.000Z","id":"846339065914032128","entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/riypFnziU9","expanded_url":"http://international.orphanews.org/newsletter-en/political/nl/id-15-march-2017.html#oa_ema-factsheet-of-human-medicines-approved-in-2016","display_url":"international.orphanews.org/newsletter-en/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":83,"end":96,"tag":"RareDiseases"},{"start":97,"end":109,"tag":"OrphanDrugs"},{"start":110,"end":120,"tag":"OrphaNews"},{"start":121,"end":128,"tag":"Health"},{"start":129,"end":140,"tag":"Treatments"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  factsheet of human medicines approved in 2016 https://t.co/riypFnziU9 | #RareDiseases #OrphanDrugs #OrphaNews #Health #Treatments","conversation_id":"846339065914032128","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1693323661","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-27T12:32:12.000Z","id":"846339065855258624","entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/CoErIjmC1u","expanded_url":"http://international.orphanews.org/newsletter-en/political/nl/id-15-march-2017.html#oa_ema-factsheet-of-human-medicines-approved-in-2016","display_url":"international.orphanews.org/newsletter-en/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":83,"end":96,"tag":"RareDiseases"},{"start":97,"end":109,"tag":"OrphanDrugs"},{"start":110,"end":120,"tag":"OrphaNews"},{"start":121,"end":128,"tag":"Health"},{"start":129,"end":140,"tag":"Treatments"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  factsheet of human medicines approved in 2016 https://t.co/CoErIjmC1u | #RareDiseases #OrphanDrugs #OrphaNews #Health #Treatments","conversation_id":"846339065855258624","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1022973996","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-27T09:04:03.000Z","id":"846286683087736833","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/jiI9bMSO2F","expanded_url":"https://www.diariofarma.com/2017/03/24/la-ema-crea-grupo-trabajo-estudiar-las-aplicaciones-del-big-data","display_url":"diariofarma.com/2017/03/24/la-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":74,"tag":"bigdata"},{"start":102,"end":115,"tag":"medicamentos"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News crea grupo de trabajo para estudiar potencialidades del #bigdata en desarrollo y evaluación #medicamentos https://t.co/jiI9bMSO2F","conversation_id":"846286683087736833","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1003782248","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-25T20:46:25.000Z","id":"845738663250157574","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/udwSwl3ZiH","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/03/news_detail_002718.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":81,"tag":"bigdata"},{"start":99,"end":109,"tag":"medicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Task force to establish roadmap and recommendations for use of #bigdata in assessment of #medicines https://t.co/udwSwl3ZiH","conversation_id":"845738663250157574","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1697360292","in_reply_to_user_id":"116716199","geo":{"place_id":"206c436ce43a43a3"},"referenced_tweets":{}},{"created_at":"2017-03-25T19:10:43.000Z","id":"845714580181540864","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News  no patient representation on the data amonymisation group?","conversation_id":"844861376375865344","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"51070159","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"844861376375865344"}]},{"created_at":"2017-03-24T14:28:15.000Z","id":"845281110334619649","entities":{"urls":[{"start":126,"end":149,"url":"https://t.co/r5PV3U4Fuj","expanded_url":"https://twitter.com/GiuseppeDeCarl0/status/845281110334619649/photo/1","display_url":"pic.twitter.com/r5PV3U4Fuj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":74,"end":87,"username":"EFA_Patients","id":"1299643704"}],"hashtags":[{"start":41,"end":50,"tag":"patients"},{"start":54,"end":63,"tag":"medicine"},{"start":88,"end":102,"tag":"crowdsourcing"},{"start":103,"end":115,"tag":"gatekeeping"},{"start":116,"end":125,"tag":"workshop"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_845281098426994688"]},"source":"Twitter for iPhone","text":"@EMA_News is fully committed in engaging #patients in #medicine lifecycle @EFA_Patients #crowdsourcing #gatekeeping #workshop https://t.co/r5PV3U4Fuj","conversation_id":"845281110334619649","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3826266027","in_reply_to_user_id":"116716199","geo":{"place_id":"5de8cffc145c486b"},"referenced_tweets":{}},{"created_at":"2017-03-24T11:55:36.000Z","id":"845242694356160513","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/4b1vZeLm0q","expanded_url":"https://twitter.com/EMA_News/status/844884655920812032","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News to establish roadmap and recommendations for use of big data in assessment of medicines https://t.co/4b1vZeLm0q","conversation_id":"845242694356160513","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"237317743","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"844884655920812032"}]},{"created_at":"2017-03-23T10:02:43.000Z","id":"844851895252348929","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News I will as soon as animal testing stops and will be replaced by decent, humane and effective research. \"Solidarity\" !!!","conversation_id":"844850798999744512","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"844850798999744512"}]},{"created_at":"2017-03-17T17:25:05.000Z","id":"842788893158268931","entities":{"urls":[{"start":41,"end":64,"url":"https://t.co/4YS7ugMo2x","expanded_url":"https://twitter.com/wef/status/842782743637495808","display_url":"twitter.com/wef/status/842…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News - we're just saying - @ema2cph https://t.co/4YS7ugMo2x","conversation_id":"842788893158268931","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":8,"quote_count":0},"author_id":"1356451398","in_reply_to_user_id":"116716199","geo":{"place_id":"d5f7d96eb1587418"},"referenced_tweets":[{"type":"quoted","id":"842782743637495808"}]},{"created_at":"2017-03-17T10:07:06.000Z","id":"842678672905719808","entities":{"urls":[{"start":141,"end":164,"url":"https://t.co/gvxTFHIJ5u","expanded_url":"https://twitter.com/asebio/status/842678672905719808/photo/1","display_url":"pic.twitter.com/gvxTFHIJ5u"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":13,"end":27,"username":"FDA_Drug_Info","id":"53039176"},{"start":119,"end":128,"username":"AEMPSGOB","id":"326845755"}],"hashtags":[{"start":52,"end":64,"tag":"vivebiotech"}],"annotations":[{"start":34,"end":44,"probability":0.9858,"type":"Person","normalized_text":"Juan Carlos"},{"start":112,"end":114,"probability":0.5888,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"attachments":{"media_keys":["3_842678446962757632"]},"source":"TweetDeck","text":"@ema_news vs @FDA_Drug_Info según Juan Carlos R. de #vivebiotech mucho menos farragosas las explicaciones de la FDA. Y @AEMPSGOB al rescate! https://t.co/gvxTFHIJ5u","conversation_id":"842678672905719808","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"386247164","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-16T12:32:06.000Z","id":"842352774213955585","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/IlDrwoSAgl","expanded_url":"http://bit.ly/2nr3hwj","display_url":"bit.ly/2nr3hwj"},{"start":117,"end":140,"url":"https://t.co/cE45T7D5Ls","expanded_url":"https://twitter.com/IAPOvoice/status/842352774213955585/photo/1","display_url":"pic.twitter.com/cE45T7D5Ls"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":37,"end":66,"tag":"SpuriousSubstandardMedicines"},{"start":68,"end":74,"tag":"SSFFC"}],"annotations":[{"start":78,"end":82,"probability":0.9952,"type":"Place","normalized_text":"India"}],"cashtags":{}},"attachments":{"media_keys":["3_842352729196490753"]},"source":"Twitter Web Client","text":"@EMA_News @US_FDA landmark survey on #SpuriousSubstandardMedicines  #SSFFC in India unveiled https://t.co/IlDrwoSAgl https://t.co/cE45T7D5Ls","conversation_id":"842352774213955585","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"180728609","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-14T12:04:57.000Z","id":"841621168385847296","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/Lem14zXAcA","expanded_url":"https://twitter.com/exoxi/status/841621168385847296/photo/1","display_url":"pic.twitter.com/Lem14zXAcA"},{"start":98,"end":121,"url":"https://t.co/Lem14zXAcA","expanded_url":"https://twitter.com/exoxi/status/841621168385847296/photo/1","display_url":"pic.twitter.com/Lem14zXAcA"},{"start":98,"end":121,"url":"https://t.co/Lem14zXAcA","expanded_url":"https://twitter.com/exoxi/status/841621168385847296/photo/1","display_url":"pic.twitter.com/Lem14zXAcA"},{"start":98,"end":121,"url":"https://t.co/Lem14zXAcA","expanded_url":"https://twitter.com/exoxi/status/841621168385847296/photo/1","display_url":"pic.twitter.com/Lem14zXAcA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":66,"tag":"personalisedmedicine"}],"annotations":[{"start":77,"end":92,"probability":0.4492,"type":"Other","normalized_text":"Orphan Condition"}],"cashtags":{}},"attachments":{"media_keys":["3_841621152757891072","3_841621152749518850","3_841621152753700864","3_841621152770461696"]},"source":"Twitter for iPhone","text":"@EMA_News PCWP &amp; HCPWP joint workshop on #personalisedmedicine discussion on Orphan Condition https://t.co/Lem14zXAcA","conversation_id":"841621168385847296","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"179536654","in_reply_to_user_id":"116716199","geo":{"place_id":"7d588036fe12e124"},"referenced_tweets":{}},{"created_at":"2017-03-14T09:47:33.000Z","id":"841586588803043328","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/GkVpvBKZZH","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2017/03/event_detail_001400.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":28,"end":37,"tag":"patients"},{"start":38,"end":49,"tag":"healthcare"},{"start":82,"end":104,"tag":"PersonalisedMedicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_news follow broadcast  #patients #healthcare professionals joint workshop on #PersonalisedMedicines https://t.co/GkVpvBKZZH","conversation_id":"841586588803043328","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-14T09:22:35.000Z","id":"841580305291051009","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":43,"tag":"personalisedmedicine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News workshop on #personalisedmedicine has started. Looking forward to fruitful discussions and hearing the recent developments","conversation_id":"841580305291051009","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2842641832","in_reply_to_user_id":"116716199","geo":{"place_id":"08be9e4ebe3d037d"},"referenced_tweets":{}},{"created_at":"2017-03-14T09:02:50.000Z","id":"841575337326718976","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":36,"end":57,"tag":"personalisedmedicine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News watching the broadcast as #personalisedmedicine is the future of pediatrics. Discuss it with us at ://bit.ly/futurepeds17","conversation_id":"839067364943609857","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"728593550275956736","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"839067364943609857"}]},{"created_at":"2017-03-13T21:42:02.000Z","id":"841404007566450688","entities":{"urls":[{"start":137,"end":160,"url":"https://t.co/tOgM5Y29sj","expanded_url":"https://twitter.com/EMA_News/status/840262023585894401","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":120,"end":136,"tag":"researchmatters"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to hold new discussions about teratogenic risk of valproate. First scientific guidance and then patient input #researchmatters https://t.co/tOgM5Y29sj","conversation_id":"841404007566450688","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"49805880","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"840262023585894401"}]},{"created_at":"2017-03-13T11:40:16.000Z","id":"841252567279640578","entities":{"urls":[{"start":50,"end":73,"url":"https://t.co/7H7pyHT9kO","expanded_url":"https://twitter.com/bbenk34/status/841251892927836160","display_url":"twitter.com/bbenk34/status…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":27,"end":37,"username":"HAS_sante","id":"395293321"},{"start":38,"end":49,"username":"HAS_veille","id":"3306558887"}],"hashtags":[{"start":10,"end":14,"tag":"IRM"},{"start":15,"end":26,"tag":"gadolinium"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #IRM #gadolinium @HAS_sante @HAS_veille https://t.co/7H7pyHT9kO","conversation_id":"841252567279640578","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"970124881","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"841251892927836160"}]},{"created_at":"2017-03-11T15:00:46.000Z","id":"840578250527105024","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/wbnMx030FX","expanded_url":"http://ow.ly/ieF9309MLVp","display_url":"ow.ly/ieF9309MLVp"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":118,"end":135,"tag":"StrongerTogether"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News &amp; @US_FDA reach landmark deal on mutual recognition of manufacturing inspection https://t.co/wbnMx030FX #StrongerTogether","conversation_id":"840578250527105024","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-10T23:01:16.000Z","id":"840336784542322695","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/B9Ca0ldV4K","expanded_url":"https://www.youtube.com/watch?v=nXUrWdcG_oY","display_url":"youtube.com/watch?v=nXUrWd…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":10,"end":24,"probability":0.7548,"type":"Person","normalized_text":"Dr Andrew Rynne"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Dr Andrew Rynne calls Finasteride a \"dangerous toxic medication\". https://t.co/B9Ca0ldV4K","conversation_id":"840336784542322695","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2908145529","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-10T11:30:11.000Z","id":"840162865860497408","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/rxrdxvCctL","expanded_url":"http://ow.ly/FngP309LTT6","display_url":"ow.ly/FngP309LTT6"},{"start":140,"end":163,"url":"https://t.co/yIBcVAFJvp","expanded_url":"https://twitter.com/EuropaBio/status/840162865860497408/photo/1","display_url":"pic.twitter.com/yIBcVAFJvp"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":71,"tag":"Participate"},{"start":72,"end":81,"tag":"Innovate"},{"start":82,"end":94,"tag":"Collaborate"},{"start":119,"end":127,"tag":"PersMed"},{"start":130,"end":139,"tag":"Patients"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_840162863226458112"]},"source":"Hootsuite","text":"@EMA_News 2 broadcast workshop on personalised medicines - #Participate #Innovate #Collaborate https://t.co/rxrdxvCctL #PersMed 4 #Patients https://t.co/yIBcVAFJvp","conversation_id":"840162865860497408","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-10T05:58:21.000Z","id":"840079359381721090","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News grants Orphan Drug Designation to Abeona's EB 101 gene therapy in recessive dystrophic epidermolysis bullosa (RDEB)","conversation_id":"840079359381721090","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-08T15:15:59.000Z","id":"839494915134472192","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/FBjHHBqmKt","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2017/03/WC500222589.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 6-9 March 2017 available at: https://t.co/FBjHHBqmKt","conversation_id":"839494915134472192","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-07T14:18:31.000Z","id":"839118067250647040","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":53,"tag":"personalisedmedicine"},{"start":58,"end":67,"tag":"patients"}],"annotations":[{"start":90,"end":95,"probability":0.9761,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News sessions dedicated to #personalisedmedicine and #patients //bit.ly/futurepeds17 Europe needs a pediatric patient centered network","conversation_id":"839067364943609857","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"728593550275956736","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"839067364943609857"}]},{"created_at":"2017-03-07T13:19:38.000Z","id":"839103245410795522","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/Kynqxudk68","expanded_url":"http://ow.ly/gWB7309Fkth","display_url":"ow.ly/gWB7309Fkth"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News Workshop 14-03 \"Personalised medicines - focus on patients and healthcare professionals\" https://t.co/Kynqxudk68","conversation_id":"839103245410795522","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"899540204","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-07T12:53:01.000Z","id":"839096548344672260","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/vzkToj6FPh","expanded_url":"http://bit.ly/2lAbjmi","display_url":"bit.ly/2lAbjmi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":[{"start":20,"end":27,"probability":0.503,"type":"Place","normalized_text":"European"},{"start":33,"end":34,"probability":0.8104,"type":"Place","normalized_text":"US"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @US_FDA - European and US regulators agree on mutual recognition of inspections of medicines manufacturers https://t.co/vzkToj6FPh","conversation_id":"839096548344672260","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4873826249","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-06T19:30:44.000Z","id":"838834250916974592","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/ksi3NUha8g","expanded_url":"http://ow.ly/WaO3309yw0U","display_url":"ow.ly/WaO3309yw0U"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":12,"end":39,"probability":0.3664,"type":"Organization","normalized_text":"GCP Inspectors Working Group"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News's GCP Inspectors Working Group outlined its priorities for 2017. https://t.co/ksi3NUha8g","conversation_id":"838834250916974592","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-03-04T20:52:06.000Z","id":"838129948598616064","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web App","text":"@EMA_News Breaking news for pharma","conversation_id":"838129948598616064","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"40862287","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-28T08:13:10.000Z","id":"836489405196034049","entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/A9GTJBB5dQ","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_001778.jsp&mid=WC0b01ac0580b18c74","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":14,"tag":"EMA"},{"start":26,"end":41,"tag":"rarediseaseday"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #EMA supporting #rarediseaseday https://t.co/A9GTJBB5dQ","conversation_id":"836489405196034049","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-27T21:03:26.000Z","id":"836320861909024768","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/y2r5Og80e9","expanded_url":"https://twitter.com/kardamyla/status/836320861909024768/photo/1","display_url":"pic.twitter.com/y2r5Og80e9"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"COMP"},{"start":16,"end":23,"tag":"orphan"},{"start":52,"end":67,"tag":"RareDiseaseDay"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_836320860097110017"]},"source":"Twitter for iPhone","text":"@EMA_News #COMP #orphan committee raising hands for #RareDiseaseDay - thanks to you all for your hard work !! https://t.co/y2r5Og80e9","conversation_id":"836320861909024768","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-27T15:30:01.000Z","id":"836236958049402880","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/qCQ1vVNkMy","expanded_url":"https://slingshotinsights.com/catalysts/3261","display_url":"slingshotinsights.com/catalysts/3261"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"}],"annotations":{},"cashtags":[{"start":49,"end":54,"tag":"ABBV"}]},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News #CHMP Recommends Approval for AbbVie's $ABBV Shorter Regimen of Viekirax + Exviera in HCV-1b Infection https://t.co/qCQ1vVNkMy","conversation_id":"836236958049402880","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4827482940","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-24T15:34:10.000Z","id":"835150838184230912","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Le risque d'amputation des orteils va être inscrit dans le RCP des antidiabétiques oraux de la classe des inhibiteurs du SGLT2","conversation_id":"835150838184230912","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"366466573","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-23T16:02:02.000Z","id":"834795460510486528","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/Zgrn8BoNAi","expanded_url":"http://ow.ly/pXPV3096Cdj","display_url":"ow.ly/pXPV3096Cdj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":65,"end":68,"probability":0.3644,"type":"Person","normalized_text":"NCAs"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News shared some ATMPS activities that EMA, the CAT, EC and NCAs will consider for a wider-EU plan. https://t.co/Zgrn8BoNAi","conversation_id":"834795460510486528","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-22T05:58:42.000Z","id":"834281239939014656","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/uXHHoXBMdZ","expanded_url":"https://www.facebook.com/Global-Goal-No13-A-solution-for-City-Pollution-The-Smart-City-147941658897870/","display_url":"facebook.com/Global-Goal-No…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"SDGs"},{"start":16,"end":26,"tag":"transport"},{"start":27,"end":40,"tag":"airpollution"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #SDGs #transport #airpollution (Right to Breath) Stop polluting cities by cars,Use GPS electric capsule https://t.co/uXHHoXBMdZ","conversation_id":"834281239939014656","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"127923382","in_reply_to_user_id":"116716199","geo":{"place_id":"317fcc4b21a604d5"},"referenced_tweets":{}},{"created_at":"2017-02-22T05:49:52.000Z","id":"834279019201888258","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/htxrBEmG9J","expanded_url":"http://lnkd.in/bB9bbsf","display_url":"lnkd.in/bB9bbsf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Global Goal #3 ATM for Medicine like Bank ATM ?Save Environment/Reduce Addiction&amp; Price of Medicine by 50% https://t.co/htxrBEmG9J","conversation_id":"834279019201888258","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"127923382","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-21T06:34:56.000Z","id":"833927972130213889","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":95,"end":110,"username":"AnnikaSaarikko","id":"137013308"}],"hashtags":[{"start":71,"end":78,"tag":"brexit"}],"annotations":[{"start":41,"end":43,"probability":0.3033,"type":"Person","normalized_text":"EMA"},{"start":57,"end":63,"probability":0.9784,"type":"Place","normalized_text":"Finland"},{"start":126,"end":131,"probability":0.9822,"type":"Place","normalized_text":"Bergen"},{"start":134,"end":135,"probability":0.5981,"type":"Place","normalized_text":"NL"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Many Finnish politicians think EMA is going to Finland after #brexit. Please tell to @AnnikaSaarikko that you go to Bergen, NL.","conversation_id":"833927972130213889","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"742683407373721600","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-20T13:23:00.000Z","id":"833668276794306560","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Nothing on the agenda for suicide related events to SSRI's? Shame on you all.","conversation_id":"833663882950504448","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"833663882950504448"}]},{"created_at":"2017-02-19T19:03:11.000Z","id":"833391496447553536","entities":{"urls":[{"start":130,"end":153,"url":"https://t.co/TTlQuawSNZ","expanded_url":"https://twitter.com/leqph_fr/status/833330486474895361","display_url":"twitter.com/leqph_fr/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"BigVangLV","id":"3042369459"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News @BigVangLV Toxicité de génériques du Taxotère (docétaxel): Selon certains cancérologues, le problème n'est pas nouveau. https://t.co/TTlQuawSNZ","conversation_id":"833391496447553536","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2343452912","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"833330486474895361"}]},{"created_at":"2017-02-17T17:26:29.000Z","id":"832642385909780480","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/RksMBYmaOO","expanded_url":"https://twitter.com/EMA_News/status/832604814349651970","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"bfarm","id":"27294035"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Corebird","text":"@EMA_News @BfArM YES, please provide more documents and foster publishing clinical reports with corresponding docs! https://t.co/RksMBYmaOO","conversation_id":"832642385909780480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"762328365835624448","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"832604814349651970"}]},{"created_at":"2017-02-16T17:16:21.000Z","id":"832277447886389248","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"RafalSwierzewsk","id":"807251123254034432"},{"start":27,"end":36,"username":"cancereu","id":"140344419"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @RafalSwierzewsk @cancereu","conversation_id":"806892911715643392","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"824686274674118661","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"806892911715643392"}]},{"created_at":"2017-02-14T16:01:46.000Z","id":"831533905027137536","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/LDob3UE0Dp","expanded_url":"http://ow.ly/kuZu308SFsG","display_url":"ow.ly/kuZu308SFsG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News's Management Board's December meeting, the 2017 work program and budget was adopted. Read more. https://t.co/LDob3UE0Dp","conversation_id":"831533905027137536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-14T15:27:51.000Z","id":"831525368825860096","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/a287K8YgKk","expanded_url":"http://bit.ly/2lcwLg1","display_url":"bit.ly/2lcwLg1"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News old parents know they r loved when their children fight 2 get them 2 come live with them. We all love EMA https://t.co/a287K8YgKk","conversation_id":"831525368825860096","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"180728609","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-14T15:05:09.000Z","id":"831519654539620352","entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/JhStpRhOWS","expanded_url":"https://twitter.com/VaccinesToday/status/831504957568323585","display_url":"twitter.com/VaccinesToday/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":13,"tag":"EU"},{"start":34,"end":41,"tag":"health"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News #EU compromising global #health https://t.co/JhStpRhOWS","conversation_id":"831519654539620352","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713557917","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"831504957568323585"}]},{"created_at":"2017-02-14T15:00:24.000Z","id":"831518458898685952","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/OGV0GDJpHi","expanded_url":"http://bit.ly/2l900QP","display_url":"bit.ly/2l900QP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":73,"tag":"Regulatory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Sprout Social","text":"@EMA_News Touts Growth of Post-Authorisation Study Database | #Regulatory Focus https://t.co/OGV0GDJpHi","conversation_id":"831518458898685952","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"111425542","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-14T14:00:09.000Z","id":"831503297165012992","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/A4ht40ckMK","expanded_url":"http://bit.ly/2kq2Nkj","display_url":"bit.ly/2kq2Nkj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":54,"username":"ICH_news","id":"305434870"}],"hashtags":[{"start":102,"end":113,"tag":"Regulatory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Sprout Social","text":"@EMA_News Pediatric Committee Seeks to Tweak @ICH_news Q&amp;A on Nonclinical Eval. of Cancer Drugs | #Regulatory Focus https://t.co/A4ht40ckMK","conversation_id":"831503297165012992","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"111425542","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-13T08:33:27.000Z","id":"831058695224176641","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/TyXPsvFIka","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/02/news_detail_002690.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":45,"tag":"PRAC"},{"start":46,"end":64,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp; PR: Meeting highlights  #PRAC #Pharmacovigilance Risk Assessment Committee 6-9 Feb 2017 available at: https://t.co/TyXPsvFIka","conversation_id":"831058695224176641","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-12T18:01:20.000Z","id":"830839218515636225","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":17,"end":24,"tag":"brexit"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News - nach #brexit werden EMA Entscheidungen vll schon bald in der Hauptstadt gefällt.","conversation_id":"830839218515636225","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"732563253923041280","in_reply_to_user_id":"116716199","geo":{"place_id":"3078869807f9dd36"},"referenced_tweets":{}},{"created_at":"2017-02-11T21:30:30.000Z","id":"830529468913577985","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/YmK8D5lp1E","expanded_url":"http://www.medscape.com/viewarticle/875649?src=rss","display_url":"medscape.com/viewarticle/87…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":70,"tag":"diabetESP"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News riesgo amputacion extremidades inferiores aumenta #diabetESP con isglt2 https://t.co/YmK8D5lp1E debe estar incluido ficha tecnica","conversation_id":"830529468913577985","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2166779714","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-11T12:01:26.000Z","id":"830386259931623424","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":29,"end":37,"probability":0.8365,"type":"Person","normalized_text":"Paul Reid"},{"start":49,"end":55,"probability":0.9836,"type":"Place","normalized_text":"Ireland"},{"start":78,"end":96,"probability":0.449,"type":"Organization","normalized_text":"EU Medicines Agency"},{"start":111,"end":116,"probability":0.9898,"type":"Place","normalized_text":"Dublin"},{"start":119,"end":135,"probability":0.2612,"type":"Place","normalized_text":"Island of Ireland"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Irish Times Pfizer Paul Reid: Brexit &amp; Ireland; its FDI focus. Will EU Medicines Agency re-locate to Dublin, Island of Ireland?","conversation_id":"830029528303009792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"145703465","in_reply_to_user_id":"116716199","geo":{"place_id":"3cdad59a91d99400"},"referenced_tweets":[{"type":"replied_to","id":"830029528303009792"}]},{"created_at":"2017-02-06T16:30:14.000Z","id":"828641963041812481","entities":{"urls":[{"start":126,"end":149,"url":"https://t.co/GwTM9fA731","expanded_url":"https://twitter.com/Wolf_S_Punk/status/828641963041812481/photo/1","display_url":"pic.twitter.com/GwTM9fA731"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":[{"start":43,"end":50,"probability":0.985,"type":"Person","normalized_text":"Dr. Anne"},{"start":52,"end":68,"probability":0.2838,"type":"Person","normalized_text":"Sophie Henry-Eude"},{"start":77,"end":123,"probability":0.3204,"type":"Other","normalized_text":"Head of Document Access and Publication Service"}],"cashtags":{}},"attachments":{"media_keys":["3_828641894615961601"]},"source":"Twitter Web Client","text":"@EMA_News @EU_Commission Please forward to Dr. Anne-Sophie Henry-Eude (EMA - Head of Document Access and Publication Service) https://t.co/GwTM9fA731","conversation_id":"828641963041812481","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-06T11:28:05.000Z","id":"828565925574098944","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/cltVe64qvM","expanded_url":"https://twitter.com/PFMDwithPatient/status/828565925574098944/photo/1","display_url":"pic.twitter.com/cltVe64qvM"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":41,"tag":"PatientsEU2017"},{"start":45,"end":63,"tag":"patientengagement"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_828565922554212352"]},"source":"Hootsuite","text":"@EMA_News presentation at #PatientsEU2017 on #patientengagement methodologies https://t.co/cltVe64qvM","conversation_id":"828565925574098944","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3944674342","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-06T07:55:52.000Z","id":"828512520163979265","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/wW2QWC2qtA","expanded_url":"https://twitter.com/SimonHarrisTD/status/828225662808895488","display_url":"twitter.com/SimonHarrisTD/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":27,"tag":"Ireland"},{"start":37,"end":45,"tag":"Denmark"},{"start":50,"end":57,"tag":"Sweden"},{"start":61,"end":64,"tag":"UK"},{"start":65,"end":72,"tag":"Brexit"},{"start":106,"end":117,"tag":"regulation"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News interest #Ireland possibly #Denmark and #Sweden as #UK #Brexit will lose influence in medicines #regulation https://t.co/wW2QWC2qtA","conversation_id":"828512520163979265","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2156890678","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"828225662808895488"}]},{"created_at":"2017-02-03T10:58:35.000Z","id":"827471339556515840","entities":{"urls":[{"start":131,"end":154,"url":"https://t.co/0oeM5GFpou","expanded_url":"https://twitter.com/sinieskola/status/827471339556515840/photo/1","display_url":"pic.twitter.com/0oeM5GFpou"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"EFPIA","id":"52084584"},{"start":17,"end":24,"username":"knedog","id":"2965604643"}],"hashtags":[{"start":110,"end":117,"tag":"safety"},{"start":121,"end":130,"tag":"patients"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_827471319281389571"]},"source":"Twitter for iPhone","text":"@EMA_News @EFPIA @knedog Achieving 10th Pharmacovigilance Industry stakeholder meeting - working together for #safety of #patients https://t.co/0oeM5GFpou","conversation_id":"827471339556515840","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"2876403948","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-02T16:18:30.000Z","id":"827189460500615168","entities":{"urls":[{"start":139,"end":162,"url":"https://t.co/YtZdYBzOeG","expanded_url":"https://twitter.com/Wolf_S_Punk/status/827189460500615168/photo/1","display_url":"pic.twitter.com/YtZdYBzOeG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_827188190771548160"]},"source":"Twitter Web Client","text":"@EMA_News Would be great if you proceed my FOIA request instead of searching the deficiencies related to DE/H/PSUR/0022/001 on my website. https://t.co/YtZdYBzOeG","conversation_id":"827189460500615168","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-01T19:30:48.000Z","id":"826875467907133440","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/ibmS37Hrid","expanded_url":"http://ow.ly/JMLs308pQ5i","display_url":"ow.ly/JMLs308pQ5i"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News’s biosimilars pilot project will provide developers with advice on the studies they should be conducting.  https://t.co/ibmS37Hrid","conversation_id":"826875467907133440","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-01T15:27:19.000Z","id":"826814192854392833","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/IROgNvX8n0","expanded_url":"http://bit.ly/2kVxYER","display_url":"bit.ly/2kVxYER"},{"start":136,"end":159,"url":"https://t.co/ZR4m9vc3Ai","expanded_url":"https://twitter.com/luyckxJM/status/826814192854392833/photo/1","display_url":"pic.twitter.com/ZR4m9vc3Ai"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":31,"username":"MSDBelgium","id":"637003549"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_826814172084236288"]},"source":"Twitter Web Client","text":"@EMA_News approuves @MSDBelgium Pembrolizumab for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer https://t.co/IROgNvX8n0 https://t.co/ZR4m9vc3Ai","conversation_id":"826814192854392833","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3392050857","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-02-01T08:44:50.000Z","id":"826712902501531648","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/wkTOwK04uu","expanded_url":"https://www.diariofarma.com/2017/01/31/la-ema-anima-la-industria-explorar-la-via-la-autorizacion-condicional","display_url":"diariofarma.com/2017/01/31/la-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":86,"end":99,"tag":"medicamentos"},{"start":100,"end":107,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News hace balance de 10 años de autorizaciones condicionales de comercialización #medicamentos #pharma https://t.co/wkTOwK04uu","conversation_id":"826712902501531648","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1003782248","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-31T16:04:17.000Z","id":"826461108621938689","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/GKDSHERsmc","expanded_url":"http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4666/full","display_url":"onlinelibrary.wiley.com/doi/10.2903/j.…"},{"start":123,"end":146,"url":"https://t.co/4vIq7PNSfD","expanded_url":"https://twitter.com/ESCMID/status/826461108621938689/photo/1","display_url":"pic.twitter.com/4vIq7PNSfD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":19,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":67,"end":79,"tag":"antibiotics"}],"annotations":[{"start":83,"end":84,"probability":0.6418,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"attachments":{"media_keys":["3_826461077990993921"]},"source":"Twitter Web Client","text":"@EMA_News, @EFSA_EU issue joint scientific opinion on reduction of #antibiotics in EU farm animals https://t.co/GKDSHERsmc https://t.co/4vIq7PNSfD","conversation_id":"826461108621938689","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"107346436","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-31T06:00:52.000Z","id":"826309251979235328","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts the MAA for BioCryst's Peramivir for treatment of symptoms typical of influenza in adults 18 years and older","conversation_id":"826309251979235328","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":6,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-27T16:45:59.000Z","id":"825022047734661120","entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/Z4nJajf13j","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2017/01/27/zulassungsempfehlung-des-chmp","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":31,"tag":"Adalimumab"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News empfiehlt #Adalimumab Biosimilars zur Zulassung https://t.co/Z4nJajf13j","conversation_id":"825022047734661120","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":1},"author_id":"2789645880","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-27T10:10:44.000Z","id":"824922582247936000","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":92,"end":97,"probability":0.9626,"type":"Place","normalized_text":"London"},{"start":104,"end":109,"probability":0.5654,"type":"Other","normalized_text":"Brexit"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Did I ask you guys if you'd settled on a new home yet? Assuming you need to leave London post-Brexit...","conversation_id":"824922582247936000","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"302776937","in_reply_to_user_id":"116716199","geo":{"place_id":"8d65596349ee2e01"},"referenced_tweets":{}},{"created_at":"2017-01-26T12:05:35.000Z","id":"824589095645171716","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/bc9JDYtzEj","expanded_url":"http://www.pinsentmasons.com/en/media/publications/lifelines/life-lines---life-sciences-through-a-legal-lens77/","display_url":"pinsentmasons.com/en/media/publi…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":89,"end":95,"tag":"PRIME"},{"start":97,"end":113,"tag":"orphanmedicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @EU_Health  Benefits of CMAs - 30 since 2006 - 14 orphans. Part of toolkit for #PRIME. #orphanmedicines https://t.co/bc9JDYtzEj","conversation_id":"824589095645171716","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1186490732","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-26T11:42:26.000Z","id":"824583271833071617","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/8GKYeEMOO0","expanded_url":"http://bit.ly/2kwnPC9","display_url":"bit.ly/2kwnPC9"},{"start":137,"end":160,"url":"https://t.co/IBwveCf7Fb","expanded_url":"https://twitter.com/thepigsite/status/824583271833071617/photo/1","display_url":"pic.twitter.com/IBwveCf7Fb"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":22,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":76,"end":100,"tag":"AntimicrobialResistance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_824583152362520576"]},"source":"TweetDeck","text":"@EMA_News and @EFSA_EU recognise there's no ‘one-size-fits-all’ solution to #AntimicrobialResistance in animals: https://t.co/8GKYeEMOO0 https://t.co/IBwveCf7Fb","conversation_id":"824583271833071617","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"68969384","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-26T06:35:35.000Z","id":"824506050091057152","entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/oZ5gR1VDq8","expanded_url":"http://raps.org/Regulatory-Focus/News/2017/01/24/26668/EMA-Reflects-on-its-First-Decade-of-Conditional-Marketing-Authorizations/","display_url":"raps.org/Regulatory-Foc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Reflects on its First Decade of Conditional Marketing Authorizations https://t.co/oZ5gR1VDq8","conversation_id":"824506050091057152","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"1697360292","in_reply_to_user_id":"116716199","geo":{"place_id":"206c436ce43a43a3"},"referenced_tweets":{}},{"created_at":"2017-01-25T07:23:08.000Z","id":"824155626326650882","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News How soon after the CHMP meeting (23-26th Jan) are the minutes published? x","conversation_id":"824155626326650882","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"186451117","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-24T13:00:33.000Z","id":"823878152556580865","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/RYUS96DR5H","expanded_url":"http://bit.ly/2knMPaS","display_url":"bit.ly/2knMPaS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":21,"tag":"farmaci"},{"start":53,"end":66,"tag":"farmaceutica"},{"start":67,"end":72,"tag":"cure"},{"start":73,"end":82,"tag":"medicina"},{"start":83,"end":93,"tag":"controlli"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News 81 #farmaci immessi in commercio nel 2016.\n#farmaceutica #cure #medicina #controlli\nhttps://t.co/RYUS96DR5H","conversation_id":"823878152556580865","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2483368484","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-24T06:13:57.000Z","id":"823775830400790528","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":35,"username":"GileadSciences","id":"309728693"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News validates @GileadSciences' MAA for sofosbuvir/velpatasvir/voxilaprevir for treating chronic Hepatitis C infections","conversation_id":"823775830400790528","possibly_sensitive":false,"lang":"no","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":9,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-18T18:24:13.000Z","id":"821785281317785604","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/WwriMtOm4C","expanded_url":"http://www.pinsentmasons.com/en/media/publications/lifelines/life-lines---life-sciences-through-a-legal-lens76/","display_url":"pinsentmasons.com/en/media/publi…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":79,"end":89,"tag":"medicines"},{"start":90,"end":103,"tag":"lifesciences"},{"start":104,"end":111,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News pilot project to support step-by-step development of new biosimilars #medicines #lifesciences #pharma https://t.co/WwriMtOm4C","conversation_id":"821785281317785604","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1186490732","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-18T13:57:53.000Z","id":"821718256595640320","entities":{"urls":[{"start":49,"end":72,"url":"https://t.co/Z6NmmUSDO7","expanded_url":"http://ow.ly/rZva3087nQb","display_url":"ow.ly/rZva3087nQb"},{"start":73,"end":96,"url":"https://t.co/4uIoCqDvOB","expanded_url":"https://twitter.com/PharPoint/status/821718256595640320/photo/1","display_url":"pic.twitter.com/4uIoCqDvOB"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":36,"tag":"HumanMedicine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_821718254116802561"]},"source":"Hootsuite","text":"@EMA_News Shares 2016 #HumanMedicine highlights: https://t.co/Z6NmmUSDO7 https://t.co/4uIoCqDvOB","conversation_id":"821718256595640320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"282805521","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-17T09:31:21.000Z","id":"821288791247847424","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/gpN557EcTv","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2017/01/WC500219499.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 9-12 January 2017 more at: https://t.co/gpN557EcTv","conversation_id":"821288791247847424","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-16T01:23:24.000Z","id":"820803607398387716","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/hrxXka7cpe","expanded_url":"http://gabriellafilippone.blogspot.it/2017/01/plasil-da-bandire-le-prove-indicano-che.html","display_url":"gabriellafilippone.blogspot.it/2017/01/plasil…"},{"start":119,"end":142,"url":"https://t.co/BK8LvUO1DO","expanded_url":"https://twitter.com/varionews/status/820803607398387716/photo/1","display_url":"pic.twitter.com/BK8LvUO1DO"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":11,"end":18,"tag":"PLASIL"},{"start":86,"end":94,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_820803593821360129"]},"source":"Twitter Web Client","text":"@EMA_News  #PLASIL da bandire. I rischi sono superiori ai benefici del metoclopramide #farmaci\nhttps://t.co/hrxXka7cpe https://t.co/BK8LvUO1DO","conversation_id":"820803607398387716","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"128688814","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-13T11:54:19.000Z","id":"819875217354981376","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/vO19gFNpws","expanded_url":"https://goo.gl/kGkE6H","display_url":"goo.gl/kGkE6H"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) reports https://t.co/vO19gFNpws use of antimicrobial agents","conversation_id":"819875217354981376","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1479739921","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2017-01-04T16:21:29.000Z","id":"816680963354886144","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/uJj3soyyiy","expanded_url":"https://twitter.com/FDA_Drug_Info/status/812413317063000064","display_url":"twitter.com/FDA_Drug_Info/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":76,"end":85,"username":"UZLeuven","id":"423442784"}],"hashtags":[{"start":47,"end":56,"tag":"SPINRAZA"},{"start":61,"end":65,"tag":"sma"},{"start":66,"end":75,"tag":"handicap"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News Any news on the European approval of #SPINRAZA for #sma #handicap @UZLeuven https://t.co/uJj3soyyiy","conversation_id":"816680963354886144","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1377675541","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"812413317063000064"}]},{"created_at":"2017-01-03T18:41:22.000Z","id":"816353776898543616","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/0yeRoCKJ4D","expanded_url":"http://bit.ly/2hMFOyo","display_url":"bit.ly/2hMFOyo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News holds annual regulatory conference on optimising development of advanced therapies to meet patient needs: https://t.co/0yeRoCKJ4D","conversation_id":"816353776898543616","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-28T12:12:56.000Z","id":"814081697184706560","entities":{"urls":[{"start":40,"end":63,"url":"https://t.co/aGzwzPHyFU","expanded_url":"https://www.spinraza.com/en_us/home.html#.WGOrfEo2-IU.twitter","display_url":"spinraza.com/en_us/home.htm…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":101,"end":116,"username":"Maggie_DeBlock","id":"2860510937"}],"hashtags":[{"start":117,"end":121,"tag":"sma"}],"annotations":[{"start":93,"end":99,"probability":0.9963,"type":"Place","normalized_text":"Belgium"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News SPINRAZA™ (nusinersen) | Home https://t.co/aGzwzPHyFU\nWhen will it be available in Belgium @Maggie_DeBlock #sma","conversation_id":"814081697184706560","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1377675541","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-26T16:44:24.000Z","id":"813425237639434240","entities":{"urls":[{"start":65,"end":88,"url":"https://t.co/Y0rzSVU85v","expanded_url":"http://nyti.ms/2iuyc4u","display_url":"nyti.ms/2iuyc4u"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":39,"end":44,"probability":0.5065,"type":"Other","normalized_text":"Brexit"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News in Limbo as Hidden Costs of ‘Brexit’ Continue to Mount https://t.co/Y0rzSVU85v","conversation_id":"813425237639434240","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1097741347","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-22T11:16:49.000Z","id":"811893250265059328","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/lSQueEoMLB","expanded_url":"http://www.gavaghancommunications.com/Iss4_2016.pdf","display_url":"gavaghancommunications.com/Iss4_2016.pdf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News What is your thinking on antimicrobial resistance. See Issue 4, 2016 Science, People &amp; Politics. Page 13. https://t.co/lSQueEoMLB","conversation_id":"811891299875979264","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"17184615","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"811891299875979264"}]},{"created_at":"2016-12-20T13:29:00.000Z","id":"811201738296426496","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":35,"tag":"offlabel"},{"start":61,"end":68,"tag":"health"},{"start":84,"end":87,"tag":"EU"},{"start":110,"end":119,"tag":"patients"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News recognises that #offlabel medicine use is a public #health concern. Clear #EU guidelines to protect #patients are needed","conversation_id":"811201738296426496","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2804198512","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-20T13:17:49.000Z","id":"811198922454659073","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/e4c28866Ye","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2016/12/WC500218206.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":121,"end":131,"username":"BioSim_es","id":"3391830214"}],"hashtags":[{"start":81,"end":93,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News Tailored scientific advice to support step-by-step \ndevelopment of new #biosimilars https://t.co/e4c28866Ye cc @BioSim_es","conversation_id":"811198922454659073","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"613396251","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-19T14:48:12.000Z","id":"810859280685563904","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/stYdG7MoCB","expanded_url":"http://raps.org/Regulatory-Focus/News/2016/12/16/26390/EMA-to-Launch-Tailored-Biosimilar-Scientific-Advice-Pilot/","display_url":"raps.org/Regulatory-Foc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":95,"end":103,"username":"RAPSorg","id":"111425542"}],"hashtags":[{"start":29,"end":40,"tag":"Biosimilar"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to Launch Tailored #Biosimilar Scientific Advice Pilot - https://t.co/stYdG7MoCB via @RAPSorg","conversation_id":"810859280685563904","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1042587218","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-19T12:50:15.000Z","id":"810829599114399744","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/ISGaeXe6JO","expanded_url":"https://www.diariofarma.com/2016/12/19/la-ema-lanza-piloto-orientar-desarrollo-biosimilares","display_url":"diariofarma.com/2016/12/19/la-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":84,"end":96,"tag":"biosimilars"},{"start":104,"end":111,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News lanzará un piloto en febrero para orientar la estrategia de desarrollo de #biosimilars de las #pharma https://t.co/ISGaeXe6JO","conversation_id":"810829599114399744","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1003782248","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-19T08:07:19.000Z","id":"810758397570191361","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/JFd6prCp6n","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004112/WC500218017.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":91,"end":102,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News's Committee for Medicinal Products for Human Use's positive opinion on rituximab #biosimilar https://t.co/JFd6prCp6n","conversation_id":"810758397570191361","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1042587218","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-18T15:45:02.000Z","id":"810511196327727104","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/p2u1N8uGVi","expanded_url":"http://bit.ly/2hJOSZq","display_url":"bit.ly/2hJOSZq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":97,"end":112,"tag":"clinicaltrials"},{"start":113,"end":124,"tag":"openCTdata"},{"start":125,"end":134,"tag":"opendata"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Buffer","text":"@EMA_News revises clinical data publication guidance, updates on program https://t.co/p2u1N8uGVi #clinicaltrials #openCTdata #opendata","conversation_id":"810511196327727104","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1351548962","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-17T15:40:43.000Z","id":"810147722460270592","entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/vFIfrYB3mX","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002677/smops/Positive/human_smop_001077.jsp&mid=WC0b01ac058001d127","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":139,"end":162,"url":"https://t.co/0UFXwKiV5a","expanded_url":"https://twitter.com/SEDiabetes/status/810147722460270592/photo/1","display_url":"pic.twitter.com/0UFXwKiV5a"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_810147686737383424"]},"source":"Twitter for Android","text":"@EMA_News MODIFICA ficha técnica JARDIANCE (empaglifozina)  https://t.co/vFIfrYB3mX reconoce eficacia seguridad PREVENCIÓN  CARDIOVASCULAR https://t.co/0UFXwKiV5a","conversation_id":"810147722460270592","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":11,"quote_count":0},"author_id":"2166779714","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-17T11:32:07.000Z","id":"810085161425637376","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/zQb0z954Nb","expanded_url":"https://twitter.com/DrRaulCordoba/status/810085161425637376/photo/1","display_url":"pic.twitter.com/zQb0z954Nb"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_810085150176505856"]},"source":"Twitter for iPhone","text":"@EMA_News takes longer time than other agencies to approve new anti-cancer drugs https://t.co/zQb0z954Nb","conversation_id":"810085161425637376","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1697360292","in_reply_to_user_id":"116716199","geo":{"place_id":"08eb5d76dc74e0e9"},"referenced_tweets":{}},{"created_at":"2016-12-17T06:13:08.000Z","id":"810004885420855297","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/cIBJbuFqP9","expanded_url":"http://bit.ly/2hx0TRy","display_url":"bit.ly/2hx0TRy"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":46,"end":56,"username":"Regeneron","id":"23077762"}],"hashtags":[{"start":88,"end":103,"tag":"AtopicDermatis"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News has accepted for review the MAA for @regeneron Dupixent® for the treatment of #AtopicDermatis https://t.co/cIBJbuFqP9","conversation_id":"810004885420855297","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"933960668","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-16T18:13:34.000Z","id":"809823799667523584","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/n4ZSCxeZny","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004112/smops/Positive/human_smop_001068.jsp&mid=WC0b01ac058001d127","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":64,"end":76,"tag":"Biosimilars"},{"start":77,"end":87,"tag":"Rituximab"},{"start":88,"end":98,"tag":"Celltrion"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News     - Human medicines - CHMP  Opinión positiva  CTP10 #Biosimilars #Rituximab #Celltrion\nhttps://t.co/n4ZSCxeZny","conversation_id":"809823799667523584","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"243824117","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-15T18:11:17.000Z","id":"809460837526032384","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/o3yaln6NIj","expanded_url":"http://bit.ly/2hpaJnW","display_url":"bit.ly/2hpaJnW"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":33,"username":"sanofi","id":"35846368"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts MAA for @sanofi's Dupilumab for use in treatment of moderate-to-severe atopic dermatitis https://t.co/o3yaln6NIj","conversation_id":"809460837526032384","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":9,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-14T06:36:32.000Z","id":"808923611662811136","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/JHhCc1rqqY","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2016/12/WC500217951.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":98,"end":113,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":76,"end":88,"tag":"innovazione"},{"start":89,"end":97,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News pubblica il resoconto del workshop sul progetto Adaptive Pathways #innovazione #farmaci @Aifa_ufficiale https://t.co/JHhCc1rqqY","conversation_id":"808923611662811136","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"1122120385","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-13T17:11:41.000Z","id":"808721061516873729","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"Veronica_Foote_","id":"336462129"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @Veronica_Foote_","conversation_id":"806820229384904704","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"701883847194107905","in_reply_to_user_id":"116716199","geo":{"place_id":"0653bb913c88c1ea"},"referenced_tweets":[{"type":"replied_to","id":"806820229384904704"}]},{"created_at":"2016-12-12T15:52:51.000Z","id":"808338836732465152","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/gf8FRMTKEY","expanded_url":"https://www.diariofarma.com/2016/12/09/prac-aemps-advierten-riesgos-antivirales-accion-directa","display_url":"diariofarma.com/2016/12/09/pra…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":21,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":[{"start":50,"end":52,"probability":0.3201,"type":"Place","normalized_text":"VHB"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News y @AEMPSGOB : riesgo de reactivación de VHB y aparición de hepatocarcinoma con antivirales acción directa https://t.co/gf8FRMTKEY","conversation_id":"808338836732465152","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1003782248","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-11T15:19:09.000Z","id":"807967968676237313","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":21,"end":33,"tag":"MDSAlliance"},{"start":58,"end":62,"tag":"MDS"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News We are the #MDSAlliance, representing worldwide #MDS patients organisations. Keep us in mind please.","conversation_id":"807967968676237313","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"780343185700712448","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-10T03:17:22.000Z","id":"807423937852350464","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/5VQDlCVFFo","expanded_url":"http://www.esmo.org/Oncology-News/EMA-Recommends-Granting-a-Marketing-Authorisation-for-Palbociclib#.WEtzg6RkFB0.twitter","display_url":"esmo.org/Oncology-News/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":79,"end":86,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":60,"end":72,"tag":"Palbociclib"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Recommends Granting a Marketing Authorisation for #Palbociclib | via @myESMO https://t.co/5VQDlCVFFo","conversation_id":"807423937852350464","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2339138737","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-08T16:54:48.000Z","id":"806904875552505856","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":51,"tag":"adaptivepathways"}],"annotations":[{"start":72,"end":73,"probability":0.7106,"type":"Organization","normalized_text":"AP"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News wants key takeaway from #adaptivepathways workshop to be that AP is not a new licensing route.","conversation_id":"806904875552505856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"552617924","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-08T12:46:52.000Z","id":"806842479672721408","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":15,"end":32,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News says #adaptivepathways doesn't lower standards yet conceptual papers acknowledge greater uncertainty on b/r. Contradictory message","conversation_id":"806842479672721408","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":1},"author_id":"1408190809","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-08T12:36:02.000Z","id":"806839754419503104","entities":{"urls":[{"start":56,"end":79,"url":"https://t.co/gLowLZFTqD","expanded_url":"https://twitter.com/exoxi/status/806839754419503104/photo/1","display_url":"pic.twitter.com/gLowLZFTqD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":27,"tag":"adaptivepathways"}],"annotations":[{"start":37,"end":47,"probability":0.6181,"type":"Person","normalized_text":"Alison Cave"}],"cashtags":{}},"attachments":{"media_keys":["3_806839751869366272"]},"source":"Twitter for iPhone","text":"@EMA_News #adaptivepathways Workshop Alison Cave on RWD https://t.co/gLowLZFTqD","conversation_id":"806839754419503104","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"179536654","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-08T10:08:19.000Z","id":"806802580122652672","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":29,"end":38,"username":"cancereu","id":"140344419"}],"hashtags":[{"start":123,"end":140,"tag":"AdaptivePathways"}],"annotations":[{"start":11,"end":26,"probability":0.8441,"type":"Person","normalized_text":"Rafal Swierzeski"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News  Rafal Swierzeski, @cancereu, recommends stronger and sustainable collaboration between regulators and patients. #AdaptivePathways","conversation_id":"806802580122652672","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"140344419","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-07T19:31:03.000Z","id":"806581807579824128","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/3PF1lircna","expanded_url":"http://ow.ly/4Q3B306J0xV","display_url":"ow.ly/4Q3B306J0xV"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News published a guidance for sponsors on post-orphan medicinal product designation procedures. https://t.co/3PF1lircna","conversation_id":"806581807579824128","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-06T21:18:19.000Z","id":"806246416037318656","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/ryGLIVXszo","expanded_url":"http://bit.ly/2h2Z8Jb","display_url":"bit.ly/2h2Z8Jb"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News revises guideline on first-in-human and early clinical trials with investigational medicinal products: https://t.co/ryGLIVXszo","conversation_id":"806246416037318656","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-06T11:03:54.000Z","id":"806091792512942080","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":124,"end":139,"username":"LungCancer_Can","id":"264134027"}],"hashtags":[{"start":88,"end":97,"tag":"WCLC2016"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News present example of patient group engagement in evaluation of cancer medicines #WCLC2016. Something to learn from. @LungCancer_Can","conversation_id":"806091792512942080","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"1004053676","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-05T19:30:57.000Z","id":"805857007437803520","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/kqehOXsgm0","expanded_url":"http://ow.ly/ZouR306IZ5G","display_url":"ow.ly/ZouR306IZ5G"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News is taking a risk-management approach to initial human trials in revised guidelines. https://t.co/kqehOXsgm0","conversation_id":"805857007437803520","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-02T17:46:05.000Z","id":"804743451984138240","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/F3uY3cp6GV","expanded_url":"http://bit.ly/2gQ2MWE","display_url":"bit.ly/2gQ2MWE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News PRAC warns of risk of hepatitis B re-activation with direct- acting antivirals for hepatitis C https://t.co/F3uY3cp6GV","conversation_id":"804743451984138240","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1887742747","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-02T12:13:40.000Z","id":"804659798730047488","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/qP6av4ZKml","expanded_url":"http://ow.ly/P2nF306K9Vl","display_url":"ow.ly/P2nF306K9Vl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News workshop on genetically modified cell-based cancer immunotherapy products 15-11-16 - slides &amp; video online https://t.co/qP6av4ZKml","conversation_id":"804659798730047488","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"899540204","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-01T12:02:02.000Z","id":"804294483856789504","entities":{"urls":[{"start":135,"end":158,"url":"https://t.co/1ruH4K8zI3","expanded_url":"https://twitter.com/medicinesforEU/status/804294483856789504/photo/1","display_url":"pic.twitter.com/1ruH4K8zI3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"CFarmaceutico","id":"277963374"},{"start":25,"end":41,"username":"apmhealtheurope","id":"138714048"}],"hashtags":[{"start":119,"end":134,"tag":"AskJacekGlinka"}],"annotations":[{"start":66,"end":77,"probability":0.8438,"type":"Person","normalized_text":"Jacek Glinka"}],"cashtags":{}},"attachments":{"media_keys":["3_804294481239568384"]},"source":"Sprout Social","text":"@EMA_news @cfarmaceutico @apmhealtheurope Follow the Tweetup with Jacek Glinka on Monday 5th from 16pm to 16.45pm CET! #AskJacekGlinka https://t.co/1ruH4K8zI3","conversation_id":"804294483856789504","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2315763655","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-12-01T11:31:40.000Z","id":"804286841495187456","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/loOvrIIifQ","expanded_url":"http://bit.ly/2goLCBd","display_url":"bit.ly/2goLCBd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"V_Andriukaitis","id":"575269517"},{"start":26,"end":34,"username":"ECDC_EU","id":"204752573"},{"start":35,"end":48,"username":"ECDC_HIVAIDS","id":"2182569746"},{"start":49,"end":63,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":64,"end":72,"tag":"AIDSDay"}],"annotations":[{"start":90,"end":108,"probability":0.9442,"type":"Person","normalized_text":"Dr Christian Jessen"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @V_Andriukaitis @ECDC_EU @ECDC_HIVAIDS @EU_Commission #AIDSDay &amp; interview with Dr Christian Jessen  https://t.co/loOvrIIifQ","conversation_id":"804286841495187456","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"132897310","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-30T13:04:24.000Z","id":"803947790233665536","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":57,"tag":"EMA"},{"start":95,"end":104,"tag":"industry"},{"start":109,"end":118,"tag":"patients"}],"annotations":[{"start":10,"end":25,"probability":0.994,"type":"Person","normalized_text":"Isabelle Moullon"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Isabelle Moullon talking about the role of #EMA in facilitating interactions between #industry and #patients at earlier stages","conversation_id":"803947790233665536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"600110872","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-30T12:11:28.000Z","id":"803934467178004480","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/4herpQdvDr","expanded_url":"http://biosensors.conferenceseries.com/","display_url":"biosensors.conferenceseries.com"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":34,"end":65,"probability":0.5058,"type":"Organization","normalized_text":"Biosensors&BioelectronicsUSA2017"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News  would be interested in Biosensors&amp;BioelectronicsUSA2017 conference held on September 27-29  visit https://t.co/4herpQdvDr","conversation_id":"803934467178004480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2836707336","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-30T11:30:47.000Z","id":"803924229402017792","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/Odud9H2lKt","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000325.jsp&mid=WC0b01ac058080c49f","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":104,"end":111,"tag":"EUjobs"},{"start":112,"end":119,"tag":"London"},{"start":120,"end":123,"tag":"UK"},{"start":124,"end":127,"tag":"IT"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News is recruiting an IT Project Manager and a Data Scientist.  Details at https://t.co/Odud9H2lKt #EUjobs #London #UK #IT","conversation_id":"803924229402017792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"17485749","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-25T13:30:17.000Z","id":"802142363686731776","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/M8UGImZgtQ","expanded_url":"http://ow.ly/8YMi306vZxu","display_url":"ow.ly/8YMi306vZxu"},{"start":113,"end":136,"url":"https://t.co/PkLgTweNID","expanded_url":"https://twitter.com/EuropaBio/status/802142363686731776/photo/1","display_url":"pic.twitter.com/PkLgTweNID"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":23,"end":40,"tag":"AdaptivePathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_802142360947691520"]},"source":"Hootsuite","text":"@EMA_News sets scene 4 #AdaptivePathways discussions on 08 December. Find out more here: https://t.co/M8UGImZgtQ https://t.co/PkLgTweNID","conversation_id":"802142363686731776","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-23T17:51:41.000Z","id":"801483374233812992","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"LorenVillato","id":"405623199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @LorenVillato recién salido del horno","conversation_id":"801480522782351360","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"285695064","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"801480522782351360"}]},{"created_at":"2016-11-23T09:28:51.000Z","id":"801356831163609089","entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/tS84wLDkRx","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/11/news_detail_002641.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - Revising the guideline on first-in-human clinical trials https://t.co/tS84wLDkRx","conversation_id":"801356831163609089","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-21T11:50:05.000Z","id":"800667597259866112","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/dSJa0d13gO","expanded_url":"http://bit.ly/2fx4R8o","display_url":"bit.ly/2fx4R8o"},{"start":104,"end":127,"url":"https://t.co/DUu8oJ8bSg","expanded_url":"https://twitter.com/SocialfarmaWeb/status/800667597259866112/photo/1","display_url":"pic.twitter.com/DUu8oJ8bSg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_800666736844476416"]},"source":"Twitter Web Client","text":"@EMA_News in Italia. Bracco: \"La nostra proposta è la più vantaggiosa per l'UE\" https://t.co/dSJa0d13gO https://t.co/DUu8oJ8bSg","conversation_id":"800667597259866112","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1879728746","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-20T09:44:01.000Z","id":"800273481954799616","entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/pAjwgk6RdD","expanded_url":"http://bit.ly/2g2OTE9","display_url":"bit.ly/2g2OTE9"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":57,"end":65,"username":"RAPSorg","id":"111425542"}],"hashtags":[{"start":90,"end":105,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Buffer","text":"@EMA_News revises guideline on first-in-human trials via @RAPSorg https://t.co/pAjwgk6RdD #clinicaltrials","conversation_id":"800273481954799616","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1351548962","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-18T11:06:37.000Z","id":"799569495979343873","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/hsf80P6JBN","expanded_url":"https://twitter.com/BenDuncanStkhlm/status/799569495979343873/photo/1","display_url":"pic.twitter.com/hsf80P6JBN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":76,"end":79,"tag":"EU"},{"start":98,"end":107,"tag":"EAAD2016"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_799569493378928641"]},"source":"Twitter for iPhone","text":"@EMA_News large differences in colistin use in treating farm animals across #EU must be addressed #EAAD2016 https://t.co/hsf80P6JBN","conversation_id":"799569495979343873","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"273942250","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-18T11:03:51.000Z","id":"799568798605049856","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/HVB2dH9nOh","expanded_url":"https://twitter.com/BenDuncanStkhlm/status/799568798605049856/photo/1","display_url":"pic.twitter.com/HVB2dH9nOh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":70,"tag":"antibiotic"},{"start":71,"end":80,"tag":"colistin"},{"start":105,"end":114,"tag":"EAAD2016"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_799568796113571840"]},"source":"Twitter for iPhone","text":"@EMA_News explains new advice to restrict use of last line #antibiotic #colistin esp in treating animals #EAAD2016 https://t.co/HVB2dH9nOh","conversation_id":"799568798605049856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"273942250","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-18T10:24:05.000Z","id":"799558789913518080","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":117,"end":126,"username":"guardian","id":"87818409"}],"hashtags":[{"start":19,"end":28,"tag":"EAAD2016"}],"annotations":[{"start":77,"end":93,"probability":0.6685,"type":"Organization","normalized_text":"Oxford Biosystems"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Today is #EAAD2016 - New DNA flow rapid test for AMR analysis from Oxford Biosystems advertised in special @guardian supplement","conversation_id":"799558789913518080","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"431678444","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-17T08:31:34.000Z","id":"799168087144726528","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/WkDdwQ7L4G","expanded_url":"http://www.medscape.com/viewarticle/870278?src=WNL_infoc_161117_MSCPEDIT_TEMP2&uac=69755FT&impID=1235015&faf=1?src=soc_tw_share","display_url":"medscape.com/viewarticle/87…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":132,"end":141,"username":"Medscape","id":"16892009"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News: Metformin can now be used for moderate CKD (eGFR 30-59); contraindication for eGFR&lt;30 remains https://t.co/WkDdwQ7L4G @Medscape","conversation_id":"799168087144726528","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"28798857","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-16T13:46:57.000Z","id":"798885066671853568","entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/SNpqOoxpA4","expanded_url":"http://sciencebusiness.net/news/79994/European-Medicines-Agency-feels-Brexit-effect","display_url":"sciencebusiness.net/news/79994/Eur…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":46,"end":51,"probability":0.7353,"type":"Other","normalized_text":"Brexit"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News is beginning to feel the effects of Brexit https://t.co/SNpqOoxpA4","conversation_id":"798885066671853568","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3880655656","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-16T11:27:16.000Z","id":"798849915065511936","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/q6tNMTFtu1","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500216158&mid=WC0b01ac058009a3dc","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":31,"end":37,"tag":"First"},{"start":47,"end":62,"tag":"ClinicalTrials"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News revises guideline on #First-in-Human #ClinicalTrials to improve safety of trial participants https://t.co/q6tNMTFtu1","conversation_id":"798849915065511936","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"781516151184564224","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-16T09:01:47.000Z","id":"798813305510862852","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/EK15wG6spH","expanded_url":"http://fexp.in/nOW244448","display_url":"fexp.in/nOW244448"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":137,"username":"ExpPharma","id":"632775011"}],"hashtags":[{"start":15,"end":24,"tag":"European"},{"start":25,"end":36,"tag":"Commission"},{"start":87,"end":102,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News with #European #Commission EU propose changes to existing guideline on human #clinicaltrials https://t.co/EK15wG6spH @ExpPharma","conversation_id":"798813305510862852","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"632775011","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-15T13:52:14.000Z","id":"798524008287195137","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News sorry, upstream channal works well !","conversation_id":"798522262240587777","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1185837546","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"798522262240587777"}]},{"created_at":"2016-11-15T13:50:31.000Z","id":"798523579113635841","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News text on slides is hard to read, not sharp, but maybe due to this computer","conversation_id":"798522262240587777","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1185837546","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"798522262240587777"}]},{"created_at":"2016-11-15T11:20:45.000Z","id":"798485889374703616","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":68,"end":85,"tag":"informed_consent"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @EMA_News Great. Research in patients instead of animals! #informed_consent","conversation_id":"798484424535003136","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"798484424535003136"}]},{"created_at":"2016-11-15T11:05:04.000Z","id":"798481941708292096","entities":{"urls":{},"mentions":[{"start":55,"end":64,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":21,"end":29,"tag":"bigdata"},{"start":30,"end":44,"tag":"digitalhealth"},{"start":45,"end":54,"tag":"workshop"}],"annotations":[{"start":94,"end":99,"probability":0.9921,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Windows","text":"Sad admission during #bigdata #digitalhealth #workshop @EMA_news \"there is little appetite in Europe for patient-level-data sharing\".","conversation_id":"798442920483241984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"2734431743","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"798442920483241984"}]},{"created_at":"2016-11-14T15:15:09.000Z","id":"798182487813853184","entities":{"urls":[{"start":48,"end":71,"url":"https://t.co/QqrzxGwBxR","expanded_url":"http://ow.ly/XHcq3069rVd","display_url":"ow.ly/XHcq3069rVd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":47,"tag":"clinicaldata"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News grants public access to #clinicaldata https://t.co/QqrzxGwBxR","conversation_id":"798182487813853184","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1965354864","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-14T15:14:18.000Z","id":"798182273405177856","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/hOWlZYaXpS","expanded_url":"http://buff.ly/2fRmgfn","display_url":"buff.ly/2fRmgfn"},{"start":141,"end":164,"url":"https://t.co/t822XNSSaN","expanded_url":"https://twitter.com/MedWatchEng/status/798182273405177856/photo/1","display_url":"pic.twitter.com/t822XNSSaN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":57,"username":"novonordisk","id":"194037150"},{"start":105,"end":112,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":16,"end":21,"tag":"CHMP"},{"start":58,"end":66,"tag":"insulin"},{"start":67,"end":73,"tag":"Fiasp"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_798182271383572484"]},"source":"Buffer","text":"@EMA_News panel #CHMP recommends approval of @novonordisk #insulin #Fiasp one month after it hit snag at @US_FDA ($) https://t.co/hOWlZYaXpS https://t.co/t822XNSSaN","conversation_id":"798182273405177856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4704692140","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-12T08:32:09.000Z","id":"797356294114045952","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"MaaT_Pharma","id":"3642662655"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @MaaT_Pharma","conversation_id":"797013779875852289","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2626263112","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"797013779875852289"}]},{"created_at":"2016-11-11T10:00:11.000Z","id":"797016059622592512","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":109,"end":115,"tag":"smaws"}],"annotations":[{"start":10,"end":20,"probability":0.9954,"type":"Person","normalized_text":"Manuel Haas"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Manuel Haas asks who better than the patients to tell us what is needed in spinal muscular atrophy #smaws","conversation_id":"797016059622592512","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-11T04:39:47.000Z","id":"796935429953961984","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/WcxUMIiHQx","expanded_url":"http://bit.ly/2fGC1WC","display_url":"bit.ly/2fGC1WC","status":200,"unwound_url":"https://adisinsight.springer.com/drugs/800038565?error=cookies_not_supported&code=810eb1c5-bf2c-4aca-b982-63db8e128118"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":82,"tag":"T2DM"},{"start":111,"end":116,"tag":"T1DM"}],"annotations":[{"start":18,"end":22,"probability":0.5129,"type":"Organization","normalized_text":"Mylan"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts Mylan's MAA for insulin glargine biosimilar in adults with #T2DM and children (6 yrs +) with #T1DM https://t.co/WcxUMIiHQx","conversation_id":"796935429953961984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":12,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-10T14:08:51.000Z","id":"796716252240736256","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/XtALm9LjvQ","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/11/news_detail_002638.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":90,"end":105,"tag":"Tcelltherapies"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News Scientific and regulatory challenges of modified T-cell based cancer therapies  #Tcelltherapies https://t.co/XtALm9LjvQ","conversation_id":"796716252240736256","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4867631259","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-10T11:09:07.000Z","id":"796671020329353216","entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"Emma4facs","id":"277466861"},{"start":11,"end":25,"username":"catherinecox2","id":"245493521"},{"start":26,"end":35,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":70,"tag":"valproate"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@Emma4facs @catherinecox2 @EMA_News but not side effects of #valproate in pregnancy.. Not enough emphasis on the subject ..!","conversation_id":"796666630982037505","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"250163834","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"796666630982037505"}]},{"created_at":"2016-11-10T11:05:02.000Z","id":"796669992641196032","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":112,"end":118,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":105,"end":111,"tag":"HCS16"}],"annotations":[{"start":10,"end":24,"probability":0.9609,"type":"Person","normalized_text":"Isabelle Moulon"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Isabelle Moulon: HCPs are just as important as patients to be involved in regulatory processes #HCS16 @EFPIA","conversation_id":"796669992641196032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2794421787","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-10T10:59:11.000Z","id":"796668522554413056","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":79,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":66,"end":72,"tag":"hcs16"}],"annotations":[{"start":10,"end":24,"probability":0.972,"type":"Person","normalized_text":"Isabelle Moulon"},{"start":59,"end":64,"probability":0.9917,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Isabelle Moulon: health literacy is declining in Europe #hcs16 @EFPIA","conversation_id":"796668522554413056","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2794421787","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-08T18:38:04.000Z","id":"796059225684316160","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"ZAAAlexander","id":"2343847004"}],"hashtags":[{"start":70,"end":78,"tag":"medical"},{"start":87,"end":106,"tag":"medischebijsluiter"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @ZAAAlexander is ready to co-operate for improvement of the #medical leaflet #medischebijsluiter","conversation_id":"796022052486582276","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2343847004","in_reply_to_user_id":"116716199","geo":{"place_id":"99cdab25eddd6bce"},"referenced_tweets":[{"type":"replied_to","id":"796022052486582276"}]},{"created_at":"2016-11-08T17:03:57.000Z","id":"796035543855464449","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/7Of1Zy9fpf","expanded_url":"http://ow.ly/X6QZ305YD4M","display_url":"ow.ly/X6QZ305YD4M"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News workshop 15-11 \"How to facilitate development of cancer treatment based on genetically modified T-cells\" https://t.co/7Of1Zy9fpf","conversation_id":"796035543855464449","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"899540204","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-08T12:25:43.000Z","id":"795965521300717568","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/nSmWfxaJPD","expanded_url":"http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=44717","display_url":"quotidianosanita.it/scienza-e-farm…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":104,"end":112,"username":"GIDMCRC","id":"2513596723"},{"start":113,"end":128,"username":"Aifa_ufficiale","id":"441940097"},{"start":129,"end":139,"username":"AIOMtweet","id":"3750618683"}],"hashtags":[{"start":70,"end":77,"tag":"trials"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News:maggiore trasparenza e rapidità nella condivisione dati dei #trials.  https://t.co/nSmWfxaJPD @GIDMCRC @Aifa_ufficiale @AIOMtweet","conversation_id":"795965521300717568","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"87271638","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-04T09:41:54.000Z","id":"794474743218872320","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/98y8mVLbxU","expanded_url":"http://fexp.in/TjW244377","display_url":"fexp.in/TjW244377"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":30,"end":40,"username":"MylanNews","id":"293754638"},{"start":45,"end":59,"username":"Bioconlimited","id":"397797941"},{"start":127,"end":137,"username":"ExpPharma","id":"632775011"}],"hashtags":[{"start":22,"end":29,"tag":"Review"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts for #Review @MylanNews and @Bioconlimited Regulatory Submission for Insulin Glargine https://t.co/98y8mVLbxU @ExpPharma","conversation_id":"794474743218872320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"632775011","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-03T14:09:24.000Z","id":"794179677736882176","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/T6fQK78Tly","expanded_url":"http://bit.ly/2ehV19c","display_url":"bit.ly/2ehV19c"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News announces adoption of the revised CVMP strategy on antimicrobials for 2016-2020: https://t.co/T6fQK78Tly","conversation_id":"794179677736882176","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-02T13:32:46.000Z","id":"793808067859193856","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/myhPJx4G2A","expanded_url":"http://ow.ly/TUNc305Mbgg","display_url":"ow.ly/TUNc305Mbgg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":83,"end":96,"tag":"RareDiseases"},{"start":123,"end":133,"tag":"OrphaNews"},{"start":134,"end":141,"tag":"Health"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News &amp; @US_FDA advance their collaboration by announcing a new cluster on #RareDiseases https://t.co/myhPJx4G2A | #OrphaNews #Health","conversation_id":"793808067859193856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1693323661","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-02T13:32:46.000Z","id":"793808067817267200","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/r6HJ9yXwTc","expanded_url":"http://ow.ly/TUNc305Mbgg","display_url":"ow.ly/TUNc305Mbgg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":83,"end":96,"tag":"RareDiseases"},{"start":123,"end":133,"tag":"OrphaNews"},{"start":134,"end":141,"tag":"Health"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News &amp; @US_FDA advance their collaboration by announcing a new cluster on #RareDiseases https://t.co/r6HJ9yXwTc | #OrphaNews #Health","conversation_id":"793808067817267200","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1022973996","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-01T16:25:27.000Z","id":"793489138242744320","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/b6RzY5JEAr","expanded_url":"https://slingshotinsights.com/catalysts/2738","display_url":"slingshotinsights.com/catalysts/2738"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":[{"start":49,"end":54,"tag":"CANF"}]},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Approves Phase 3 Design for Can-Fite's $CANF Trial Evaluating CF101 in Psoriasis https://t.co/b6RzY5JEAr","conversation_id":"793489138242744320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"4827482940","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-11-01T11:39:11.000Z","id":"793417098127106048","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/GhfHP8WAsi","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2016/08/event_detail_001314.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"bigdata"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #bigdata workshop takes place on 14/15 November. Take part or check out the live broadcast https://t.co/GhfHP8WAsi","conversation_id":"793417098127106048","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3880655656","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-31T13:19:05.000Z","id":"793079851196514304","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/sTOEPO7EvN","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/10/news_detail_002629.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp; PR:Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 24-27 October 2016 more at: https://t.co/sTOEPO7EvN","conversation_id":"793079851196514304","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-29T21:28:15.000Z","id":"792478177100697602","entities":{"urls":[{"start":48,"end":71,"url":"https://t.co/zQnXTMJa8z","expanded_url":"http://www.alltrials.net/news/european-medicines-agency-csr-transparency-policy-0070/","display_url":"alltrials.net/news/european-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":76,"end":86,"username":"alltrials","id":"908693395"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News releases first Clinical Study Reports https://t.co/zQnXTMJa8z via @alltrials","conversation_id":"792478177100697602","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"28824136","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-29T07:57:10.000Z","id":"792274061351059456","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/D95rKb6xCN","expanded_url":"http://www.diariofarma.com/2016/10/25/la-ema-inicia-la-publicacion-resultados-todos-los-ensayos-clinicos/28414","display_url":"diariofarma.com/2016/10/25/la-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News inicia la publicación de resultados de todos los ensayos clínicos https://t.co/D95rKb6xCN","conversation_id":"792274061351059456","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1097741347","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-28T15:50:29.000Z","id":"792030787839389696","entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/OSIcMTrN60","expanded_url":"https://twitter.com/fionapettit71/status/792030373848940545","display_url":"twitter.com/fionapettit71/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News https://t.co/OSIcMTrN60","conversation_id":"792030787839389696","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"238385284","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"792030373848940545"}]},{"created_at":"2016-10-28T12:41:43.000Z","id":"791983283886252032","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/zm03u5jFtD","expanded_url":"http://bit.ly/2eCPEVI","display_url":"bit.ly/2eCPEVI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News opens public consultation on Guideline on clinical investigation of medicinal products in paediatrics: https://t.co/zm03u5jFtD","conversation_id":"791983283886252032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-28T07:06:37.000Z","id":"791898952174043136","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/gpSMf6wS3V","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-workshop-su-registri-raccogliere-dati-di-alta-qualit%C3%A0-sui-medicinali","display_url":"agenziafarmaco.gov.it/it/content/ema…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News workshop su registri per raccogliere dati di alta qualità sui medicinali https://t.co/gpSMf6wS3V","conversation_id":"791898952174043136","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"441940097","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-28T04:19:18.000Z","id":"791856845073879040","entities":{"urls":[{"start":122,"end":145,"url":"https://t.co/lRJSyXJoTG","expanded_url":"https://twitter.com/RobertoDeCani/status/791856845073879040/photo/1","display_url":"pic.twitter.com/lRJSyXJoTG"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":93,"end":108,"username":"Aifa_ufficiale","id":"441940097"},{"start":114,"end":121,"username":"Nature","id":"15862891"}],"hashtags":[{"start":51,"end":66,"tag":"clinicaltrials"},{"start":67,"end":76,"tag":"opendata"},{"start":77,"end":92,"tag":"openinnovation"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_791856824106483713"]},"source":"Twitter for iPhone","text":"@EMA_News prima RegulatoryAgency a pubblicare dati #clinicaltrials #opendata #openinnovation\n@Aifa_ufficiale \nvia @nature https://t.co/lRJSyXJoTG","conversation_id":"791856845073879040","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"441890888","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-27T21:30:49.000Z","id":"791754047850151936","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/oijHLiVQNi","expanded_url":"https://twitter.com/erictopol/status/791739053712416768","display_url":"twitter.com/erictopol/stat…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":63,"end":78,"username":"Aifa_ufficiale","id":"441940097"},{"start":79,"end":90,"username":"WRicciardi","id":"305236970"},{"start":91,"end":102,"username":"mmelazzini","id":"1122120385"}],"hashtags":[{"start":28,"end":39,"tag":"healthcare"},{"start":40,"end":52,"tag":"DataScience"},{"start":53,"end":62,"tag":"OpenData"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News is a model for US #healthcare #DataScience #OpenData @Aifa_ufficiale @WRicciardi @mmelazzini https://t.co/oijHLiVQNi","conversation_id":"791754047850151936","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":6,"quote_count":0},"author_id":"4396246217","in_reply_to_user_id":"116716199","geo":{"place_id":"cbd9bd7672d9b0e2"},"referenced_tweets":[{"type":"quoted","id":"791739053712416768"}]},{"created_at":"2016-10-27T20:52:55.000Z","id":"791744508329398272","entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/oM3f0BicCN","expanded_url":"https://twitter.com/erictopol/status/791739053712416768","display_url":"twitter.com/erictopol/stat…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News https://t.co/oM3f0BicCN","conversation_id":"791744508329398272","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"20719587","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"791739053712416768"}]},{"created_at":"2016-10-27T17:11:43.000Z","id":"791688842013212672","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/P3lMppP0V7","expanded_url":"http://www.pharmafile.com/news/511075/ema-opens-clinical-trial-data-public#.WA8cCBfHVcM.linkedin","display_url":"pharmafile.com/news/511075/em…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":29,"tag":"Medicines"},{"start":43,"end":58,"tag":"clinicaltrials"},{"start":83,"end":94,"tag":"drugpolicy"},{"start":95,"end":108,"tag":"healthpolicy"},{"start":109,"end":116,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News European #Medicines Agency makes #clinicaltrials data open to the public #drugpolicy #healthpolicy #pharma https://t.co/P3lMppP0V7","conversation_id":"791688842013212672","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"13506772","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-27T15:50:02.000Z","id":"791668284290629632","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/15BTHXNcCT","expanded_url":"https://twitter.com/EMA_News/status/790919586904477696","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":56,"tag":"openctdata"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News is the first institution to launch #openctdata on clinical trials https://t.co/15BTHXNcCT","conversation_id":"791668284290629632","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1979320764","in_reply_to_user_id":"116716199","geo":{"place_id":"08be9e4ebe3d037d"},"referenced_tweets":[{"type":"quoted","id":"790919586904477696"}]},{"created_at":"2016-10-26T13:13:33.000Z","id":"791266517673447424","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":125,"end":135,"tag":"TotalSham"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @eurordis Patients will have access? LOL. Yeh, as long as they jump through a zillion hoops and happen to be a Dr. #TotalSham","conversation_id":"791252329756524544","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"791252329756524544"}]},{"created_at":"2016-10-26T08:26:09.000Z","id":"791194191271428096","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":46,"end":51,"probability":0.9823,"type":"Place","normalized_text":"London"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Mobile Web (M2)","text":"@EMA_News brexit EMA. Think about moving from London to Nice, French riviera. International airport, big building available, best will come!","conversation_id":"791194191271428096","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"132825754","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-25T15:40:34.000Z","id":"790941126358405120","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/NN7GM2ntSN","expanded_url":"http://miguelangelblanes.com/2016/10/25/mea","display_url":"miguelangelblanes.com/2016/10/25/mea"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Measures to increase transparency, accountability and integrity in the EU. In my blog https://t.co/NN7GM2ntSN…","conversation_id":"790919586904477696","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"516897567","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"790919586904477696"}]},{"created_at":"2016-10-25T15:11:25.000Z","id":"790933791544119296","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/eImYbfOkjO","expanded_url":"http://www.imfarmacias.es/noticia/10787/la-ema-publicara-todos-los-informes-clinicos-de-los-futuros-medicamentos-en-la-ue","display_url":"imfarmacias.es/noticia/10787/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":97,"username":"imfarmacias","id":"347757533"}],"hashtags":[{"start":98,"end":115,"tag":"ContiacSanitario"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"OS X","text":"@EMA_News publicará todos los informes clínicos de futuros medicamentos en la UE vía @imfarmacias #ContiacSanitario https://t.co/eImYbfOkjO","conversation_id":"790933791544119296","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3888865889","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-25T07:24:45.000Z","id":"790816350344212480","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":47,"end":48,"probability":0.8884,"type":"Place","normalized_text":"UK"},{"start":114,"end":119,"probability":0.5444,"type":"Other","normalized_text":"Brexit"},{"start":125,"end":126,"probability":0.9267,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Could you tell me how much money the UK currently contributes to the EMA and how this would change post-Brexit, if UK stays in EMA","conversation_id":"790816350344212480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"22989971","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-25T05:28:34.000Z","id":"790787112668921856","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/EmjoZ6FkA1","expanded_url":"https://goo.gl/ONXIC5","display_url":"goo.gl/ONXIC5"},{"start":92,"end":115,"url":"https://t.co/YScoNm4gNN","expanded_url":"https://twitter.com/pesceinrete/status/790787112668921856/photo/1","display_url":"pic.twitter.com/YScoNm4gNN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":13,"tag":"EU"},{"start":44,"end":56,"tag":"antibiotici"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_790787054179418112"]},"source":"Twitter Web Client","text":"@EMA_News #EU, in diminuzione le vendite di #antibiotici veterinari\nhttps://t.co/EmjoZ6FkA1 https://t.co/YScoNm4gNN","conversation_id":"790787112668921856","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2923595561","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-24T16:43:08.000Z","id":"790594483654197248","entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/AyloaY18HD","expanded_url":"http://ow.ly/jjYr305tRaj","display_url":"ow.ly/jjYr305tRaj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":65,"tag":"Regulatory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News Sets Deadlines for 2016 Type I Variations | #Regulatory Focus https://t.co/AyloaY18HD","conversation_id":"790594483654197248","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"111425542","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-24T16:01:37.000Z","id":"790584035659644928","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Yes - thanks for the clarification","conversation_id":"789501776072417280","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"308526080","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"790581827811639296"}]},{"created_at":"2016-10-24T15:27:07.000Z","id":"790575354394054660","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":75,"tag":"animal_testing"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News 3 R's dating back to 1959. Implementing in 2016?! #animal_testing","conversation_id":"790572310478647297","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"790572310478647297"}]},{"created_at":"2016-10-24T09:13:02.000Z","id":"790481213861527552","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/qJ1dczJZDn","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2016/10/WC500214989.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":116,"end":126,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_news now provides public access to clinical data on new medicines in clinical reports: https://t.co/qJ1dczJZDn #alltrials","conversation_id":"790481213861527552","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"author_id":"409903803","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-23T21:43:56.000Z","id":"790307795836952577","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"myESMO","id":"69232855"},{"start":99,"end":104,"username":"uicc","id":"53023973"},{"start":105,"end":109,"username":"NIH","id":"15134240"},{"start":110,"end":123,"username":"janoldenburg","id":"16912546"},{"start":124,"end":138,"username":"PhilipsHealth","id":"745667849918754816"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @myESMO Congratulations, I will say stop clinical trials to redesign the research system @uicc @NIH @janoldenburg @PhilipsHealth","conversation_id":"789111434672279552","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"744606863224774656","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"789111434672279552"}]},{"created_at":"2016-10-23T11:41:00.000Z","id":"790156062548713472","entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/RTQ3XZ0tpO","expanded_url":"http://buff.ly/2eDyZOP","display_url":"buff.ly/2eDyZOP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":85,"tag":"farmaci"},{"start":86,"end":109,"tag":"sperimentazioneanimale"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Buffer","text":"@EMA_News rende accessibili i dati sui trial clinici https://t.co/RTQ3XZ0tpO #farmaci #sperimentazioneanimale","conversation_id":"790156062548713472","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2755206512","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-21T07:50:40.000Z","id":"789373322173751296","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Les premiers dossiers d'AMM en \"open data: Krypolis et Zurampic ouvrent le bal!","conversation_id":"789107714869690368","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"788996789672275968","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"789107714869690368"}]},{"created_at":"2016-10-20T21:55:59.000Z","id":"789223663572754432","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Why cannot ALL citizens download those datas as PDF ???","conversation_id":"789116463667933184","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2684774340","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"789116463667933184"}]},{"created_at":"2016-10-20T14:50:35.000Z","id":"789116609050841088","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/yrY5EynJqK","expanded_url":"http://www.rue89strasbourg.com/strasbourg-doit-se-bouger-ame-112998","display_url":"rue89strasbourg.com/strasbourg-doi…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":24,"tag":"Strasbourg"},{"start":53,"end":57,"tag":"EMA"},{"start":91,"end":98,"tag":"alsace"},{"start":99,"end":110,"tag":"medicament"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@ema_news If #Strasbourg wants to be the seat of the #EMA, we must be active and mobilised #alsace #medicament https://t.co/yrY5EynJqK","conversation_id":"789116609050841088","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"301351765","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-20T07:46:56.000Z","id":"789009994868023296","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News le projet PRIME, cela concerne qui?","conversation_id":"788782605051301888","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"788996789672275968","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"788782605051301888"}]},{"created_at":"2016-10-18T14:20:26.000Z","id":"788384245534318592","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/7NEP2BhH68","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/10/news_detail_002620.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function https://t.co/7NEP2BhH68","conversation_id":"788384245534318592","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"215384125","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-18T13:00:03.000Z","id":"788364017794420737","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/Su3Xog1Ka9","expanded_url":"https://www.theguardian.com/environment/2016/oct/17/use-of-strongest-antibiotics-rises-to-record-levels-on-european-farms","display_url":"theguardian.com/environment/20…"},{"start":131,"end":154,"url":"https://t.co/qX8RcP3wPn","expanded_url":"https://twitter.com/sustainIt/status/788364017794420737/photo/1","display_url":"pic.twitter.com/qX8RcP3wPn"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":106,"end":121,"username":"ASOAntibiotics","id":"526576312"}],"hashtags":[{"start":28,"end":40,"tag":"antibiotics"},{"start":122,"end":130,"tag":"farming"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_788311081940819968"]},"source":"TweetDeck","text":"@EMA_News: use of strongest #antibiotics rises to record levels on European farms https://t.co/Su3Xog1Ka9 @ASOAntibiotics #farming https://t.co/qX8RcP3wPn","conversation_id":"788364017794420737","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"97184109","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-17T13:31:46.000Z","id":"788009611907457025","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/zxWpG7n4ju","expanded_url":"http://fiddaman.blogspot.co.uk/2016/10/prime-minister-of-netherlands-offers.html","display_url":"fiddaman.blogspot.co.uk/2016/10/prime-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":30,"tag":"Paediatric"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Are your #Paediatric Committee put in place to protect children from unsafe drugs? - https://t.co/zxWpG7n4ju","conversation_id":"788009172981866498","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"788009172981866498"}]},{"created_at":"2016-10-17T13:30:00.000Z","id":"788009168737226752","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/tfviDEaoY2","expanded_url":"https://slingshotinsights.com/catalysts/2623","display_url":"slingshotinsights.com/catalysts/2623"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":[{"start":37,"end":42,"tag":"TEVA"}]},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News Adopts Positive Opinion of $TEVA's Trisenox in Promyelocytic Leukemia. Decision Expected in ~60 Days. https://t.co/tfviDEaoY2","conversation_id":"788009168737226752","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4827482940","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-17T13:11:56.000Z","id":"788004620970913792","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":12,"tag":"A"},{"start":46,"end":49,"tag":"CT"}],"annotations":[{"start":13,"end":18,"probability":0.3918,"type":"Person","normalized_text":"Marcal"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News #A.Marcal tells that development of #CT portal and database is going well forward - it is a key to implement the new Regulation","conversation_id":"788004620970913792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2876403948","in_reply_to_user_id":"116716199","geo":{"place_id":"018e2bf71a3ef896"},"referenced_tweets":{}},{"created_at":"2016-10-14T10:20:46.000Z","id":"786874379238072320","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Many thanks, it's done!","conversation_id":"786868079254966273","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"517469921","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"786873537244037120"}]},{"created_at":"2016-10-12T09:43:19.000Z","id":"786140181954867200","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/gfmNpv2M4T","expanded_url":"http://bit.ly/2dsBMtK","display_url":"bit.ly/2dsBMtK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":18,"username":"ESCMID","id":"107346436"},{"start":25,"end":40,"username":"ASMicrobiology","id":"285165232"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News .@ESCMID &amp; @ASMicrobiology review need for new strategies and tactics to fight antimicrobial resistance https://t.co/gfmNpv2M4T","conversation_id":"786140181954867200","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2154631964","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-11T16:35:18.000Z","id":"785881471877865473","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/lzA2A9ioc7","expanded_url":"http://bit.ly/2d96ur7","display_url":"bit.ly/2d96ur7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":83,"end":91,"username":"RAPSorg","id":"111425542"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"},{"start":92,"end":105,"tag":"onlinehealth"},{"start":106,"end":124,"tag":"digitalhealthcare"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News EMA board signs off new #medicines web portal || https://t.co/lzA2A9ioc7 @RAPSorg #onlinehealth #digitalhealthcare","conversation_id":"785881471877865473","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-11T09:27:38.000Z","id":"785773846083215360","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":117,"end":124,"tag":"AHCS16"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News EMA's Eichler: \"We’ll see more orphanization of drugs...That’s the success of science – precision medicine\"#AHCS16","conversation_id":"785773846083215360","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"869333647","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-10T12:15:35.000Z","id":"785453726119133184","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/VXZi5JD9SM","expanded_url":"http://ow.ly/nPNH304PHpt","display_url":"ow.ly/nPNH304PHpt"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":13,"end":20,"username":"US_FDA","id":"208120290"},{"start":125,"end":140,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":83,"end":96,"tag":"MalattieRare"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  e @US_FDA  unite per il rilancio dello sviluppo di nuovi farmaci contro #MalattieRare https://t.co/VXZi5JD9SM via @Aifa_ufficiale","conversation_id":"785453726119133184","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"2827724028","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-09T14:35:00.000Z","id":"785126420829831168","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"},{"start":73,"end":83,"username":"FEDER_ONG","id":"19394390"},{"start":84,"end":97,"username":"NoInvisibles","id":"1389099654"},{"start":98,"end":110,"username":"RarasReales","id":"3261814737"}],"hashtags":[{"start":65,"end":68,"tag":"EE"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News y @US_FDA ponen en marcha un ‘clúster’ para avanzar en #EE.RR. @FEDER_ONG @NoInvisibles @RarasReales \nColaborar es el camino","conversation_id":"785126420829831168","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"543802399","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-07T23:07:16.000Z","id":"784530560349790208","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News","conversation_id":"784390251150278660","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4252304357","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"784390251150278660"}]},{"created_at":"2016-10-07T01:22:48.000Z","id":"784202281478520832","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/yXccaHVHtM","expanded_url":"https://www.youtube.com/watch?v=rBO8z9pHAuA","display_url":"youtube.com/watch?v=rBO8z9…"},{"start":79,"end":102,"url":"https://t.co/7WQBoJMqMP","expanded_url":"http://www.cheniere.org/books/aids/priore.htm","display_url":"cheniere.org/books/aids/pri…"},{"start":104,"end":127,"url":"https://t.co/AG1cRA9irf","expanded_url":"http://energyfromthevacuum.com/BediniBPRX/BediniBPRX.html","display_url":"energyfromthevacuum.com/BediniBPRX/Bed…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News\n\nTECHNOLOGY TRANSFER WILL BENEFIT MEDICINE\n\nhttps://t.co/yXccaHVHtM\n\nhttps://t.co/7WQBoJMqMP\n\nhttps://t.co/AG1cRA9irf","conversation_id":"784202281478520832","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4890466992","in_reply_to_user_id":"116716199","geo":{"place_id":"b49b3053b5c25bf5"},"referenced_tweets":{}},{"created_at":"2016-10-06T20:28:10.000Z","id":"784128135549841408","entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/YZK5HpXo0Z","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/09/news_detail_002609.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":30,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp; @FDA_Drug_Info EU-US collaboration on rare diseases to share regulatory experiences and best practices https://t.co/YZK5HpXo0Z","conversation_id":"784128135549841408","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"2194335170","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-06T16:46:48.000Z","id":"784072428586762240","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/EIuGvmMhSZ","expanded_url":"http://bit.ly/2dAlHnf","display_url":"bit.ly/2dAlHnf"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News and @US_FDA set up new working group on rare diseases. Get all of the details here: https://t.co/EIuGvmMhSZ","conversation_id":"784072428586762240","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-05T11:39:36.000Z","id":"783632731137802240","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/nJyVnPKxUy","expanded_url":"http://bit.ly/2dwLrkr","display_url":"bit.ly/2dwLrkr"},{"start":119,"end":142,"url":"https://t.co/pOMoky0vsi","expanded_url":"http://bit.ly/2ds0mOo","display_url":"bit.ly/2ds0mOo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":84,"tag":"pharma"},{"start":85,"end":94,"tag":"intrigue"}],"annotations":[{"start":57,"end":58,"probability":0.7392,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News mgnt bd meets today &amp; tomoz for 1st time since UK Brexit vote. #pharma #intrigue https://t.co/nJyVnPKxUy https://t.co/pOMoky0vsi","conversation_id":"783632731137802240","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"552617924","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-04T15:15:23.000Z","id":"783324643931324416","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/VXZi5JD9SM","expanded_url":"http://ow.ly/nPNH304PHpt","display_url":"ow.ly/nPNH304PHpt"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":13,"end":20,"username":"US_FDA","id":"208120290"},{"start":125,"end":140,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":83,"end":96,"tag":"MalattieRare"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  e @US_FDA  unite per il rilancio dello sviluppo di nuovi farmaci contro #MalattieRare https://t.co/VXZi5JD9SM via @Aifa_ufficiale","conversation_id":"783324643931324416","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"2827724028","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-04T06:32:04.000Z","id":"783192946573209600","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News To cure EMA-incest: Working Party members should not be EU/national regulators and appointed for 1 term of 4 years.","conversation_id":"783192946573209600","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"822029077","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-04T06:28:13.000Z","id":"783191978716594176","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News CHMP Working Parties are to get up-to-date outside expertise, but most members are from the regulatory system who stay for life.","conversation_id":"783191978716594176","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"822029077","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-03T19:33:09.000Z","id":"783027126891077632","entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/axCLYp1rW4","expanded_url":"http://pharmaexpertise.com/ema-y-fda-crean-un-grupo-de-intercambio-de-informacion-regulatoria/","display_url":"pharmaexpertise.com/ema-y-fda-crea…"},{"start":101,"end":124,"url":"https://t.co/RyA1SNYjST","expanded_url":"https://twitter.com/PharmaExpertise/status/783027126891077632/photo/1","display_url":"pic.twitter.com/RyA1SNYjST"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_783027113175707648"]},"source":"Twitter Web Client","text":"@EMA_News y @US_FDA crean un grupo de intercambio de información regulatoria\nhttps://t.co/axCLYp1rW4 https://t.co/RyA1SNYjST","conversation_id":"783027126891077632","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1242516320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-03T17:05:38.000Z","id":"782990003903148032","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/WS2rEmDyQh","expanded_url":"http://bit.ly/2dLv8Ub","display_url":"bit.ly/2dLv8Ub"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":39,"username":"ABScience_US","id":"478713224"}],"hashtags":[{"start":42,"end":52,"tag":"masitinib"}],"annotations":[{"start":74,"end":102,"probability":0.4477,"type":"Other","normalized_text":"Amyotrophic Lateral Sclerosis"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts MAA for @ABScience_US's #masitinib for the treatment of Amyotrophic Lateral Sclerosis (ALS) https://t.co/WS2rEmDyQh","conversation_id":"782990003903148032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":10,"quote_count":0},"author_id":"2853401031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-03T15:37:00.000Z","id":"782967698603053056","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/zgmpzU4rUD","expanded_url":"http://bit.ly/2dc9IwT","display_url":"bit.ly/2dc9IwT"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":71,"end":81,"tag":"alzheimer"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Buffer","text":"@EMA_News – Data sharing and collaboration can fill scientific gaps in #alzheimer https://t.co/zgmpzU4rUD","conversation_id":"782967698603053056","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1351548962","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-03T10:30:13.000Z","id":"782890492275073024","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/SdBIP7qdQF","expanded_url":"http://ow.ly/MeMt304MPz7","display_url":"ow.ly/MeMt304MPz7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":70,"end":82,"tag":"RareDisease"},{"start":109,"end":122,"tag":"biotech4life"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News &amp; @US_FDA join forces to boost medicine development for #RareDisease - https://t.co/SdBIP7qdQF #biotech4life","conversation_id":"782890492275073024","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-03T08:50:48.000Z","id":"782865474086244352","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/h3obSvGPRR","expanded_url":"https://lnkd.in/ezJfk-P","display_url":"lnkd.in/ezJfk-P"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":68,"end":80,"tag":"raredisease"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"LinkedIn","text":"@EMA_News - @US_FDA collaboration to boost medicine development for #raredisease \nhttps://t.co/h3obSvGPRR","conversation_id":"782865474086244352","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"98873327","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-10-02T07:41:01.000Z","id":"782485524980244480","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/EiBFK6fE1K","expanded_url":"http://bit.ly/2d5rHnw","display_url":"bit.ly/2d5rHnw"},{"start":116,"end":139,"url":"https://t.co/8ihTbZm6x7","expanded_url":"https://twitter.com/myTomorrows/status/782485524980244480/photo/1","display_url":"pic.twitter.com/8ihTbZm6x7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":68,"end":80,"tag":"raredisease"},{"start":105,"end":115,"tag":"treatment"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_782485522665000960"]},"source":"Buffer","text":"@EMA_News - @US_FDA collaboration to boost medicine development for #raredisease https://t.co/EiBFK6fE1K #treatment https://t.co/8ihTbZm6x7","conversation_id":"782485524980244480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1351548962","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-29T12:26:34.000Z","id":"781470223484522496","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/e7WWLoYi9n","expanded_url":"http://www.maximiseconference.co.uk","display_url":"maximiseconference.co.uk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":65,"end":78,"tag":"Maximise2016"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Thank you for connecting with me, have you heard about #Maximise2016 Conference? https://t.co/e7WWLoYi9n","conversation_id":"781470223484522496","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1899620984","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-28T21:43:07.000Z","id":"781247892560502784","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News are PSUR/PBRERs publicly available on your website? Can't seem to find any..","conversation_id":"781247892560502784","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2518423562","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-28T15:35:34.000Z","id":"781155395616276480","entities":{"urls":{},"mentions":[{"start":72,"end":81,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"Good to see use of adjuvants in vaccines 4 use w/ animals R scrutinised @EMA_News - hv adjuvants in vaxes 4 humans been thro same scrutiny","conversation_id":"781153159301435392","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"264174110","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"781153159301435392"}]},{"created_at":"2016-09-28T12:55:20.000Z","id":"781115071963471872","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/B1tMCNlTNF","expanded_url":"http://goo.gl/mQzDEh","display_url":"goo.gl/mQzDEh"},{"start":102,"end":125,"url":"https://t.co/5kmDxQZH1r","expanded_url":"https://twitter.com/PharPoint/status/781115071963471872/photo/1","display_url":"pic.twitter.com/5kmDxQZH1r"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":52,"end":64,"tag":"raredisease"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_781114980477308929"]},"source":"Twitter Web Client","text":"@EMA_News and @US_FDA will improve info sharing for #raredisease medications: https://t.co/B1tMCNlTNF https://t.co/5kmDxQZH1r","conversation_id":"781115071963471872","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"282805521","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-26T12:09:58.000Z","id":"780378882167959552","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/vM6Gvcyfuk","expanded_url":"http://bit.ly/2daFc69","display_url":"bit.ly/2daFc69"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":68,"end":71,"probability":0.6735,"type":"Place","normalized_text":"Zika"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News determines plasma- and urine- derived medicines safe from Zika contamination: https://t.co/vM6Gvcyfuk","conversation_id":"780378882167959552","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-23T15:52:14.000Z","id":"779347650172841984","entities":{"urls":[{"start":62,"end":85,"url":"https://t.co/KKhmjs6N58","expanded_url":"http://bit.ly/2ctdyDr","display_url":"bit.ly/2ctdyDr"},{"start":116,"end":139,"url":"https://t.co/41zLwbl4kT","expanded_url":"http://bit.ly/295bZVw","display_url":"bit.ly/295bZVw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":92,"end":97,"username":"beuc","id":"237222584"}],"hashtags":[{"start":36,"end":53,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to organise a workshop on #adaptivepathways on 8/12 https://t.co/KKhmjs6N58. Here @beuc pending questions:https://t.co/41zLwbl4kT","conversation_id":"779347650172841984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1106659014","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-22T16:38:00.000Z","id":"778996782021869568","entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/3U0MAvzVQd","expanded_url":"http://pharmaexpertise.com/ema_news-recommends-approval-of-10-drugs/","display_url":"pharmaexpertise.com/ema_news-recom…"},{"start":66,"end":89,"url":"https://t.co/CndWvFZtwM","expanded_url":"https://twitter.com/PharmaExpertise/status/778996782021869568/photo/1","display_url":"pic.twitter.com/CndWvFZtwM"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_778996768109424640"]},"source":"Twitter Web Client","text":"@EMA_News recommends approval of 10 drugs\nhttps://t.co/3U0MAvzVQd https://t.co/CndWvFZtwM","conversation_id":"778996782021869568","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1242516320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-21T12:26:47.000Z","id":"778571171516276736","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":54,"end":68,"username":"Bristol_Myers","id":"37746748"},{"start":103,"end":115,"username":"DRGinsights","id":"193936020"}],"hashtags":[{"start":88,"end":102,"tag":"bladdercancer"},{"start":116,"end":130,"tag":"AskDRGexperts"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News validates Type II variation application for @Bristol_Myers Opdivo in advanced #bladdercancer @DRGinsights #AskDRGexperts","conversation_id":"778571171516276736","possibly_sensitive":false,"lang":"da","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"726106535802363904","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-21T08:13:34.000Z","id":"778507449049505792","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/V4D86O6vDV","expanded_url":"https://twitter.com/JamieNWilkinson/status/778507449049505792/photo/1","display_url":"pic.twitter.com/V4D86O6vDV"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":98,"end":116,"tag":"pharmacovigilance"}],"annotations":[{"start":27,"end":31,"probability":0.3697,"type":"Person","normalized_text":"Raine"}],"cashtags":{}},"attachments":{"media_keys":["3_778507446881021952"]},"source":"Twitter for BlackBerry","text":"@EMA_News #PRAC Chair June Raine \"together we can deliver excellence in public health protection\" #pharmacovigilance https://t.co/V4D86O6vDV","conversation_id":"778507449049505792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"210623862","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-20T15:45:16.000Z","id":"778258734480961536","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/dLCA25g5Kb","expanded_url":"https://slingshotinsights.com/catalysts/2435","display_url":"slingshotinsights.com/catalysts/2435"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":26,"end":37,"probability":0.4578,"type":"Person","normalized_text":"Myers Squibb"}],"cashtags":[{"start":41,"end":45,"tag":"BMY"}]},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News Accepts Bristol-Myers Squibb's $BMY Marketing Application for New Use of Opdivo in Urothelial Carcinoma https://t.co/dLCA25g5Kb","conversation_id":"778258734480961536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4827482940","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-19T10:28:56.000Z","id":"777816739451170816","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/cZCKVl0tzI","expanded_url":"http://eacpt.blogspot.co.uk/2016/09/digital-media-for-health-and-european.html","display_url":"eacpt.blogspot.co.uk/2016/09/digita…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":58,"end":69,"username":"gulmezezgi","id":"1659938466"},{"start":70,"end":79,"username":"jbethell","id":"21903796"},{"start":80,"end":89,"username":"ColumbaQ","id":"846228950"}],"hashtags":[{"start":45,"end":57,"tag":"SocMedWkshp"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News discussing social media for health #SocMedWkshp @gulmezezgi @jbethell @ColumbaQ https://t.co/cZCKVl0tzI","conversation_id":"777816739451170816","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"author_id":"27751277","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-19T09:35:14.000Z","id":"777803226007633920","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":15,"end":22,"tag":"brexit"},{"start":120,"end":134,"tag":"MahatmaGandhi"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News post #brexit will continue using English as social media language. The English left, but left behind English! #MahatmaGandhi 1947","conversation_id":"777803226007633920","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3435573694","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-19T09:28:07.000Z","id":"777801434096078848","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/bmmJ3RATad","expanded_url":"https://twitter.com/eumsplatform/status/777801434096078848/photo/1","display_url":"pic.twitter.com/bmmJ3RATad"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":63,"end":66,"tag":"MS"},{"start":98,"end":110,"tag":"SocMedWkshp"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_777801430677741568"]},"source":"Twitter for Windows Phone","text":"@EMA_News heading towards more engagement on social media. Our #MS community is ready to support! #SocMedWkshp@EMA https://t.co/bmmJ3RATad","conversation_id":"777801434096078848","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"600110872","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-16T20:03:27.000Z","id":"776874156784750592","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"myESMO","id":"69232855"},{"start":60,"end":70,"username":"RAMOSERIK","id":"66915267"},{"start":71,"end":86,"username":"arturosuplee27","id":"249013448"},{"start":87,"end":101,"username":"LorenaMontijo","id":"621575514"},{"start":102,"end":110,"username":"yvano07","id":"262958474"},{"start":111,"end":123,"username":"dra_gvargas","id":"747303998600810496"},{"start":124,"end":138,"username":"DurazoAlberto","id":"395426686"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @myESMO Let's see this data in the original paper @RAMOSERIK @arturosuplee27 @LorenaMontijo @yvano07 @dra_gvargas @DurazoAlberto","conversation_id":"776741724190306304","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"author_id":"744606863224774656","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"776741724190306304"}]},{"created_at":"2016-09-13T07:40:11.000Z","id":"775599946431070209","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/HJ8FN0uzWa","expanded_url":"http://goo.gl/ccqBoj","display_url":"goo.gl/ccqBoj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":82,"end":96,"username":"DaniloMazzara","id":"617399514"}],"hashtags":[{"start":41,"end":56,"tag":"DrugRegulation"},{"start":57,"end":70,"tag":"celltheraphy"},{"start":71,"end":81,"tag":"EMAMilano"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News is looking for a new office... #DrugRegulation #celltheraphy #EMAMilano @DaniloMazzara https://t.co/HJ8FN0uzWa","conversation_id":"775599946431070209","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":2},"author_id":"4396246217","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-12T21:52:00.000Z","id":"775451923877076992","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News great!!!","conversation_id":"775359915158282244","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"421874846","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"775359915158282244"}]},{"created_at":"2016-09-09T16:30:39.000Z","id":"774283887967109120","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/nHYC36YO7D","expanded_url":"http://ow.ly/SKLS3043O3k","display_url":"ow.ly/SKLS3043O3k"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":55,"tag":"AdaptivePathways"},{"start":121,"end":137,"tag":"PatientsBenefit"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News wants to hear your views on #AdaptivePathways! Book your seat for its workshop on 8/12 https://t.co/nHYC36YO7D #PatientsBenefit","conversation_id":"774283887967109120","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-09T14:36:19.000Z","id":"774255116669087744","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":70,"end":74,"username":"WHO","id":"14499829"}],"hashtags":[{"start":119,"end":126,"tag":"pharma"},{"start":127,"end":137,"tag":"medicines"}],"annotations":[{"start":42,"end":51,"probability":0.9543,"type":"Person","normalized_text":"Emer Cooke"},{"start":76,"end":94,"probability":0.7048,"type":"Person","normalized_text":"Agnès Saint-Raymond"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News's Head of International Affairs Emer Cooke gets new role at @WHO; Agnès Saint-Raymond to take interim charge #pharma #medicines","conversation_id":"774255116669087744","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"459335626","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-09T09:12:28.000Z","id":"774173616174870528","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":28,"end":37,"tag":"Giappone"},{"start":79,"end":87,"tag":"batteri"},{"start":91,"end":103,"tag":"antibiotici"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @US_FDA e agenzia #Giappone verso regole condivise contro resistenza #batteri ad #antibiotici","conversation_id":"774173616174870528","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"408478366","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-08T19:56:29.000Z","id":"773973299655303168","entities":{"urls":[{"start":51,"end":74,"url":"https://t.co/xy0E4cbC4F","expanded_url":"http://bit.ly/2cdimbv","display_url":"bit.ly/2cdimbv"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News will revise herbal medicine guildelines: https://t.co/xy0E4cbC4F","conversation_id":"773973299655303168","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-07T13:34:22.000Z","id":"773514752937062400","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News registration appears to be closed. Any way for interested parties to see the live broadcast?","conversation_id":"773506628951867392","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"257890789","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"773506628951867392"}]},{"created_at":"2016-09-07T08:37:17.000Z","id":"773439987383607296","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/aW9X6dQr5P","expanded_url":"http://www.pmfarma.es/noticias/23247-ema-acepta-revision-de-solicitud-de-comercializacion-para-sarilumab.html?utm_source=feedly-empleo&utm_medium=rss","display_url":"pmfarma.es/noticias/23247…"},{"start":107,"end":130,"url":"https://t.co/3OuOChkOMr","expanded_url":"https://twitter.com/abogadofarmacia/status/773439987383607296/photo/1","display_url":"pic.twitter.com/3OuOChkOMr"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":74,"end":82,"username":"PMFarma","id":"152983899"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_773419778178449408"]},"source":"TweetDeck","text":"@EMA_News acepta revisión de solicitud de comercialización para sarilumab @PMFARMA https://t.co/aW9X6dQr5P https://t.co/3OuOChkOMr","conversation_id":"773439987383607296","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"3313048648","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-06T23:20:48.000Z","id":"773299942521729024","entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/ylpyqR6fZO","expanded_url":"https://twitter.com/joanne4142/status/773281725183062016","display_url":"twitter.com/joanne4142/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News https://t.co/ylpyqR6fZO","conversation_id":"773299942521729024","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"39797707","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-05T08:49:04.000Z","id":"772718178443128832","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/AZurn71GUD","expanded_url":"https://twitter.com/fimmgnotizie/status/772714059636568064","display_url":"twitter.com/fimmgnotizie/s…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":34,"tag":"EFPC2016"},{"start":74,"end":86,"tag":"PrimaryCare"}],"annotations":[{"start":10,"end":20,"probability":0.9397,"type":"Person","normalized_text":"Ivana Silva"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Ivana Silva at #EFPC2016 explaning the need to collaborate with #PrimaryCare professionals https://t.co/AZurn71GUD","conversation_id":"772718178443128832","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"164835748","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"772714059636568064"}]},{"created_at":"2016-09-05T07:52:06.000Z","id":"772703840705576962","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/U7aNY2psGV","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/09/news_detail_002593.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 30 Aug-2 Sept 2016 more at: https://t.co/U7aNY2psGV","conversation_id":"772703840705576962","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-02T20:31:21.000Z","id":"771807749361598464","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/ANQrzbyEE9","expanded_url":"http://ow.ly/p3zo303CQV5","display_url":"ow.ly/p3zo303CQV5"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News announced organizational adjustments designed to improve operational efficiency. https://t.co/ANQrzbyEE9","conversation_id":"771807749361598464","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-09-02T14:01:30.000Z","id":"771709641411690496","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/45x73qu5R1","expanded_url":"http://ow.ly/z5ud303PUhQ","display_url":"ow.ly/z5ud303PUhQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":60,"tag":"Regulatory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News to Revise Herbal Medicines Guideline | #Regulatory Focus https://t.co/45x73qu5R1","conversation_id":"771709641411690496","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"111425542","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-31T16:34:46.000Z","id":"771023435132702720","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/KaIwqmqNGc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/general/general_content_000575.jsp&mid=WC0b01ac058077ce81","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":35,"tag":"EMABasics"},{"start":40,"end":49,"tag":"patients"},{"start":54,"end":65,"tag":"healthcare"},{"start":80,"end":89,"tag":"training"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News publishes more #EMABasics for #patients and #healthcare-professionals #training  https://t.co/KaIwqmqNGc","conversation_id":"771023435132702720","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-30T18:31:18.000Z","id":"770690374700597248","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/bdvkbFQp5T","expanded_url":"http://ow.ly/5EAq303CN1o","display_url":"ow.ly/5EAq303CN1o"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News has announced new recommendations for monitoring the safety of biologics and biosimilars. https://t.co/bdvkbFQp5T","conversation_id":"770690374700597248","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-30T12:30:15.000Z","id":"770599512729608192","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/qdpCh7gENZ","expanded_url":"https://twitter.com/Fiddaman/status/770599512729608192/photo/1","display_url":"pic.twitter.com/qdpCh7gENZ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_770599468714627073"]},"source":"Twitter Web Client","text":"@EMA_News @OlgaLeclercq - Busy again I see? How about answering the question - list the benefits of SSRi's. https://t.co/qdpCh7gENZ","conversation_id":"770599512729608192","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-29T14:28:35.000Z","id":"770266903252262912","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":59,"tag":"pros"},{"start":82,"end":92,"tag":"beyondA1c"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News rep days need to consider Time in Range and #pros to evaluate new drugs #beyondA1c","conversation_id":"770266903252262912","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"22931050","in_reply_to_user_id":"116716199","geo":{"place_id":"888a737e5a80300c"},"referenced_tweets":{}},{"created_at":"2016-08-25T16:15:16.000Z","id":"768844200980938752","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/mD3myxebde","expanded_url":"http://ow.ly/ClfO303xzeR","display_url":"ow.ly/ClfO303xzeR"},{"start":102,"end":125,"url":"https://t.co/MT16oiKi75","expanded_url":"https://twitter.com/EuropaBio/status/768844200980938752/photo/1","display_url":"pic.twitter.com/MT16oiKi75"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":51,"tag":"Biosimilars"}],"annotations":[{"start":67,"end":72,"probability":0.9934,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":["3_768844198866980864"]},"source":"Hootsuite","text":"@EMA_News new chapter in monitoring of #Biosimilars &amp; biologics in Europe https://t.co/mD3myxebde https://t.co/MT16oiKi75","conversation_id":"768844200980938752","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-25T13:05:02.000Z","id":"768796327060922369","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/0s4V0cAv9S","expanded_url":"http://fexp.in/HMf243823","display_url":"fexp.in/HMf243823"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":30,"username":"MylanNews","id":"293754638"},{"start":35,"end":49,"username":"Bioconlimited","id":"397797941"}],"hashtags":[{"start":50,"end":61,"tag":"Regulatory"},{"start":63,"end":75,"tag":"submissions"},{"start":89,"end":101,"tag":"Biosimilars"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to review @MylanNews and @Bioconlimited #Regulatory  #submissions for proposed #Biosimilars Trastuzumab https://t.co/0s4V0cAv9S","conversation_id":"768796327060922369","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"632775011","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-23T14:56:27.000Z","id":"768099591648604160","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/gA4R6dneFl","expanded_url":"https://www.facebook.com/events/284632105262014/","display_url":"facebook.com/events/2846321…","status":200,"unwound_url":"https://www.facebook.com/events/284632105262014/"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":52,"end":67,"probability":0.9479,"type":"Person","normalized_text":"Shirley Melendez"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News EMPADRONAN VICTIMAS DE CARNICERIA ESSALUD-Shirley Melendez-989634753-J25Ago-4pm Pq Kennedy-Miraf.https://t.co/gA4R6dneFl","conversation_id":"768099591648604160","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"262237757","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-22T12:52:17.000Z","id":"767705952938237952","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/gPfXcuAdNm","expanded_url":"https://twitter.com/Fiddaman/status/767705952938237952/photo/1","display_url":"pic.twitter.com/gPfXcuAdNm"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":43,"username":"GSK","id":"5383942"}],"hashtags":[{"start":44,"end":51,"tag":"Sierre"},{"start":52,"end":60,"tag":"Seroxat"},{"start":61,"end":70,"tag":"Homicide"},{"start":71,"end":79,"tag":"Suicide"},{"start":80,"end":99,"tag":"MedicineRegulators"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_767705788802564096"]},"source":"Twitter Web Client","text":"@EMA_News Never mind reading it - Tell @GSK #Sierre #Seroxat #Homicide #Suicide #MedicineRegulators https://t.co/gPfXcuAdNm","conversation_id":"767705952938237952","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":1},"author_id":"43524728","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-17T20:19:32.000Z","id":"766006567569387528","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Mobile Web (M2)","text":"@EMA_News where's independentEVIDENCE generics ARE exactly same as originals? Cream given me byNHS was mostly water,used 2x amount.cost MORE","conversation_id":"766006567569387528","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1426211588","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-17T20:16:56.000Z","id":"766005916659486720","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Mobile Web (M2)","text":"@EMA_News clinical trials: ha ha ha 5 million (£ or €?) max insurance for  = a joke? Mega disability just one person costs millions ACTUALLY","conversation_id":"766005916659486720","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1426211588","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-17T09:34:18.000Z","id":"765844190131527680","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/K9Vnx6XotR","expanded_url":"https://twitter.com/EMA_News/status/765486112018169856","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":23,"tag":"Availability"},{"start":105,"end":111,"tag":"price"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News #Availability in all EU in the same time yes and no  u don’t consider specificity on territory #price  https://t.co/K9Vnx6XotR","conversation_id":"765844190131527680","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"134450541","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"765486112018169856"}]},{"created_at":"2016-08-16T13:01:20.000Z","id":"765533903029473280","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/fd91mXk0TY","expanded_url":"http://ow.ly/jC7B303gs2G","display_url":"ow.ly/jC7B303gs2G"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":71,"end":82,"tag":"Regulatory"},{"start":113,"end":125,"tag":"biosimilars"},{"start":126,"end":133,"tag":"pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News Adopts New Biologic, Biosimilar Pharmacovigilance Guidance | #Regulatory Focus https://t.co/fd91mXk0TY #biosimilars #pharma","conversation_id":"765533903029473280","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"111425542","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-12T08:51:58.000Z","id":"764021596239519744","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/HW6zOjaETx","expanded_url":"http://ow.ly/yRaz3038ZdJ","display_url":"ow.ly/yRaz3038ZdJ"},{"start":117,"end":140,"url":"https://t.co/2J4Txy07gq","expanded_url":"https://twitter.com/EuropaBio/status/764021596239519744/photo/1","display_url":"pic.twitter.com/2J4Txy07gq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_764021593093791744"]},"source":"Hootsuite","text":"@EMA_News releases new good manufacturing practice guidance to ensure the integrity of data  https://t.co/HW6zOjaETx https://t.co/2J4Txy07gq","conversation_id":"764021596239519744","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-10T15:59:47.000Z","id":"763404484915716097","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/pZrfp7buYq","expanded_url":"http://www.raps.org/Regulatory-Focus/News/2016/08/03/25509/EMA-to-Continue-Adaptive-Pathways-Program-as-Pilot-Ends/","display_url":"raps.org/Regulatory-Foc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":112,"end":123,"tag":"healthdata"},{"start":124,"end":135,"tag":"RWEvidence"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News to continue adaptive pathways program requiring use of RWE to complement RCTs https://t.co/pZrfp7buYq #healthdata #RWEvidence","conversation_id":"763404484915716097","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"23363225","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-10T15:17:31.000Z","id":"763393848177557506","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Thanks for clarifying","conversation_id":"763382021938745345","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"763393096981815297"}]},{"created_at":"2016-08-10T14:47:30.000Z","id":"763386294378586113","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Picture you tweet is confusing. Is there a different document apart from the report itself?","conversation_id":"763382021938745345","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"763382021938745345"}]},{"created_at":"2016-08-09T16:49:28.000Z","id":"763054599385321472","entities":{"urls":[{"start":32,"end":55,"url":"https://t.co/SAKjouiGPt","expanded_url":"https://twitter.com/EMA_News/status/763041678559023108","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News  see new consultation https://t.co/SAKjouiGPt","conversation_id":"763054599385321472","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"761133565199384576","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"763041678559023108"}]},{"created_at":"2016-08-06T12:01:32.000Z","id":"761894977928650752","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News suspends generic drugs on data integrity concerns","conversation_id":"761894977928650752","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"164226447","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-06T10:05:10.000Z","id":"761865692249460736","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/a82XCLhU5Z","expanded_url":"http://ow.ly/cO4N302Xj96","display_url":"ow.ly/cO4N302Xj96"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":106,"end":116,"tag":"medicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News launches report on a project aimed at giving patients with unmet medical needs faster access to #medicines https://t.co/a82XCLhU5Z","conversation_id":"761865692249460736","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-06T08:53:11.000Z","id":"761847578241724417","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/h5OgYsVVMf","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/08/news_detail_002583.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":104,"tag":"tb"},{"start":105,"end":112,"tag":"tbchat"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News launched a public consultation on revised guidance on development of new medicines 2 treat #tb #tbchat  https://t.co/h5OgYsVVMf","conversation_id":"761847578241724417","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"920721606","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-05T15:49:03.000Z","id":"761589847035371522","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/OA1DDIGFuu","expanded_url":"http://bit.ly/2b10lOP","display_url":"bit.ly/2b10lOP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News seeks more payer and patient involvement in its adaptive licensing pathway https://t.co/OA1DDIGFuu","conversation_id":"761589847035371522","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"577355799","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-05T15:01:13.000Z","id":"761577807503847426","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/RWH86BqltE","expanded_url":"http://goo.gl/7JN4R0","display_url":"goo.gl/7JN4R0"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"TGAgovau","id":"3800463014"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @TGAgovau My doctoral thesis on transparency in public administrations https://t.co/RWH86BqltE","conversation_id":"761501354321928192","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"516897567","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"761501354321928192"}]},{"created_at":"2016-08-05T12:23:36.000Z","id":"761538143120134144","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/NUYRrPv5nn","expanded_url":"https://twitter.com/EMA_News/status/761222752564973570","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":77,"tag":"veterinary"},{"start":78,"end":87,"tag":"vaccines"},{"start":88,"end":98,"tag":"OneHealth"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News implements action plan to help increase availability of #veterinary #vaccines #OneHealth VetCast https://t.co/NUYRrPv5nn","conversation_id":"761538143120134144","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"107346436","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"761222752564973570"}]},{"created_at":"2016-08-04T10:45:02.000Z","id":"761150951025770496","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/1wE5AlNJ3u","expanded_url":"http://bit.ly/2aPrLde","display_url":"bit.ly/2aPrLde"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":123,"end":129,"username":"EFPIA","id":"52084584"},{"start":130,"end":137,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":75,"end":92,"tag":"Adaptivepathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News PR \"Adaptive pathways: key learnings and next steps\" - Report on #Adaptivepathways pilot https://t.co/1wE5AlNJ3u @EFPIA @IMI_JU","conversation_id":"761150951025770496","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3434258763","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-03T14:35:36.000Z","id":"760846585425080320","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/EFBn0FhN7u","expanded_url":"https://twitter.com/EMA_News/status/760794862216241152","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":57,"end":74,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News veröffentlicht Schlussbericht zum Pilotprojekt #adaptivepathways. https://t.co/EFBn0FhN7u","conversation_id":"760846585425080320","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2473947624","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"760794862216241152"}]},{"created_at":"2016-08-03T11:17:01.000Z","id":"760796612264427520","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/gdr7CCtuRe","expanded_url":"http://bit.ly/2aPrLde","display_url":"bit.ly/2aPrLde"},{"start":96,"end":119,"url":"https://t.co/41zLwbl4kT","expanded_url":"http://bit.ly/295bZVw","display_url":"bit.ly/295bZVw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":84,"end":89,"username":"beuc","id":"237222584"}],"hashtags":[{"start":20,"end":37,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News report on #adaptivepathways published today:https://t.co/gdr7CCtuRe. Here @beuc views https://t.co/41zLwbl4kT","conversation_id":"760796612264427520","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":2},"author_id":"1106659014","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-03T07:47:38.000Z","id":"760743915364446208","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/aSzNX9HneG","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/clinical_pharmacology_pharmacokinetics/general_content_001729.jsp&mid=WC0b01ac0580032ec5","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News launch consultation on Modelling &amp; Simulation, determine “qualified” or “validated” models. Draft guidance https://t.co/aSzNX9HneG","conversation_id":"760743915364446208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"707843478307397633","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-02T15:38:04.000Z","id":"760499917395677184","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/3kRcxYmizT","expanded_url":"http://antibiotic-action.com/ema-recommends-countries-reduce-colistin-use-in-animals/","display_url":"antibiotic-action.com/ema-recommends…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":68,"end":76,"tag":"saveabx"},{"start":85,"end":106,"tag":"antibioticresistance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News recommends curbing use of colistin in European animals to #saveabx , fight #antibioticresistance https://t.co/3kRcxYmizT","conversation_id":"760499917395677184","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"384787749","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-02T13:16:23.000Z","id":"760464262192037888","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/rJRcuueLL7","expanded_url":"http://bit.ly/2aMrp7n","display_url":"bit.ly/2aMrp7n"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":49,"tag":"AdaptivePathways"},{"start":99,"end":108,"tag":"medicine"},{"start":110,"end":115,"tag":"blog"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to release results of #AdaptivePathways study this week to improve patient access to new #medicine. #blog https://t.co/rJRcuueLL7","conversation_id":"760464262192037888","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2217383007","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-08-02T07:17:16.000Z","id":"760373886945026048","entities":{"urls":[{"start":52,"end":75,"url":"https://t.co/aB25nFqIsI","expanded_url":"https://twitter.com/eupatients/status/760358290115137536","display_url":"twitter.com/eupatients/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"patientpower_es","id":"2749174196"},{"start":27,"end":42,"username":"patientpowereu","id":"2383500127"},{"start":43,"end":50,"username":"GEPAC_","id":"198151775"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @patientpower_es @patientpowereu @GEPAC_  https://t.co/aB25nFqIsI","conversation_id":"760373886945026048","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1697360292","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"760358290115137536"}]},{"created_at":"2016-08-01T13:59:09.000Z","id":"760112638533726208","entities":{"urls":[{"start":35,"end":58,"url":"https://t.co/hKx2IIi49o","expanded_url":"http://unambro.it/html/pdf/Perso","display_url":"unambro.it/html/pdf/Perso"},{"start":66,"end":89,"url":"https://t.co/KR0wlidn5U","expanded_url":"http://unambro.it/html/pdf/smist","display_url":"unambro.it/html/pdf/smist"},{"start":115,"end":138,"url":"https://t.co/RKSr70pWfE","expanded_url":"https://twitter.com/ambrouniversity/status/760112638533726208/photo/1","display_url":"pic.twitter.com/RKSr70pWfE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_760112580182564864"]},"source":"Twitter Web Client","text":"@EMA_News\nRenaissance in  Medicine https://t.co/hKx2IIi49o  … … … https://t.co/KR0wlidn5U  70% reduction for stud. https://t.co/RKSr70pWfE","conversation_id":"760112638533726208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"50355768","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-31T12:47:29.000Z","id":"759732213684408321","entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/YE6MD39KeM","expanded_url":"https://www.facebook.com/We-want-peace-in-the-world-471948136311213/","display_url":"facebook.com/We-want-peace-…"},{"start":103,"end":126,"url":"https://t.co/GqN8krBH5P","expanded_url":"https://twitter.com/asibur_md/status/759732213684408321/photo/1","display_url":"pic.twitter.com/GqN8krBH5P"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_759732204045905921"]},"source":"Twitter Web Client","text":"@EMA_News 100 MILLION USD REWARD TO CATCH ISLAMIC FUNDAMENTAL TERRORIST GROUP\n\nhttps://t.co/YE6MD39KeM https://t.co/GqN8krBH5P","conversation_id":"759732213684408321","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4234597934","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-31T12:45:14.000Z","id":"759731647654658053","entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/YE6MD39KeM","expanded_url":"https://www.facebook.com/We-want-peace-in-the-world-471948136311213/","display_url":"facebook.com/We-want-peace-…"},{"start":103,"end":126,"url":"https://t.co/DJJqvkM4p0","expanded_url":"https://twitter.com/asibur_md/status/759731647654658053/photo/1","display_url":"pic.twitter.com/DJJqvkM4p0"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_759731634421641216"]},"source":"Twitter Web Client","text":"@EMA_News 100 MILLION USD REWARD TO CATCH ISLAMIC FUNDAMENTAL TERRORIST GROUP\n\nhttps://t.co/YE6MD39KeM https://t.co/DJJqvkM4p0","conversation_id":"759731647654658053","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4234597934","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-29T15:25:11.000Z","id":"759047124323446784","entities":{"urls":[{"start":52,"end":75,"url":"https://t.co/3WuZSJvwl6","expanded_url":"http://bit.ly/2ajvKgh","display_url":"bit.ly/2ajvKgh"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News EMA Adds Four New Drugs to PRIME Scheme - https://t.co/3WuZSJvwl6","conversation_id":"759047124323446784","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-29T14:36:06.000Z","id":"759034772639223808","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/5aHbcoNpme","expanded_url":"http://drive-ab.eu/news/ema-recommends-countries-reduce-colistin-use-in-animals/","display_url":"drive-ab.eu/news/ema-recom…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":71,"end":79,"tag":"saveabx"},{"start":88,"end":109,"tag":"antibioticresistance"}],"annotations":[{"start":61,"end":66,"probability":0.993,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News recommends reducing colistin use in animals across Europe to #saveabx , fight #antibioticresistance https://t.co/5aHbcoNpme","conversation_id":"759034772639223808","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3061562807","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-28T17:47:56.000Z","id":"758720659358965760","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":51,"end":65,"username":"MHRAmedicines","id":"960436586"}],"hashtags":[{"start":138,"end":148,"tag":"valproate"}],"annotations":[{"start":68,"end":69,"probability":0.6677,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @Emma4facs more needs to be done to keep @MHRAmedicines &amp; UK Gov on track &amp; avoid babies harmed or losing their life to #valproate","conversation_id":"758720659358965760","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"250163834","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-28T17:45:45.000Z","id":"758720111251431432","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":21,"end":35,"username":"catherinecox2","id":"245493521"}],"hashtags":[{"start":36,"end":53,"tag":"valproatetoolkit"},{"start":109,"end":118,"tag":"epilepsy"},{"start":125,"end":133,"tag":"bipolar"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @Emma4facs @catherinecox2 #valproatetoolkit still not getting through to female patients, for both #epilepsy &amp; #bipolar patients","conversation_id":"758720111251431432","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"250163834","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-28T17:44:06.000Z","id":"758719695050706944","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":21,"end":35,"username":"catherinecox2","id":"245493521"}],"hashtags":[{"start":94,"end":104,"tag":"valproate"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @Emma4facs @catherinecox2 at last it's taken almost 2yrs to see warnings in preg on #valproate boxes @MHRA are failing though..","conversation_id":"758719695050706944","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"250163834","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-28T14:39:01.000Z","id":"758673119640813568","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/3kRcxYmizT","expanded_url":"http://antibiotic-action.com/ema-recommends-countries-reduce-colistin-use-in-animals/","display_url":"antibiotic-action.com/ema-recommends…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":75,"end":96,"tag":"antibioticresistance"},{"start":103,"end":111,"tag":"saveabx"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News recommends reducing use of colistin in European animals to fight #antibioticresistance &amp; #saveabx https://t.co/3kRcxYmizT","conversation_id":"758673119640813568","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"384787749","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-28T07:04:46.000Z","id":"758558803109478400","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/9CRURbWm1c","expanded_url":"http://www.ticbeat.com/salud/ensayos-clinicos-defectuosos-fuerzan-a-la-ue-a-retirar-genericos/","display_url":"ticbeat.com/salud/ensayos-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News recomendó suspender  decenas genéricos x posibles errores de empresa hindú responsable ensayos clínicos\nhttps://t.co/9CRURbWm1c","conversation_id":"758558803109478400","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1242516320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-27T18:31:59.000Z","id":"758369359714713600","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/4vkSAIPgjA","expanded_url":"https://twitter.com/Adaptimmune/status/757932864595951620","display_url":"twitter.com/Adaptimmune/st…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":57,"end":69,"probability":0.4752,"type":"Organization","normalized_text":"Medigene Ltd."},{"start":94,"end":102,"probability":0.43,"type":"Place","normalized_text":"UK Avidex"}],"cashtags":[{"start":19,"end":24,"tag":"ADAP"},{"start":112,"end":116,"tag":"GLX"}]},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News No 1. is $ADAP Adaptimmune a spinout of former Medigene Ltd. ako half recreation of UK Avidex partner $GLX https://t.co/4vkSAIPgjA","conversation_id":"758298142177714179","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"67066114","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"757932864595951620"},{"type":"replied_to","id":"758298142177714179"}]},{"created_at":"2016-07-27T01:01:13.000Z","id":"758104926220328960","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/fsuRNIpEQm","expanded_url":"http://ow.ly/dRKz302tZ3t","display_url":"ow.ly/dRKz302tZ3t"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":29,"tag":"Brexit"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News stated that #Brexit will not affect the EMA’s work streams and procedures. https://t.co/fsuRNIpEQm","conversation_id":"758104926220328960","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-26T19:41:21.000Z","id":"758024428433313792","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/IIhVPYX2YJ","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/07/26/ema-und-bfarm-planen-verscharfte-regeln-fur-phase-i-studien","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":87,"end":98,"username":"hfeldwisch","id":"1562740009"}],"hashtags":[{"start":15,"end":21,"tag":"BfArM"},{"start":73,"end":77,"tag":"BIA"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Mac","text":"@EMA_News  und #BfArM planen verschärfte Regeln für Phase-I-Studie (nach #BIA 10-2474) @hfeldwisch  https://t.co/IIhVPYX2YJ","conversation_id":"758024428433313792","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"15460376","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-25T06:43:39.000Z","id":"757466326474616832","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/F5Ortic7Wb","expanded_url":"http://fexp.in/pBO243214","display_url":"fexp.in/pBO243214"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":29,"end":39,"username":"MylanNews","id":"293754638"},{"start":44,"end":58,"username":"Bioconlimited","id":"397797941"},{"start":129,"end":139,"username":"ExpPharma","id":"632775011"}],"hashtags":[{"start":21,"end":28,"tag":"review"},{"start":73,"end":85,"tag":"submissions"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News accepts to #review @MylanNews and @Bioconlimited ’s regulatory #submissions for Pegfilgrastim https://t.co/F5Ortic7Wb  @ExpPharma","conversation_id":"757466326474616832","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"632775011","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-23T22:00:16.000Z","id":"756972224310116353","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"funmzy16","id":"723978556615888897"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web App","text":"@EMA_News @funmzy16","conversation_id":"756447212268294144","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"326491909","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"756447212268294144"}]},{"created_at":"2016-07-23T20:36:16.000Z","id":"756951085181526020","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/eiiM9eZBCa","expanded_url":"http://tinyurl.com/gq7ncn8","display_url":"tinyurl.com/gq7ncn8"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News how many of us must die? How many parents have to switch off life support? https://t.co/eiiM9eZBCa","conversation_id":"756951085181526020","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"745730407472205824","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-23T09:57:22.000Z","id":"756790298810937345","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/FYsWW9msdc","expanded_url":"http://tinyurl.com/jnq3oc8","display_url":"tinyurl.com/jnq3oc8"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":40,"tag":"PrEP"},{"start":46,"end":54,"tag":"Truvada"},{"start":59,"end":63,"tag":"HIV"}],"annotations":[{"start":78,"end":83,"probability":0.9929,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News takes first step towards #PrEP with #Truvada for #HIV prevention in Europe. https://t.co/FYsWW9msdc","conversation_id":"756790298810937345","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2307338958","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-22T18:38:48.000Z","id":"756559135068553216","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/EyKstYYFps","expanded_url":"http://in.reuters.com/article/us-genericdrugs-eu-suspension-idINKCN10226H?feedType=RSS&feedName=health&utm_source=Twitter&utm_medium=Social&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29","display_url":"in.reuters.com/article/us-gen…"},{"start":98,"end":121,"url":"https://t.co/jUMi0XOzHq","expanded_url":"http://www.fda.gov/Drugs/DrugSafety/ucm495778.htm","display_url":"fda.gov/Drugs/DrugSafe…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":[{"start":123,"end":127,"tag":"MYL"},{"start":128,"end":133,"tag":"TEVA"},{"start":134,"end":138,"tag":"NVS"}]},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News \nrecommended suspending sales of Semler lab tested Biosimilars\nhttps://t.co/EyKstYYFps\n\nhttps://t.co/jUMi0XOzHq\n\n$MYL $TEVA $NVS","conversation_id":"756559135068553216","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"2522249316","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-22T14:51:23.000Z","id":"756501904906194944","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/8f935VgA2d","expanded_url":"http://www.politico.eu/pro/ema-advises-suspension-of-scores-of-indian-tested-generics/","display_url":"politico.eu/pro/ema-advise…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":49,"tag":"Indian"},{"start":57,"end":66,"tag":"generics"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News advises suspension of scores of #Indian-tested #generics. https://t.co/8f935VgA2d","conversation_id":"756501904906194944","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"14259768","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-22T12:51:14.000Z","id":"756471665828040704","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/durYwCm2te","expanded_url":"http://fb.me/7ktK91NpI","display_url":"fb.me/7ktK91NpI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":44,"end":57,"tag":"firstinhuman"},{"start":58,"end":73,"tag":"clinicaltrials"},{"start":74,"end":83,"tag":"identify"},{"start":84,"end":93,"tag":"mitigate"},{"start":94,"end":99,"tag":"risk"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Facebook","text":"@EMA_News - Proposals to revise guidance on #firstinhuman #clinicaltrials\n#identify #mitigate #risk... https://t.co/durYwCm2te","conversation_id":"756471665828040704","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1244094438","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-20T19:39:15.000Z","id":"755849570370752513","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Windows Phone","text":"@EMA_News","conversation_id":"751419851441307648","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"258002579","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"751419851441307648"}]},{"created_at":"2016-07-19T18:58:47.000Z","id":"755477000920240128","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/gcpdnO0JzP","expanded_url":"http://bit.ly/tweet_thanks_","display_url":"bit.ly/tweet_thanks_"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Commun.it","text":"@EMA_News thanks for sharing EU, have a great Tuesday :) (Want this 🆓? &gt;&gt; https://t.co/gcpdnO0JzP)","conversation_id":"755372919195332608","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2810884837","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"755372919195332608"}]},{"created_at":"2016-07-19T16:01:05.000Z","id":"755432282043867136","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":46,"end":55,"probability":0.4884,"type":"Organization","normalized_text":"Nusinersen"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News could you please provide update for Nusinersen approvals? What is the delay? Our babies are dying...","conversation_id":"755432282043867136","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"745730407472205824","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-18T17:13:25.000Z","id":"755088095830241281","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/MPCuyW6YAF","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_001432.jsp&mid=WC0b01ac0580a221a4","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":80,"end":87,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News - Public hearings - ökad öppenhet alltid välkommet, ökar förtroendet! @LV_MPA https://t.co/MPCuyW6YAF","conversation_id":"755088095830241281","possibly_sensitive":false,"lang":"sv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"26791880","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-18T16:10:36.000Z","id":"755072285720084482","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/0BZwpkAtv4","expanded_url":"http://www.medscape.com/viewarticle/865686","display_url":"medscape.com/viewarticle/86…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"DES_Journal","id":"260926865"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News @DES_Journal \n\nToo bad you were shot down by these guys\n\nhttps://t.co/0BZwpkAtv4\n\nand your ethics and methods exposed.","conversation_id":"753348355984617472","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"722823561275187200","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"753619212158074880"}]},{"created_at":"2016-07-18T14:46:29.000Z","id":"755051117806022656","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/8AYD81KlRU","expanded_url":"https://twitter.com/quequesierra/status/755051117806022656/photo/1","display_url":"pic.twitter.com/8AYD81KlRU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"fararod","id":"525798275"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_755051100781285376"]},"source":"Twitter for iPhone","text":"@EMA_News @fararod And... what about patients receiving placebo instead of agalsidase? https://t.co/8AYD81KlRU","conversation_id":"740874328347168768","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"353926930","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"740874328347168768"}]},{"created_at":"2016-07-18T08:37:42.000Z","id":"754958312584704000","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":45,"tag":"medicines"},{"start":66,"end":71,"tag":"CHMP"},{"start":74,"end":78,"tag":"NHS"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News \n\nFind out about the new #medicines under evaluation by #CHMP \n\n#NHS","conversation_id":"754958312584704000","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-16T03:13:00.000Z","id":"754151821330018304","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/0HvtZv6Odc","expanded_url":"http://buff.ly/29wVeHw","display_url":"buff.ly/29wVeHw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Buffer","text":"@EMA_News and @US_FDA reinforce collaboration on patient engagement https://t.co/0HvtZv6Odc","conversation_id":"754151821330018304","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"22080808","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-15T06:24:41.000Z","id":"753837672414650368","entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/FuBRMAZ8GX","expanded_url":"http://wp.me/p1zQ5v-4gK","display_url":"wp.me/p1zQ5v-4gK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News thank you for letting us know - I have updated our post https://t.co/FuBRMAZ8GX","conversation_id":"753348355984617472","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"260926865","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"753619212158074880"}]},{"created_at":"2016-07-12T21:06:16.000Z","id":"752972366175670273","entities":{"urls":[{"start":47,"end":70,"url":"https://t.co/xQkPlUd69y","expanded_url":"http://medicine.co.uk/?p=522","display_url":"medicine.co.uk/?p=522"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":96,"end":109,"username":"UKParliament","id":"6467332"},{"start":110,"end":125,"username":"UkPrimeMinster","id":"711528746986168320"}],"hashtags":[{"start":21,"end":28,"tag":"brexit"},{"start":42,"end":46,"tag":"NHS"},{"start":71,"end":86,"tag":"NHSdaringtoask"},{"start":87,"end":95,"tag":"Bremain"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News What might #brexit mean for the #NHS https://t.co/xQkPlUd69y #NHSdaringtoask #Bremain @UKParliament @UkPrimeMinster","conversation_id":"752972366175670273","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2990551427","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-12T13:13:20.000Z","id":"752853350966759424","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/VhrV4F8zmB","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002566.jsp&mid=WC0b01ac058004d5c","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":34,"end":39,"probability":0.5281,"type":"Other","normalized_text":"Brexit"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News shared a statement post Brexit: “EMA’s procedures and work streams continue as usual”. More info at:\n   https://t.co/VhrV4F8zmB","conversation_id":"752853350966759424","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-12T09:16:50.000Z","id":"752793831163170816","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/Z4OKHDqebO","expanded_url":"http://bit.ly/29DzQ1z","display_url":"bit.ly/29DzQ1z"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"},{"start":65,"end":70,"tag":"CHMP"},{"start":72,"end":76,"tag":"NHS"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News\n\nFind out about the new #medicines under evaluation by #CHMP\n\n#NHS\n\nhttps://t.co/Z4OKHDqebO","conversation_id":"752793831163170816","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-11T15:55:55.000Z","id":"752531877714591745","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/dsf0C9MrQy","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002564.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":79,"end":88,"username":"Roche_de","id":"32151143"},{"start":99,"end":113,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Abschlussbericht wg. 80.000 nicht weitergeleiteter SafetyReports von @Roche_de zurück an @EU_Commission https://t.co/dsf0C9MrQy","conversation_id":"752531877714591745","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-11T14:09:19.000Z","id":"752505049549602816","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/9J6NX5BojW","expanded_url":"https://twitter.com/Wolf_S_Punk/status/752505049549602816/photo/1","display_url":"pic.twitter.com/9J6NX5BojW"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":68,"end":74,"tag":"Roche"},{"start":81,"end":92,"tag":"Mefloquine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_752503739819421696"]},"source":"Twitter Web Client","text":"@EMA_News Wrong publishing date for \"Infringement procedure against #Roche\" Btw. #Mefloquine was on the list as well https://t.co/9J6NX5BojW","conversation_id":"752505049549602816","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":3,"like_count":0,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-11T09:23:48.000Z","id":"752433199465242624","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/jrkLBwq1bh","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002567.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":46,"end":51,"tag":"PRAC"},{"start":52,"end":70,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR - to see Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 4-8 July 2016 go to  https://t.co/jrkLBwq1bh","conversation_id":"752433199465242624","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-09T20:41:44.000Z","id":"751879028445945856","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News expedite approval of SMA drug. Save lives. Approve SMA drug or advise pharma to release compassion use! Don't kill our children!","conversation_id":"751879028445945856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"745730407472205824","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-07T15:38:19.000Z","id":"751077895175540740","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":36,"end":42,"username":"Roche","id":"20815041"}],"hashtags":[{"start":122,"end":139,"tag":"NeverEndingStory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Infringement proc against @Roche:\nInpection on Oct 12\nReport on Apr 14\nBack to EMA jul 15\nUpdated report jul 16\n#NeverEndingStory","conversation_id":"751077895175540740","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-07T15:21:32.000Z","id":"751073671540801536","entities":{"urls":[{"start":56,"end":79,"url":"https://t.co/LzBmq6mg13","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002566.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":42,"end":43,"probability":0.9118,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Statement on the outcome of the UK referendum\nhttps://t.co/LzBmq6mg13","conversation_id":"751073671540801536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-06T16:25:01.000Z","id":"750727260420866048","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/sWVY3iLdW9","expanded_url":"http://bit.ly/29uoU7y","display_url":"bit.ly/29uoU7y"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":27,"tag":"Brexit"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News EMA notes #Brexit may result in its relocation (how could it not?) but decision not in its hands https://t.co/sWVY3iLdW9","conversation_id":"750727260420866048","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"308526080","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-06T11:56:20.000Z","id":"750659644507430912","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/nUpFZeQTgm","expanded_url":"http://www.praktoreio-ygeias.gr/category/4/Iatrika","display_url":"praktoreio-ygeias.gr/category/4/Iat…"},{"start":120,"end":143,"url":"https://t.co/nWPL81H3di","expanded_url":"https://twitter.com/amna_news/status/750659644507430912/photo/1","display_url":"pic.twitter.com/nWPL81H3di"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_750658503413497856"]},"source":"Twitter Web Client","text":"@EMA_News: τα δισκία και το πόσιμο Noxafil έχουν διαφορετικές δόσεις &amp; δεν είναι εναλλάξιμα https://t.co/nUpFZeQTgm https://t.co/nWPL81H3di","conversation_id":"750659644507430912","possibly_sensitive":false,"lang":"el","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"250058740","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-04T11:10:29.000Z","id":"749923329956511744","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"pharmacist","id":"14303378"},{"start":125,"end":139,"username":"ArnavSharmaUK","id":"739849855879761920"}],"hashtags":[{"start":109,"end":124,"tag":"T4GArnavSharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News @Pharmacist Truly inspiring 2 see a 9 yr old kid creating life changing technology. I've voted for #T4GArnavSharma @ArnavSharmaUK","conversation_id":"747470816514838528","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3315908143","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"747470816514838528"}]},{"created_at":"2016-07-03T05:40:04.000Z","id":"749477788458057728","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/ZUbTbQEHp7","expanded_url":"http://bit.ly/28pqmi5","display_url":"bit.ly/28pqmi5"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":67,"end":76,"tag":"medicine"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News:Use of central repository for submitting PSURs for human #medicine in the EU mandatory from 13 June 2016: https://t.co/ZUbTbQEHp7","conversation_id":"749477788458057728","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1049587548","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-02T16:50:19.000Z","id":"749284074393591808","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/wnrglMfKQ4","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/home/Home_Page.jsp&mid=","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":115,"end":138,"url":"https://t.co/rzYTa0fcGz","expanded_url":"https://twitter.com/realarthurdent/status/749268381874913280","display_url":"twitter.com/realarthurdent…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPad","text":"@EMA_News regulates the medicines we use, which I am quite pleased about- have a look here https://t.co/wnrglMfKQ4 https://t.co/rzYTa0fcGz","conversation_id":"749284074393591808","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"569921322","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"749268381874913280"}]},{"created_at":"2016-07-01T10:30:50.000Z","id":"748826189213622273","entities":{"urls":[{"start":50,"end":73,"url":"https://t.co/vPXhCNlbxq","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/06/news_detail_002563.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":74,"end":97,"url":"https://t.co/QcCuVHzkxQ","expanded_url":"https://twitter.com/Jordi_Falco/status/748826189213622273/photo/1","display_url":"pic.twitter.com/QcCuVHzkxQ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["16_748825832601378816"]},"source":"Twitter Web Client","text":"@EMA_News Strengthening interaction with academia https://t.co/vPXhCNlbxq https://t.co/QcCuVHzkxQ","conversation_id":"748826189213622273","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-07-01T07:41:39.000Z","id":"748783613202735108","entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/jivayO2TWi","expanded_url":"https://twitter.com/EvonneBrennan/status/748783613202735108/photo/1","display_url":"pic.twitter.com/jivayO2TWi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":107,"end":118,"tag":"innovation"}],"annotations":[{"start":51,"end":64,"probability":0.705,"type":"Person","normalized_text":"Maria Papaluca"}],"cashtags":{}},"attachments":{"media_keys":["3_748783595800567809"]},"source":"Twitter for Android","text":"@EMA_News HCPWP workshop with academia, slide from Maria Papaluca showing academia &amp; SMEs at origin of #innovation https://t.co/jivayO2TWi","conversation_id":"748783613202735108","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"2273521479","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:20:16.000Z","id":"748128954016497664","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/lh8y7LelZ4","expanded_url":"http://bit.ly/1SiOIAM","display_url":"bit.ly/1SiOIAM"},{"start":110,"end":133,"url":"https://t.co/oceYTj6hgx","expanded_url":"https://twitter.com/JonassonPhD/status/748128954016497664/photo/1","display_url":"pic.twitter.com/oceYTj6hgx"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":56,"end":61,"probability":0.7201,"type":"Person","normalized_text":"Darvon"},{"start":76,"end":84,"probability":0.9721,"type":"Person","normalized_text":"Eli Lilly"}],"cashtags":{}},"attachments":{"media_keys":["3_748128942318575616"]},"source":"Twitter Web Client","text":"@EMA_News - The heroin epidemic could have started with Darvon years ago by Eli Lilly https://t.co/lh8y7LelZ4 https://t.co/oceYTj6hgx","conversation_id":"748128954016497664","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:19:56.000Z","id":"748128867618070528","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/XQPJVPZg33","expanded_url":"http://bit.ly/1PJ0ZhD","display_url":"bit.ly/1PJ0ZhD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - People who are addicted to opioid painkillers are 40 x more likely to be addicted to heroin\" https://t.co/XQPJVPZg33","conversation_id":"748128867618070528","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:19:29.000Z","id":"748128753969172480","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/qilQR3hmOO","expanded_url":"http://bit.ly/1PAAMUg","display_url":"bit.ly/1PAAMUg"},{"start":111,"end":134,"url":"https://t.co/sROfl1hJxO","expanded_url":"https://twitter.com/JonassonPhD/status/748128753969172480/photo/1","display_url":"pic.twitter.com/sROfl1hJxO"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":39,"end":57,"probability":0.6149,"type":"Organization","normalized_text":"National Press Club"}],"cashtags":{}},"attachments":{"media_keys":["3_748128744502628353"]},"source":"Twitter Web Client","text":"@EMA_News - My press conference at the National Press Club about Darvon Sept 10th 2013 https://t.co/qilQR3hmOO https://t.co/sROfl1hJxO","conversation_id":"748128753969172480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:19:01.000Z","id":"748128639783477250","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/fjYDP6zcdc","expanded_url":"http://bit.ly/1N8Fad3","display_url":"bit.ly/1N8Fad3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":94,"end":98,"probability":0.9948,"type":"Place","normalized_text":"India"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - Letter to Central Drugs Standard Control Organization about Dextropropoxyphene in India https://t.co/fjYDP6zcdc","conversation_id":"748128639783477250","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:18:04.000Z","id":"748128398917140480","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/JmUu0rJwqN","expanded_url":"http://bit.ly/1PLRG14","display_url":"bit.ly/1PLRG14"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":20,"end":24,"probability":0.91,"type":"Place","normalized_text":"India"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - In 2011 India consumed 92% of the world-consumption of Dextropropoxyphene https://t.co/JmUu0rJwqN","conversation_id":"748128398917140480","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:17:44.000Z","id":"748128314137653248","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/TVrsBhcWz0","expanded_url":"http://bit.ly/1RWoYwo","display_url":"bit.ly/1RWoYwo"},{"start":115,"end":138,"url":"https://t.co/pYoI0YGnKi","expanded_url":"https://twitter.com/JonassonPhD/status/748128314137653248/photo/1","display_url":"pic.twitter.com/pYoI0YGnKi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":42,"end":47,"probability":0.9976,"type":"Place","normalized_text":"Sweden"}],"cashtags":{}},"attachments":{"media_keys":["3_748128302863425537"]},"source":"Twitter Web Client","text":"@EMA_News - We got some good attention in Sweden to our research about Darvon&amp;Darvocet https://t.co/TVrsBhcWz0 https://t.co/pYoI0YGnKi","conversation_id":"748128314137653248","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:17:21.000Z","id":"748128219858149377","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/lh8y7LelZ4","expanded_url":"http://bit.ly/1SiOIAM","display_url":"bit.ly/1SiOIAM"},{"start":108,"end":131,"url":"https://t.co/ehTYysnx97","expanded_url":"https://twitter.com/JonassonPhD/status/748128219858149377/photo/1","display_url":"pic.twitter.com/ehTYysnx97"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_748128207090638848"]},"source":"Twitter Web Client","text":"@EMA_News - Some of our books/research about the painkilling substance Propoxyphene https://t.co/lh8y7LelZ4 https://t.co/ehTYysnx97","conversation_id":"748128219858149377","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:16:57.000Z","id":"748128119282872320","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/qilQR3hmOO","expanded_url":"http://bit.ly/1PAAMUg","display_url":"bit.ly/1PAAMUg"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":82,"end":93,"probability":0.4142,"type":"Place","normalized_text":"Propoxyphene"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - 523 000 persons in the world could have been poisoned to death due to Propoxyphene during 1985–2011 https://t.co/qilQR3hmOO","conversation_id":"748128119282872320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:16:37.000Z","id":"748128034780131328","entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/5uYBGGzRw5","expanded_url":"http://bit.ly/1OdansN","display_url":"bit.ly/1OdansN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":39,"end":40,"probability":0.9747,"type":"Place","normalized_text":"US"},{"start":45,"end":50,"probability":0.4817,"type":"Place","normalized_text":"Darvon"},{"start":56,"end":63,"probability":0.4514,"type":"Place","normalized_text":"Darvocet"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - Around 178 000 died due in US to Darvon and Darvocet  in 29 years. https://t.co/5uYBGGzRw5","conversation_id":"748128034780131328","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:16:14.000Z","id":"748127938290290688","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/Bw1sbvqJLx","expanded_url":"http://bit.ly/1krpGUV","display_url":"bit.ly/1krpGUV"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":64,"end":69,"probability":0.3508,"type":"Person","normalized_text":"Darvon"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News -  20 years of research have saved thousands of lives Darvon is now banned almost all over the world https://t.co/Bw1sbvqJLx","conversation_id":"748127938290290688","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T12:15:56.000Z","id":"748127864067923968","entities":{"urls":[{"start":36,"end":59,"url":"https://t.co/xaF5iBmk9o","expanded_url":"http://bit.ly/ncHuoh","display_url":"bit.ly/ncHuoh"},{"start":62,"end":85,"url":"https://t.co/u8dtlEhOJy","expanded_url":"http://bit.ly/OWATsO","display_url":"bit.ly/OWATsO"},{"start":87,"end":110,"url":"https://t.co/ednihF1Q2v","expanded_url":"http://bit.ly/QATj3e","display_url":"bit.ly/QATj3e"},{"start":111,"end":134,"url":"https://t.co/q9qKpiIMOk","expanded_url":"https://twitter.com/JonassonPhD/status/748127864067923968/photo/1","display_url":"pic.twitter.com/q9qKpiIMOk"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_748127852512559104"]},"source":"Twitter Web Client","text":"@EMA_News - Our report about Darvon https://t.co/xaF5iBmk9o   https://t.co/u8dtlEhOJy  https://t.co/ednihF1Q2v https://t.co/q9qKpiIMOk","conversation_id":"748127864067923968","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4158149141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-29T09:42:43.000Z","id":"748089301876023296","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/oc089CrEDi","expanded_url":"http://www.ema.europa.eu/ema/","display_url":"ema.europa.eu/ema/"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":114,"end":129,"tag":"iCANSummit2016"}],"annotations":[{"start":10,"end":34,"probability":0.8246,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News European Medicines Agency has lots of information for the public about research https://t.co/oc089CrEDi #iCANSummit2016","conversation_id":"748089301876023296","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"702433564902760449","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-27T19:05:10.000Z","id":"747506071904849921","entities":{"urls":[{"start":64,"end":87,"url":"https://t.co/WTnbeWLX5Q","expanded_url":"http://ow.ly/lQMs301GILq","display_url":"ow.ly/lQMs301GILq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News and FDA reinforce collaboration on patient engagement https://t.co/WTnbeWLX5Q","conversation_id":"747506071904849921","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"351884905","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-27T14:33:47.000Z","id":"747437778355519488","entities":{"urls":[{"start":43,"end":66,"url":"https://t.co/7moBj3vcjP","expanded_url":"http://bit.ly/290Yf2I","display_url":"bit.ly/290Yf2I"},{"start":67,"end":90,"url":"https://t.co/BJlz28TLxl","expanded_url":"https://twitter.com/SocialfarmaWeb/status/747437778355519488/photo/1","display_url":"pic.twitter.com/BJlz28TLxl"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":42,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_747437328881311744"]},"source":"Twitter Web Client","text":"@EMA_News. Via libera a sei nuovi #farmaci https://t.co/7moBj3vcjP https://t.co/BJlz28TLxl","conversation_id":"747437778355519488","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1879728746","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-27T13:15:07.000Z","id":"747417980066213888","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/V9aepkttTd","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/06/27/ema-empfiehlt-sechs-neuzulassungen","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":28,"tag":"Cinqaero"},{"start":29,"end":40,"tag":"Atazanavir"},{"start":41,"end":47,"tag":"Mylan"},{"start":48,"end":56,"tag":"Aerivio"},{"start":70,"end":78,"tag":"Airexar"},{"start":88,"end":97,"tag":"Nordimet"},{"start":98,"end":107,"tag":"Zalmoxis"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News empfielt #Cinqaero #Atazanavir #Mylan #Aerivio Spiromax und #Airexar Spiromax #Nordimet #Zalmoxis https://t.co/V9aepkttTd","conversation_id":"747417980066213888","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2789645880","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-27T09:57:20.000Z","id":"747368207766462464","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/IQJda76alb","expanded_url":"http://ow.ly/LXNi301FhX7","display_url":"ow.ly/LXNi301FhX7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News New cell-based therapy to support stem cell transplantation in patients with high-risk blood cancer https://t.co/IQJda76alb","conversation_id":"747368207766462464","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"899540204","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-26T14:06:11.000Z","id":"747068445569720320","entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/eZG9FME4bK","expanded_url":"http://bit.ly/28RDrGA","display_url":"bit.ly/28RDrGA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":67,"tag":"CHMP"},{"start":96,"end":106,"tag":"medicines"},{"start":107,"end":111,"tag":"NHS"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News\n\nNew cell-based therapy recommended for approval by #CHMP\n\n https://t.co/eZG9FME4bK \n\n#medicines #NHS","conversation_id":"747068445569720320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-26T03:57:20.000Z","id":"746915222485630976","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/66RrYgKglM","expanded_url":"http://www.pmlive.com/pharma_news/ema_recruits_patient_voices_for_its_management_board_1041919","display_url":"pmlive.com/pharma_news/em…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":113,"end":123,"username":"MHRAgovuk","id":"330993102"},{"start":124,"end":134,"username":"MHRApress","id":"330990243"}],"hashtags":[{"start":59,"end":69,"tag":"medicines"},{"start":70,"end":88,"tag":"patientengagement"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News recruits patient voices for its management board #medicines #patientengagement https://t.co/66RrYgKglM @MHRAgovuk @MHRApress","conversation_id":"746915222485630976","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"612922732","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-26T02:06:55.000Z","id":"746887435594797056","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"jmacpher","id":"43102919"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @jmacpher Good news! Thank you!","conversation_id":"746304036341702656","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"14063950","in_reply_to_user_id":"116716199","geo":{"place_id":"795003fb11ee9829"},"referenced_tweets":[{"type":"replied_to","id":"746304036341702656"}]},{"created_at":"2016-06-25T13:09:29.000Z","id":"746691785787904000","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/xcpfApdh6i","expanded_url":"https://twitter.com/Wolf_S_Punk/status/746691785787904000/photo/1","display_url":"pic.twitter.com/xcpfApdh6i"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":98,"end":112,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_746691696616968192"]},"source":"Twitter Web Client","text":"@EMA_News How is the status from this since 2012 ongoing case? You returned the report already to @EU_Commission ? https://t.co/xcpfApdh6i","conversation_id":"746691785787904000","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-25T09:11:13.000Z","id":"746631825787854848","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":31,"username":"EMA_News","id":"116716199"},{"start":46,"end":62,"username":"MinisteroSalute","id":"1904010924"},{"start":63,"end":78,"username":"Aifa_ufficiale","id":"441940097"},{"start":79,"end":91,"username":"BeaLorenzin","id":"515229378"},{"start":92,"end":106,"username":"EmiliaDeBiasi","id":"934863998"}],"hashtags":[{"start":12,"end":19,"tag":"Brexit"},{"start":35,"end":41,"tag":"Italy"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News + #Brexit = @EMA_News in #Italy ... @MinisteroSalute @Aifa_ufficiale @bealorenzin @EmiliaDeBiasi","conversation_id":"746631825787854848","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4876992285","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-24T20:32:32.000Z","id":"746440894715396096","entities":{"urls":[{"start":38,"end":61,"url":"https://t.co/uFUZg1rlmV","expanded_url":"https://twitter.com/acVfit/status/746440484323790848","display_url":"twitter.com/acVfit/status/…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"LeemFrance","id":"53008598"},{"start":22,"end":37,"username":"esante_gouv_fr","id":"160541317"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News @LeemFrance @esante_gouv_fr https://t.co/uFUZg1rlmV","conversation_id":"746440894715396096","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2937621693","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"746440484323790848"}]},{"created_at":"2016-06-24T14:30:27.000Z","id":"746349773448413185","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/KDpATPQbmD","expanded_url":"http://ow.ly/ojSi301AYye","display_url":"ow.ly/ojSi301AYye"},{"start":120,"end":143,"url":"https://t.co/crl4VcnhEz","expanded_url":"https://twitter.com/EuropaBio/status/746349773448413185/photo/1","display_url":"pic.twitter.com/crl4VcnhEz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":17,"end":24,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":68,"end":77,"tag":"patients"},{"start":102,"end":119,"tag":"StrongerTogether"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_746349768906051584"]},"source":"Hootsuite","text":"@EMA_News  &amp; @US_FDA set up a new cluster for the well-being of #patients https://t.co/KDpATPQbmD #StrongerTogether https://t.co/crl4VcnhEz","conversation_id":"746349773448413185","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-24T08:14:10.000Z","id":"746255078064013312","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/usY0QdrwzW","expanded_url":"http://politi.co/28RtAkq","display_url":"politi.co/28RtAkq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":109,"end":114,"probability":0.9798,"type":"Place","normalized_text":"London"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News: too early for it to say what's going to happen.What appears certain is that it will have to leave London.https://t.co/usY0QdrwzW","conversation_id":"746255078064013312","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"14259768","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-22T15:14:36.000Z","id":"745636108499746817","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News another great example of a global collaboration to yield insights that really matter","conversation_id":"745635142727774208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3819195808","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"745635142727774208"}]},{"created_at":"2016-06-17T18:45:41.000Z","id":"743877291961376768","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/7LHSTmu3AX","expanded_url":"http://ow.ly/V06w3016iks","display_url":"ow.ly/V06w3016iks"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News released a guide that describes the types of information the Agency publishes for authorized medicines. https://t.co/7LHSTmu3AX","conversation_id":"743877291961376768","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-17T16:35:41.000Z","id":"743844576616714240","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Mobile Web (M2)","text":"@EMA_News plz can I subscribe to recieve email on news and drugs from EMA","conversation_id":"743844576616714240","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"728617705650163712","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-16T09:09:14.000Z","id":"743369835111931905","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/LebOSpIIXe","expanded_url":"https://twitter.com/Jordi_Falco/status/743369835111931905/photo/1","display_url":"pic.twitter.com/LebOSpIIXe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":36,"tag":"AdvancedTherapy"},{"start":70,"end":75,"tag":"ATMP"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["16_743369625417682944"]},"source":"Twitter Web Client","text":"@EMA_News to foster #AdvancedTherapy Medicinal Products in UE. Only 5 #ATMP authorised since first regulation n 2008 https://t.co/LebOSpIIXe","conversation_id":"743369835111931905","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T22:35:15.000Z","id":"742847899650957312","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/rUbv3gqLto","expanded_url":"http://ow.ly/7aw33016dXm","display_url":"ow.ly/7aw33016dXm"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":60,"end":64,"probability":0.5435,"type":"Organization","normalized_text":"ATMPs"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News released a report outlining concerns expressed by ATMPs stakeholders. https://t.co/rUbv3gqLto","conversation_id":"742847899650957312","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T15:56:32.000Z","id":"742747561765838848","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/MgHC3rETge","expanded_url":"https://twitter.com/kardamyla/status/742747561765838848/photo/1","display_url":"pic.twitter.com/MgHC3rETge"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":35,"end":44,"tag":"patients"},{"start":108,"end":115,"tag":"PCWP10"}],"annotations":[{"start":15,"end":28,"probability":0.7398,"type":"Person","normalized_text":"Dir Guido Rasi"}],"cashtags":{}},"attachments":{"media_keys":["3_742747559530254336"]},"source":"Twitter for iPhone","text":"@EMA_News Exec Dir Guido Rasi asks #patients how can we best support you- EMA ready take new ideas on board #PCWP10 https://t.co/MgHC3rETge","conversation_id":"742747561765838848","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T15:49:31.000Z","id":"742745792293797888","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/f7qhMdy8qH","expanded_url":"https://twitter.com/kardamyla/status/742745792293797888/photo/1","display_url":"pic.twitter.com/f7qhMdy8qH"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"PCWP10"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_742745789231960064"]},"source":"Twitter for iPhone","text":"@EMA_News #PCWP10 coming to the end of a great day - what a line up! Happy 10th anniversary PCWP!! Congratulations https://t.co/f7qhMdy8qH","conversation_id":"742745792293797888","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T15:38:29.000Z","id":"742743017614913536","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/13QWRrb4nb","expanded_url":"http://bit.ly/25TG3zi","display_url":"bit.ly/25TG3zi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":105,"end":109,"tag":"FDA"},{"start":136,"end":143,"tag":"PCWP10"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News marks 10 yrs of Patients’ &amp; Consumers’ Working Party https://t.co/13QWRrb4nb  CTTI to help #FDA launch similar initiative #PCWP10","conversation_id":"742743017614913536","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"author_id":"755163601","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T15:37:56.000Z","id":"742742878431150085","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":103,"tag":"patients"},{"start":104,"end":114,"tag":"consumers"},{"start":134,"end":141,"tag":"PCWP10"}],"annotations":[{"start":22,"end":37,"probability":0.4786,"type":"Person","normalized_text":"Dir Noel Wathion"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Deputy Exec Dir Noel Wathion 3 paradigm shifts influencing regulation authorisation #patients #consumers &amp; transparency #PCWP10","conversation_id":"742742878431150085","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T15:25:29.000Z","id":"742739745223127041","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":66,"tag":"pcwp10"}],"annotations":[{"start":10,"end":22,"probability":0.9873,"type":"Person","normalized_text":"Nathalie Bere"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Nathalie Bere presents an overview of success of #pcwp10 and future directions including stronger links with @FDA_Patient_Net","conversation_id":"742739745223127041","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-14T13:27:43.000Z","id":"742710109890056193","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"PCWP10"},{"start":63,"end":71,"tag":"patient"}],"annotations":[{"start":23,"end":36,"probability":0.6777,"type":"Person","normalized_text":"Dir Guido Rasi"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #PCWP10 Exec Dir Guido Rasi - unique contribution of #patient can not be brought by anyone else","conversation_id":"742710109890056193","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-13T09:25:38.000Z","id":"742286799532396544","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/uBEdEFOKFU","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/06/news_detail_002546.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee  6-9 June 2016more at: https://t.co/uBEdEFOKFU","conversation_id":"742286799532396544","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-09T12:09:20.000Z","id":"740878444284792832","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Enzyme replacement may be effective in slowing the progression of the disease. \nNo cure.","conversation_id":"740874328347168768","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1452235320","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"740874328347168768"}]},{"created_at":"2016-06-08T08:34:48.000Z","id":"740462068655116288","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/9C4m0MVadP","expanded_url":"https://twitter.com/kardamyla/status/740462068655116288/photo/1","display_url":"pic.twitter.com/9C4m0MVadP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":53,"end":62,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":10,"end":21,"tag":"committees"},{"start":77,"end":85,"tag":"patient"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_740462008823336960"]},"source":"Twitter for iPhone","text":"@EMA_News #committees presented by members and staff @eurordis summer school #patient training https://t.co/9C4m0MVadP","conversation_id":"740462068655116288","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T14:36:26.000Z","id":"740190688470573056","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/Uvq2j79WD0","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500207233&mid=WC0b01ac058009a3dc","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":114,"end":137,"url":"https://t.co/OrIRbPpNwv","expanded_url":"https://twitter.com/ESCMID/status/740190688470573056/photo/1","display_url":"pic.twitter.com/OrIRbPpNwv"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":79,"end":89,"tag":"onehealth"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_740190685286961152"]},"source":"Twitter Web Client","text":"@EMA_News draft on colistin use in animals open for consultation until 26 June #onehealth https://t.co/Uvq2j79WD0 https://t.co/OrIRbPpNwv","conversation_id":"740190688470573056","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"107346436","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T12:20:18.000Z","id":"740156426241355776","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommendations on extensions of therapeutic indications for Adcetris, Humira, Kyprolis, Revestive, Simponi and Tysabri","conversation_id":"740156426241355776","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T12:10:19.000Z","id":"740153914524377089","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":108,"end":121,"username":"TakedaPharma","id":"46654897"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":78,"end":87,"tag":"Adcetris"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extensions of therapeutic indications #Adcetris brentuximab vedotin @TakedaPharma","conversation_id":"740153914524377089","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T12:01:25.000Z","id":"740151676821241856","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":97,"end":109,"username":"JanssenEMEA","id":"1969148522"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":78,"end":86,"tag":"Simponi"},{"start":110,"end":120,"tag":"Biologics"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extensions of therapeutic indications #Simponi golimumab @JanssenEMEA #Biologics","conversation_id":"740151676821241856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T11:50:20.000Z","id":"740148887122546688","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":78,"end":88,"tag":"Revestive"},{"start":101,"end":111,"tag":"NPSPharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extensions of therapeutic indications #Revestive teduglutide #NPSPharma","conversation_id":"740148887122546688","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T11:40:17.000Z","id":"740146357114183680","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":106,"username":"Amgen","id":"28436760"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":78,"end":87,"tag":"Kyprolis"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extensions of therapeutic indications #Kyprolis carfilzomib @Amgen","conversation_id":"740146357114183680","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T11:30:42.000Z","id":"740143943619383296","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":97,"end":104,"username":"abbvie","id":"531892451"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":78,"end":85,"tag":"Humira"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extensions of therapeutic indications #Humira adalimumab @abbvie","conversation_id":"740143943619383296","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T08:30:32.000Z","id":"740098605118279680","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":36,"end":47,"tag":"Pemetrexed"},{"start":48,"end":62,"tag":"FreseniusKabi"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends generic: #Pemetrexed #FreseniusKabi for malignant pleural mesothelioma, metastatic non-small cell lung cancer","conversation_id":"740098605118279680","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T08:10:12.000Z","id":"740093489178935296","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":79,"end":94,"username":"SunPharma_Live","id":"2879642113"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":35,"end":44,"tag":"medicine"},{"start":45,"end":56,"tag":"Bortezomib"},{"start":57,"end":65,"tag":"Hospira"},{"start":109,"end":117,"tag":"Myeloma"},{"start":134,"end":143,"tag":"Lymphoma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends generic #medicine #Bortezomib #Hospira , Bortezomib @SunPharma_Live, for Multiple #Myeloma &amp;MantleCell #Lymphoma","conversation_id":"740093489178935296","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T07:50:10.000Z","id":"740088445746483201","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":117,"end":131,"username":"ASTRAZENECAUK","id":"2900752222"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":31,"end":41,"tag":"medicines"},{"start":43,"end":49,"tag":"Qtern"},{"start":102,"end":106,"tag":"T2D"},{"start":107,"end":116,"tag":"mellitus"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends new #medicines. #Qtern (saxagliptin / dapagliflozin) for type two diabetes #T2D #mellitus @ASTRAZENECAUK","conversation_id":"740088445746483201","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T07:40:12.000Z","id":"740085940157349888","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":131,"username":"Merck","id":"35961145"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":31,"end":41,"tag":"medicines"},{"start":83,"end":88,"tag":"hepC"},{"start":90,"end":99,"tag":"Zepatier"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends new #medicines. Combination therapies chronic/long-term #hepC  #Zepatier (elbasvir / grazoprevir) @Merck","conversation_id":"740085940157349888","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-07T07:30:26.000Z","id":"740083479828942848","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":124,"end":139,"username":"GileadSciences","id":"309728693"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":31,"end":41,"tag":"medicines"},{"start":83,"end":88,"tag":"hepC"},{"start":89,"end":97,"tag":"Epclusa"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends new #medicines. Combination therapies chronic/long-term #hepC #Epclusa (sofosbuvir /velpatasvir) @GileadSciences","conversation_id":"740083479828942848","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-06T19:50:06.000Z","id":"739907234046545920","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":96,"end":103,"username":"abbvie","id":"531892451"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":37,"tag":"medicines"},{"start":77,"end":84,"tag":"Humira"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #CHMP recommends #medicines : extension of therapeutic indications #Humira adalimumab @abbvie","conversation_id":"739907234046545920","possibly_sensitive":false,"lang":"fr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3311856665","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-06T12:36:48.000Z","id":"739798193479655426","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/uHJTrvmVCZ","expanded_url":"http://www.pharmafocusasia.com/articles","display_url":"pharmafocusasia.com/articles"},{"start":111,"end":134,"url":"https://t.co/YzUceZu8mz","expanded_url":"https://twitter.com/pharmafocusasia/status/739798193479655426/photo/1","display_url":"pic.twitter.com/YzUceZu8mz"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_739798188614254592"]},"source":"Twitter Web Client","text":"@EMA_News ARE YOU A PHARMA FANATIC?SO ARE WE!PUBLISH UR ARTICLES IN OUR MAGAZINE NOW : https://t.co/uHJTrvmVCZ https://t.co/YzUceZu8mz","conversation_id":"739798193479655426","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2154682987","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-03T12:50:19.000Z","id":"738714431237029888","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/KEXUVYci01","expanded_url":"http://bit.ly/1VAT36y","display_url":"bit.ly/1VAT36y"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":21,"end":27,"tag":"heart"},{"start":54,"end":64,"tag":"Occlutech"},{"start":70,"end":73,"tag":"CE"},{"start":95,"end":103,"tag":"medical"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News Structural #heart disease implant developer #Occlutech wins #CE Mark for LAA occlude #medical - https://t.co/KEXUVYci01","conversation_id":"738714431237029888","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-03T11:21:08.000Z","id":"738691984559378432","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/tTyeQLjzQo","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/06/news_detail_002543.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":53,"tag":"medicines"},{"start":78,"end":85,"tag":"pharma"},{"start":86,"end":90,"tag":"HTA"},{"start":91,"end":96,"tag":"heor"},{"start":97,"end":108,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - Regulation of advanced therapy #medicines https://t.co/tTyeQLjzQo #pharma #HTA #heor #regulatory","conversation_id":"738691984559378432","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2834291205","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-03T11:16:42.000Z","id":"738690869654622208","entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/tTyeQLjzQo","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/06/news_detail_002543.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":53,"tag":"medicines"},{"start":78,"end":85,"tag":"pharma"},{"start":86,"end":90,"tag":"HTA"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News - Regulation of advanced therapy #medicines https://t.co/tTyeQLjzQo #pharma #HTA","conversation_id":"738690869654622208","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2834291205","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-03T10:45:21.000Z","id":"738682980764377088","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/EyslYu3xfq","expanded_url":"http://ow.ly/uJey300KnX1","display_url":"ow.ly/uJey300KnX1"},{"start":112,"end":135,"url":"https://t.co/6Azk45Ut8t","expanded_url":"https://twitter.com/TRACServices/status/738682980764377088/photo/1","display_url":"pic.twitter.com/6Azk45Ut8t"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":33,"username":"pfizer","id":"56488059"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_738682978885373953"]},"source":"Hootsuite","text":"@EMA_News approves MA for @pfizer treatment for life-threatening disease in adolescents https://t.co/EyslYu3xfq https://t.co/6Azk45Ut8t","conversation_id":"738682980764377088","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"197435213","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-03T08:24:18.000Z","id":"738647483262308352","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/03K7smUpgT","expanded_url":"http://bit.ly/1sRdkcD","display_url":"bit.ly/1sRdkcD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":63,"end":80,"tag":"Immunodeficiency"},{"start":81,"end":89,"tag":"Disease"},{"start":102,"end":106,"tag":"Bio"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  approves Groundbreaking Gene Therapy for Super Rare #Immunodeficiency #Disease in Children #Bio- https://t.co/03K7smUpgT","conversation_id":"738647483262308352","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-02T15:44:14.000Z","id":"738395808039587842","entities":{"urls":[{"start":35,"end":58,"url":"https://t.co/lwzNhfgkWn","expanded_url":"http://www.researchcareers.com","display_url":"researchcareers.com"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News POST RESEARCH JOBS FREE! https://t.co/lwzNhfgkWn","conversation_id":"738395808039587842","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"547050678","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-02T14:30:21.000Z","id":"738377214849372160","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/wYZQuhNHnL","expanded_url":"http://ow.ly/V3if300Qr3y","display_url":"ow.ly/V3if300Qr3y"},{"start":116,"end":139,"url":"https://t.co/BFfooQposN","expanded_url":"https://twitter.com/EuropaBio/status/738377214849372160/photo/1","display_url":"pic.twitter.com/BFfooQposN"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":25,"tag":"PRIME"},{"start":45,"end":55,"tag":"medicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_738377211925909504"]},"source":"Hootsuite","text":"@EMA_News to grant #PRIME treatment to 4 new #medicines. See their statistics for more info https://t.co/wYZQuhNHnL https://t.co/BFfooQposN","conversation_id":"738377214849372160","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-02T11:00:31.000Z","id":"738324408780115969","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/PKI7r6WzzY","expanded_url":"https://twitter.com/EMA_News/status/736124769880408064","display_url":"twitter.com/EMA_News/statu…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":74,"tag":"clinicaltrial"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News begins EU-wide reflection on necessary changes to #clinicaltrial best practices https://t.co/PKI7r6WzzY","conversation_id":"738324408780115969","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"728526095352467456","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"736124769880408064"}]},{"created_at":"2016-06-01T22:58:17.000Z","id":"738142653926113282","entities":{"urls":[{"start":62,"end":85,"url":"https://t.co/uhsczcf6x3","expanded_url":"http://www.medscape.com/viewarticle/863944?src=soc_tw_160601-PM_mscpedt_news_mednews","display_url":"medscape.com/viewarticle/86…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":90,"end":99,"username":"Medscape","id":"16892009"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News Launches Major Review After Fatal French Drug Trial https://t.co/uhsczcf6x3 via @Medscape","conversation_id":"738142653926113282","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"28824136","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-06-01T16:10:22.000Z","id":"738040000751775744","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/YvBnWcFkRr","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/06/news_detail_002541.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":76,"end":82,"tag":"PRIME"}],"annotations":[{"start":50,"end":74,"probability":0.4418,"type":"Other","normalized_text":"Medicamentos Prioritarios"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News publica las primeras estadisticas sobre Medicamentos Prioritarios #PRIME [ENG] https://t.co/YvBnWcFkRr","conversation_id":"738040000751775744","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"1488143666","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-31T13:32:44.000Z","id":"737637943163117569","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/LhxjDXJ14b","expanded_url":"https://twitter.com/Wolf_S_Punk/status/737637943163117569/photo/1","display_url":"pic.twitter.com/LhxjDXJ14b"},{"start":114,"end":137,"url":"https://t.co/LhxjDXJ14b","expanded_url":"https://twitter.com/Wolf_S_Punk/status/737637943163117569/photo/1","display_url":"pic.twitter.com/LhxjDXJ14b"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":91,"end":98,"tag":"Lariam"},{"start":99,"end":105,"tag":"Roche"},{"start":106,"end":113,"tag":"Pharma"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_737637940101275648","3_737637941384740864"]},"source":"Twitter Web Client","text":"@EMA_News Where is the word \"permanent\" lost? The \"persistance\" is just half of the truth. #Lariam #Roche #Pharma https://t.co/LhxjDXJ14b","conversation_id":"737637943163117569","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-29T10:25:18.000Z","id":"736865996628238337","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/wECclz8nbL","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/05/news_detail_002538.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":124,"end":133,"tag":"Biotrial"},{"start":134,"end":139,"tag":"Bial"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News has started review of guidelines on phase I clinical trials after fatal French drug trial https://t.co/wECclz8nbL #Biotrial #Bial","conversation_id":"736865996628238337","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2826292747","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-28T08:14:57.000Z","id":"736470806079889408","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/Ib4BHopcOj","expanded_url":"http://blogs.biomedcentral.com/on-medicine/2016/05/27/safeguarding-privacy-clinical-trial-patients/","display_url":"blogs.biomedcentral.com/on-medicine/20…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":24,"end":33,"username":"SamHamMW","id":"2407513628"}],"hashtags":[{"start":10,"end":18,"tag":"CORERef"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #CORERef Read @SamHamMW's blog for patients, doctors &amp; researchers: https://t.co/Ib4BHopcOj","conversation_id":"736470806079889408","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2407513628","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-27T10:37:51.000Z","id":"736144379350556672","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/MG8dFpMjqV","expanded_url":"https://shar.es/1dKvqt","display_url":"shar.es/1dKvqt"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":59,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News Proposes More Structured Convergence With @US_FDA on Pharma Regulations https://t.co/MG8dFpMjqV via RAPS","conversation_id":"736144379350556672","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4054478777","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-27T10:14:28.000Z","id":"736138494121250816","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/1MwwPVZ03J","expanded_url":"https://twitter.com/YNatsis/status/736133095305383936","display_url":"twitter.com/YNatsis/status…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News proposes to drastically cut-back safety/efficacy med tests for early market access = +pharma profits.  https://t.co/1MwwPVZ03J","conversation_id":"736138494121250816","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"18483956","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"quoted","id":"736133095305383936"}]},{"created_at":"2016-05-27T08:33:18.000Z","id":"736113034150694912","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/7J3IK1qbZN","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/05/news_detail_002536.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":116,"end":139,"url":"https://t.co/j1FmP20pPc","expanded_url":"https://twitter.com/Finnpal/status/736113034150694912/photo/1","display_url":"pic.twitter.com/j1FmP20pPc"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":27,"tag":"colistin"},{"start":111,"end":115,"tag":"AMR"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_736113033211215872"]},"source":"Twitter Web Client","text":"@EMA_News: Use of #colistin in animals should be reduced to manage risk of resistance  https://t.co/7J3IK1qbZN #AMR https://t.co/j1FmP20pPc","conversation_id":"736113034150694912","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"254470222","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-26T16:11:56.000Z","id":"735866065880748032","entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/syUTfMMmkp","expanded_url":"http://www.fiercebiotech.com/biotech/trial-rules-to-be-tightened-after-fatal-french-drug-study","display_url":"fiercebiotech.com/biotech/trial-…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":50,"end":56,"tag":"trial"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to hold major review after fatal French #trial  https://t.co/syUTfMMmkp","conversation_id":"735866065880748032","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"467280533","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-20T06:30:31.000Z","id":"733545419871911936","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/s2mejkFper","expanded_url":"http://ow.ly/uP4v300kvcO","display_url":"ow.ly/uP4v300kvcO"},{"start":119,"end":142,"url":"https://t.co/WEB34HZEqC","expanded_url":"https://twitter.com/EuropaBio/status/733545419871911936/photo/1","display_url":"pic.twitter.com/WEB34HZEqC"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":67,"tag":"pharma"},{"start":107,"end":118,"tag":"Healthcare"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_733545419272159233"]},"source":"Hootsuite","text":"@EMA_News looks back w/ pride &amp; optimism at the growing #pharma market https://t.co/s2mejkFper Dvlping #Healthcare https://t.co/WEB34HZEqC","conversation_id":"733545419871911936","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-19T15:19:22.000Z","id":"733316123211534336","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/myVBa6siHr","expanded_url":"http://bit.ly/1suPNhd","display_url":"bit.ly/1suPNhd"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":129,"username":"cancereu","id":"140344419"},{"start":130,"end":140,"username":"esmart_eu","id":"2472092443"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News publishes new guidance on the use of PROs in clinical studies of anticancer medicines https://t.co/myVBa6siHr @cancereu @esmart_eu","conversation_id":"733316123211534336","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"187453356","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-19T14:30:38.000Z","id":"733303857099485185","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/1oZhzwrlMc","expanded_url":"http://ow.ly/Oc5f300kowb","display_url":"ow.ly/Oc5f300kowb"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":49,"tag":"healthcare"},{"start":130,"end":143,"tag":"biotech4life"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News's scientific advice - key 4 #healthcare companies &amp; their innovative medicines, report says https://t.co/1oZhzwrlMc #biotech4life","conversation_id":"733303857099485185","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-18T15:50:22.000Z","id":"732961536562593792","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/PMTomZMijP","expanded_url":"http://bit.ly/1sxjO0u","display_url":"bit.ly/1sxjO0u"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":108,"end":115,"tag":"pharma"}],"annotations":[{"start":19,"end":33,"probability":0.5728,"type":"Person","normalized_text":"Portuguese Bial"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  accepts Portuguese Bial’s submission for Zebinix use as a monotherapy for partial-onset seizures #pharma- https://t.co/PMTomZMijP","conversation_id":"732961536562593792","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-16T08:05:27.000Z","id":"732119761266573312","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/XNWvWL1v8h","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/05/news_detail_002528.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":45,"end":63,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp; PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 10-13 May 2016 more at https://t.co/XNWvWL1v8h","conversation_id":"732119761266573312","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-15T17:07:15.000Z","id":"731893720363237376","entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/3cyNqRYiUo","expanded_url":"https://twitter.com/joanne4142/status/731883997685534720","display_url":"twitter.com/joanne4142/sta…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News https://t.co/3cyNqRYiUo","conversation_id":"731893720363237376","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"39797707","in_reply_to_user_id":"116716199","geo":{"place_id":"15d90627b230db4d"},"referenced_tweets":[{"type":"quoted","id":"731883997685534720"}]},{"created_at":"2016-05-12T12:03:11.000Z","id":"730730037440356352","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"juangarcia","id":"14217181"},{"start":94,"end":108,"username":"Official_EMWA","id":"215785753"},{"start":109,"end":117,"username":"turacoz","id":"2576232176"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for Android","text":"@EMA_News @juangarcia describing transparency in clinical trials and new updates coming up at @Official_EMWA @turacoz @TuracozTraining","conversation_id":"730730037440356352","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"28064259","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-05T10:16:24.000Z","id":"728166447436816384","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/Z8dvvGkJ4g","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/04/news_detail_002523.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News: marketing authorisation for ceftazidime/avibactam against multi-drug resistant bacteria\nhttps://t.co/Z8dvvGkJ4g","conversation_id":"728166447436816384","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"254470222","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-04T20:58:00.000Z","id":"727965522873208832","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/7SoeLZC8eZ","expanded_url":"https://twitter.com/Wolf_S_Punk/status/727965522873208832/photo/1","display_url":"pic.twitter.com/7SoeLZC8eZ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"Roche","id":"20815041"}],"hashtags":[{"start":68,"end":79,"tag":"Mefloquine"},{"start":80,"end":87,"tag":"Lariam"},{"start":88,"end":106,"tag":"Pharmacovigilance"},{"start":107,"end":112,"tag":"psur"},{"start":113,"end":116,"tag":"eu"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_727965521807855616"]},"source":"Twitter Web Client","text":"@EMA_News @Roche No news in this already the 4th year ongoing case?\n#Mefloquine #Lariam #Pharmacovigilance #psur #eu https://t.co/7SoeLZC8eZ","conversation_id":"727965522873208832","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":1,"quote_count":0},"author_id":"1171771501","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-03T22:30:45.000Z","id":"727626475671834624","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/XqblFvjZQg","expanded_url":"http://ow.ly/4naG28","display_url":"ow.ly/4naG28"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News   latest draft guideline describes required documentation for a marketing authorization application. https://t.co/XqblFvjZQg","conversation_id":"727626475671834624","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"3331528055","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-03T11:57:36.000Z","id":"727467141931343872","entities":{"urls":[{"start":27,"end":50,"url":"https://t.co/qn4niKIZ7G","expanded_url":"http://bit.ly/1QQfRaX","display_url":"bit.ly/1QQfRaX"},{"start":72,"end":95,"url":"https://t.co/0ZeOgkhx9y","expanded_url":"http://www.core-reference.org","display_url":"core-reference.org"},{"start":110,"end":133,"url":"https://t.co/7MP8OEdpFE","expanded_url":"http://bit.ly/1Z6q49h","display_url":"bit.ly/1Z6q49h"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"CORERef"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #CORERef launch: https://t.co/qn4niKIZ7G; CSR authoring tool: https://t.co/0ZeOgkhx9y; Publication: https://t.co/7MP8OEdpFE","conversation_id":"727467141931343872","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2407513628","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-03T11:50:10.000Z","id":"727465271020130304","entities":{"urls":[{"start":51,"end":74,"url":"https://t.co/FFhm8BGJzw","expanded_url":"http://bit.ly/1Y4B7j9","display_url":"bit.ly/1Y4B7j9"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  Finalizes Process Validation Guidance - https://t.co/FFhm8BGJzw","conversation_id":"727465271020130304","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"713848298","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-03T11:26:04.000Z","id":"727459203560968196","entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/OBeeIoafOx","expanded_url":"http://bit.ly/1Y4XKnw","display_url":"bit.ly/1Y4XKnw"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":21,"end":28,"username":"biogen","id":"155650832"}],"hashtags":[{"start":70,"end":73,"tag":"MS"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"TweetDeck","text":"@EMA_News recommends @biogen ’s multiple sclerosis treatment Zinbryta #MS https://t.co/OBeeIoafOx","conversation_id":"727459203560968196","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"717709153616138240","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-05-03T05:55:35.000Z","id":"727376036212690946","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/JV8HV1Dq29","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/04/news_detail_002523.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":99,"end":122,"url":"https://t.co/UJu6SjNifB","expanded_url":"https://twitter.com/Scienceconsult/status/727376036212690946/photo/1","display_url":"pic.twitter.com/UJu6SjNifB"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_727376034438348800"]},"source":"Twitter Web Client","text":"@EMA_News announces new medicine in fight against antimicrobial resistance https://t.co/JV8HV1Dq29 https://t.co/UJu6SjNifB","conversation_id":"727376036212690946","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"298344031","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-28T08:07:03.000Z","id":"725597182787784705","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/L2dQUEYvj4","expanded_url":"http://goo.gl/4BOC8I","display_url":"goo.gl/4BOC8I"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":73,"tag":"tumore"},{"start":78,"end":84,"tag":"colon"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News approva combinazione trifluridina e tipiracil contro il #tumore del #colon https://t.co/L2dQUEYvj4","conversation_id":"725597182787784705","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"702444481006706688","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-28T08:05:53.000Z","id":"725596888028876800","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/BWYfvOSn9M","expanded_url":"http://goo.gl/4BOC8I","display_url":"goo.gl/4BOC8I"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":73,"tag":"tumore"},{"start":78,"end":84,"tag":"colon"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News approva combinazione trifluridina e tipiracil contro il #tumore del #colon https://t.co/BWYfvOSn9M","conversation_id":"725596888028876800","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"295555896","in_reply_to_user_id":"116716199","geo":{"place_id":"c799e2d3a79f810e"},"referenced_tweets":{}},{"created_at":"2016-04-27T12:04:26.000Z","id":"725294530312941569","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/L2dQUEYvj4","expanded_url":"http://goo.gl/4BOC8I","display_url":"goo.gl/4BOC8I"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":73,"tag":"tumore"},{"start":78,"end":86,"tag":"polmone"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News approva combinazione trifluridina e tipiracil contro il #tumore del #polmone https://t.co/L2dQUEYvj4","conversation_id":"725294530312941569","possibly_sensitive":false,"lang":"it","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"702444481006706688","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-26T08:25:36.000Z","id":"724877074066976768","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/Z7tZGxTLiu","expanded_url":"http://ow.ly/4n6aMU","display_url":"ow.ly/4n6aMU"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":68,"end":79,"username":"CTCatapult","id":"940559888266219520"}],"hashtags":[{"start":80,"end":95,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News publishes draft guideline on medicinal product sterility. @CTCatapult #Regulatorynews https://t.co/Z7tZGxTLiu","conversation_id":"724877074066976768","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"845904529","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-25T16:15:04.000Z","id":"724632832551849984","entities":{"urls":[{"start":41,"end":64,"url":"https://t.co/1gbBno1mV2","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000002.jsp&mid=","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":21,"tag":"Healthcare"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News #Healthcare prof pages updated https://t.co/1gbBno1mV2","conversation_id":"724632832551849984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-25T16:13:46.000Z","id":"724632503143813121","entities":{"urls":[{"start":45,"end":68,"url":"https://t.co/VhfOoiflGl","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000001.jsp&mid","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":27,"tag":"Patients"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Updated #Patients and carers pages https://t.co/VhfOoiflGl","conversation_id":"724632503143813121","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-25T13:01:50.000Z","id":"724584201081769984","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/bpa1SFmPQm","expanded_url":"http://ow.ly/4n3Q9U","display_url":"ow.ly/4n3Q9U"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":96,"username":"CTCatapult","id":"940559888266219520"}],"hashtags":[{"start":97,"end":112,"tag":"Regulatorynews"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News publishes a draft reflection paper on development of paediatric medicines. @CTCatapult #Regulatorynews https://t.co/bpa1SFmPQm","conversation_id":"724584201081769984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"845904529","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-21T15:05:23.000Z","id":"723165744607928320","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/1AoSERNe0C","expanded_url":"http://bit.ly/1Wemfjc","display_url":"bit.ly/1Wemfjc"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":108,"end":116,"tag":"DIA2016"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News Sr Medical Officer and meeting co-chair explains marketplace of “golden nugget” ideas awaiting at #DIA2016 https://t.co/1AoSERNe0C","conversation_id":"723165744607928320","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"28870127","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-21T13:41:08.000Z","id":"723144541637734401","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/axJiBzmmxb","expanded_url":"http://bit.ly/1WHvDwj","display_url":"bit.ly/1WHvDwj"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News publishes draft guidelines on sterilisation of medicinal products. Read more: https://t.co/axJiBzmmxb","conversation_id":"723144541637734401","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2968453613","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-21T11:26:12.000Z","id":"723110585479487488","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/4IhR96oj94","expanded_url":"https://twitter.com/WEBRADR/status/723110585479487488/photo/1","display_url":"pic.twitter.com/4IhR96oj94"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":47,"username":"WEBRADR","id":"2797520425"}],"hashtags":[{"start":99,"end":115,"tag":"WEBRADRassembly"}],"annotations":[{"start":11,"end":27,"probability":0.7877,"type":"Person","normalized_text":"Victoria Newbould"}],"cashtags":{}},"attachments":{"media_keys":["3_723110583550238720"]},"source":"Twitter Web Client","text":"@EMA_News' Victoria Newbould speaks of @WEBRADR next steps - policy framework with recommendations #WEBRADRassembly https://t.co/4IhR96oj94","conversation_id":"723110585479487488","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2797520425","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-21T07:50:59.000Z","id":"723056421970022400","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/tc6aqqGx2g","expanded_url":"https://twitter.com/kardamyla/status/723056421970022400/photo/1","display_url":"pic.twitter.com/tc6aqqGx2g"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":24,"end":35,"username":"eupatients","id":"465674067"}],"hashtags":[{"start":36,"end":44,"tag":"raising"},{"start":45,"end":55,"tag":"awareness"},{"start":56,"end":76,"tag":"patient_involvement"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_723056409626181633"]},"source":"Twitter for iPhone","text":"@EMA_News Nathalie Bere @eupatients #raising #awareness #patient_involvement in Barcelona https://t.co/tc6aqqGx2g","conversation_id":"723056421970022400","possibly_sensitive":false,"lang":"ro","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-20T15:01:31.000Z","id":"722802382619459584","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/InsAe6ggXQ","expanded_url":"http://ow.ly/4mSyQ3","display_url":"ow.ly/4mSyQ3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":14,"tag":"EMA"},{"start":72,"end":90,"tag":"fármacoshuérfanos"}],"annotations":[{"start":62,"end":69,"probability":0.2812,"type":"Person","normalized_text":"Alprolix"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News #EMA recomienda mantener la designación huérfana de Alprolix. #fármacoshuérfanos https://t.co/InsAe6ggXQ","conversation_id":"722802382619459584","possibly_sensitive":false,"lang":"es","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"190171304","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-20T09:59:20.000Z","id":"722726336821882880","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/ubAiTQtQA7","expanded_url":"https://twitter.com/kardamyla/status/722726336821882880/photo/1","display_url":"pic.twitter.com/ubAiTQtQA7"},{"start":113,"end":136,"url":"https://t.co/ubAiTQtQA7","expanded_url":"https://twitter.com/kardamyla/status/722726336821882880/photo/1","display_url":"pic.twitter.com/ubAiTQtQA7"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":46,"tag":"WONCA"},{"start":54,"end":59,"tag":"UEMO"},{"start":60,"end":65,"tag":"EFPC"},{"start":87,"end":94,"tag":"better"},{"start":102,"end":112,"tag":"medicines"}],"annotations":[{"start":47,"end":52,"probability":0.8895,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"attachments":{"media_keys":["3_722726334976389120","3_722726335496523776"]},"source":"Twitter Web Client","text":"@EMA_News Meeting GPs/Family Physicians #WONCA-Europe #UEMO #EFPC working together for #better use of #medicines https://t.co/ubAiTQtQA7","conversation_id":"722726336821882880","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"59722141","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-19T12:43:12.000Z","id":"722405186254303232","entities":{"urls":[{"start":62,"end":85,"url":"https://t.co/bc0LzDD4gr","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/04/18/ema-erweitert-uberprufung-neuer-hepatitis-c-arzneimittel","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"},{"start":86,"end":109,"url":"https://t.co/jd28K81M1F","expanded_url":"https://twitter.com/DAZheute/status/722405186254303232/photo/1","display_url":"pic.twitter.com/jd28K81M1F"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":["3_722405184144601088"]},"source":"Twitter Web Client","text":"@EMA_News erweitert Überprüfung von Hepatitis C-Arzneimitteln https://t.co/bc0LzDD4gr https://t.co/jd28K81M1F","conversation_id":"722405186254303232","possibly_sensitive":false,"lang":"de","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2789645880","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-18T19:43:45.000Z","id":"722148633601294336","entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/GM5HiDb6SV","expanded_url":"https://twitter.com/fimmgnotizie/status/722148633601294336/photo/1","display_url":"pic.twitter.com/GM5HiDb6SV"},{"start":70,"end":93,"url":"https://t.co/GM5HiDb6SV","expanded_url":"https://twitter.com/fimmgnotizie/status/722148633601294336/photo/1","display_url":"pic.twitter.com/GM5HiDb6SV"},{"start":70,"end":93,"url":"https://t.co/GM5HiDb6SV","expanded_url":"https://twitter.com/fimmgnotizie/status/722148633601294336/photo/1","display_url":"pic.twitter.com/GM5HiDb6SV"},{"start":70,"end":93,"url":"https://t.co/GM5HiDb6SV","expanded_url":"https://twitter.com/fimmgnotizie/status/722148633601294336/photo/1","display_url":"pic.twitter.com/GM5HiDb6SV"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":21,"end":35,"probability":0.9247,"type":"Person","normalized_text":"Walter Marrocco"},{"start":59,"end":64,"probability":0.9971,"type":"Place","normalized_text":"London"}],"cashtags":{}},"attachments":{"media_keys":["3_722148568652451845","3_722148569222918144","3_722148569805950976","3_722148570258911232"]},"source":"Twitter for iPad","text":"@EMA_News \nEMA &amp; GPs\nWalter Marrocco presenting meeting in London https://t.co/GM5HiDb6SV","conversation_id":"722148633601294336","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2354558196","in_reply_to_user_id":"116716199","geo":{"place_id":"08be9e4ebe3d037d"},"referenced_tweets":{}},{"created_at":"2016-04-18T15:15:20.000Z","id":"722081084876406784","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/TuEwsLLi66","expanded_url":"http://europa.eu/!wR66Tq","display_url":"europa.eu/!wR66Tq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":25,"username":"EUnetHTA","id":"56493220"},{"start":124,"end":134,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":91,"end":95,"tag":"HTA"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News &amp; @EUnetHTA: synergies between regulators &amp; health technology assessment #HTA https://t.co/TuEwsLLi66 via @EU_Health","conversation_id":"722081084876406784","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1588972196","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-18T10:40:06.000Z","id":"722011818680590336","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/1OoDN5yCJq","expanded_url":"http://ow.ly/4mJyZD","display_url":"ow.ly/4mJyZD"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":17,"end":26,"username":"EUnetHTA","id":"56493220"}],"hashtags":[{"start":88,"end":95,"tag":"health"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  &amp; @EUnetHTA  will continue their collaboration for the benefit of public #health in the EU https://t.co/1OoDN5yCJq","conversation_id":"722011818680590336","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"19642657","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-18T07:20:21.000Z","id":"721961549166940160","entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/zw59ZPvcLf","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002489.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"PRAC"},{"start":44,"end":62,"tag":"Pharmacovigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News &amp;PR: Meeting highlights #PRAC #Pharmacovigilance Risk Assessment Committee 11-14 April 2016 more at: \n  https://t.co/zw59ZPvcLf","conversation_id":"721961549166940160","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2615562036","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-15T13:21:13.000Z","id":"720965202565545984","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/Y2YvW8I3Dg","expanded_url":"http://bit.ly/1Nst7SY","display_url":"bit.ly/1Nst7SY"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News to test run public hearings at its pharmacovigilance committee meeting in July https://t.co/Y2YvW8I3Dg","conversation_id":"720965202565545984","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"21854075","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-15T07:22:17.000Z","id":"720874871400435712","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/2FPmXxtSxM","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2016/02/WC500200827.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":82,"tag":"academia"},{"start":94,"end":104,"tag":"medicines"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Consultation on the proposal of a collaboration framework with #academia ends today #medicines\nhttps://t.co/2FPmXxtSxM","conversation_id":"720874871400435712","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"612922732","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-15T07:18:21.000Z","id":"720873882953977856","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":89,"username":"monmouthpartner","id":"1550423300"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Could you outline how patients contribute to your work please? @monmouthpartner","conversation_id":"720873882953977856","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"612922732","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-14T22:49:43.000Z","id":"720745881473933312","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/yPadgjG9Hv","expanded_url":"https://lnkd.in/ebsnjEJ","display_url":"lnkd.in/ebsnjEJ"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":88,"end":115,"probability":0.4416,"type":"Other","normalized_text":"EU Clinical Trial Regulation"}],"cashtags":{}},"attachments":{"media_keys":{}},"source":"LinkedIn","text":"@EMA_News at this workshop, a panel debate on pediatric clinical trials in light of new EU Clinical Trial Regulation https://t.co/yPadgjG9Hv","conversation_id":"720745881473933312","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"author_id":"102471765","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-14T20:41:24.000Z","id":"720713590085443585","entities":{"urls":[{"start":37,"end":60,"url":"https://t.co/SaPrOPRV6T","expanded_url":"http://standardissuemagazine.com/in-the-news/not-suitable-for-minors/","display_url":"standardissuemagazine.com/in-the-news/no…"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News Child suicide prevention...https://t.co/SaPrOPRV6T","conversation_id":"720713590085443585","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"361108851","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-14T19:27:56.000Z","id":"720695102012792833","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/C2OiFYFkhx","expanded_url":"http://youtu.be/O5sJViuLkcI","display_url":"youtu.be/O5sJViuLkcI"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News أنا أحب الخير لكامل الناس و مانديرش العيب..نولي و ماسمحتش .كيف كيف انا و جمال..و..https://t.co/C2OiFYFkhx .NIGRO","conversation_id":"720695102012792833","possibly_sensitive":false,"lang":"ar","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"714506036250611712","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-14T16:05:56.000Z","id":"720644266524065793","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/8MyPa01tPh","expanded_url":"http://ow.ly/10FnXK","display_url":"ow.ly/10FnXK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News got an html 'Appendix V' list of national reporting agencies to link to? https://t.co/8MyPa01tPh is a .doc with tracked changes","conversation_id":"720644266524065793","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"2902360799","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-11T06:52:18.000Z","id":"719417777711411200","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":132,"end":141,"username":"AEMPSGOB","id":"326845755"}],"hashtags":[{"start":17,"end":35,"tag":"Pharmacovigilance"},{"start":116,"end":131,"tag":"EudraVigilance"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News Begins #Pharmacovigilance Training Courses to help companies &amp; regulators meet obligations when using #EudraVigilance @AEMPSGOB","conversation_id":"719417777711411200","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"2715091074","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-08T12:37:48.000Z","id":"718417561856159745","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":51,"end":64,"username":"SIContraccez","id":"2775766509"},{"start":65,"end":80,"username":"ValueRelations","id":"2911124620"}],"hashtags":[{"start":45,"end":50,"tag":"Pisa"},{"start":82,"end":91,"tag":"SICdocet"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News coc's benefits are more than risks #Pisa @SIContraccez @ValueRelations  #SICdocet","conversation_id":"718417561856159745","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"author_id":"1150345548","in_reply_to_user_id":"116716199","geo":{"place_id":"af51e8f00db663de"},"referenced_tweets":{}},{"created_at":"2016-04-08T08:55:14.000Z","id":"718361550403289088","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"DIA_Europe","id":"271864727"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter for iPhone","text":"@EMA_News @DIA_Europe","conversation_id":"718360747479343104","possibly_sensitive":false,"lang":"und","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"4415909123","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":[{"type":"replied_to","id":"718360747479343104"}]},{"created_at":"2016-04-07T10:13:36.000Z","id":"718018883563753472","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/49sRduA0zl","expanded_url":"http://ow.ly/10oixX","display_url":"ow.ly/10oixX"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":69,"end":82,"tag":"palonosetron"}],"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Hootsuite","text":"@EMA_News  recommends granting a marketing authorisation for generic #palonosetron https://t.co/49sRduA0zl","conversation_id":"718018883563753472","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"69232855","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}},{"created_at":"2016-04-07T10:08:05.000Z","id":"718017495534321664","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{},"cashtags":{}},"attachments":{"media_keys":{}},"source":"Twitter Web Client","text":"@EMA_News could you share the report on the EMA-HTA pilot please? Thank you :-)","conversation_id":"718017495534321664","possibly_sensitive":false,"lang":"en","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"author_id":"810969654","in_reply_to_user_id":"116716199","geo":{},"referenced_tweets":{}}]
